----------
Model: gpt-4o-mini
Temperature: 0.5
Embedding model: avsolatorio/GIST-small-Embedding-v0
Prompt: input_variables=['agent_scratchpad', 'options', 'question', 'tool_names', 'tools'] input_types={} partial_variables={} messages=[HumanMessagePromptTemplate(prompt=PromptTemplate(input_variables=['agent_scratchpad', 'options', 'question', 'tool_names', 'tools'], input_types={}, partial_variables={}, template='Solve the question answering task alternating between Question, Thought, Action, Input and Observation steps.\nYou only have access to the following tools: {tools}\n\nUse the following format:\nQuestion: the input question you must answer.\nOptions: a list of possible answers to the question.\nThought: you should always think about what to do.\nAction: the action to take, must be one of [{tool_names}]. If no action is needed, return your Final answer instead.\nAction Input: the input to the action.\nObservation: the output of the action.\n(this Thought/Action/Action Input/Observation can repeat any number of times)\n\nFinal Answer: provide the right alternative (one of A, B, C, or D).\n\nBegin!\nQuestion: {question}\nOptions: {options}\nThought: {agent_scratchpad}'), additional_kwargs={})]
----------
[{"0": {"question": "A 35-year-old woman comes to your office with a variety of complaints. As part of her evaluation, she undergoes laboratory testing which reveals the presence of anti-centromere antibodies. All of the following symptoms and signs would be expected to be present EXCEPT:", "options": {"A": "Pallor, cyanosis, and erythema of the hands", "B": "Blanching vascular abnormalities", "C": "Hypercoagulable state", "D": "Heartburn and regurgitation"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "anti-centromere antibodies symptoms limited scleroderma CREST syndrome\"\n", "log": "The presence of anti-centromere antibodies is typically associated with limited scleroderma (also known as CREST syndrome), which can manifest with symptoms like skin changes, esophageal motility issues, and vascular problems. I need to determine which of the provided options is least likely to be associated with this condition.\n\nAction: search_docs\nAction Input: \"anti-centromere antibodies symptoms limited scleroderma CREST syndrome\"\n", "type": "AgentAction"}}, "has been termed the CREST syndrome. Centromere antibodies have been reported in a very high percentage of patients with the CREST syndrome but in only a small minority of patients with scleroderma. Skin biopsy reveals thickening of the dermis and homogenization of collagen bundles. Direct\n\nRF and ANA may be .\n\nAnticentromere antibodies are specific for CREST syndrome (see Table 2.9-4).\n\nAnti-Scl-70 (antitopoisomerase 1) antibodies are associated with diffuse disease and a poor prognosis (see Table 2.9-4).\n\nEosinophilia may be seen.\n\nLimited scleroderma\u2014limited skin involvement confined to fingers and face. Also with CREST syndrome: Calcinosis cutis C , anti-Centromere antibody, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia. More benign clinical course."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "CREST syndrome hypercoagulable state association\"\n", "log": "The information retrieved indicates that anti-centromere antibodies are specific for CREST syndrome, which includes symptoms like calcinosis, Raynaud's phenomenon, esophageal dysmotility, and telangiectasia. The symptoms listed in the options include vascular abnormalities and gastrointestinal symptoms, which align with CREST syndrome. However, a hypercoagulable state is not typically associated with this condition.\n\nAction: search_docs\nAction Input: \"CREST syndrome hypercoagulable state association\"\n", "type": "AgentAction"}}, "associated hypercoagulability state (factor V Leiden).\n\nsyndrome, which probably requires long-term anticoagulation to\n\nExam may reveal symmetric thickening of the skin of face and/or distal extremities.\n\nCREST syndrome involves Calcinosis, Raynaud\u2019s phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasias.\n\n(lupus cerebritis,"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "limited scleroderma CREST syndrome symptoms overview\"\n", "log": "The retrieved information suggests that while CREST syndrome is associated with various symptoms such as calcinosis and esophageal dysmotility, there is no mention of a hypercoagulable state being a typical feature of this condition. In fact, it seems to be a more generic concern that may not specifically relate to CREST syndrome. \n\nAction: search_docs\nAction Input: \"limited scleroderma CREST syndrome symptoms overview\"\n", "type": "AgentAction"}}, "Limited scleroderma\u2014limited skin involvement confined to fingers and face. Also with CREST syndrome: Calcinosis cutis C , anti-Centromere antibody, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia. More benign clinical course.\n\nLimited systemic sclerosis, with relatively mild skin involvement, often confined to the fingers and face. Involvement of the viscera occurs late, so the disease generally follows a fairly benign course. This presentation also is called CREST syndrome because of its frequent features of calcinosis,\n\nAlso called systemic sclerosis; characterized by in\ufb02ammation that leads to progressive tissue fibrosis through excessive deposition of type I and type III collagen. Commonly manifests as CREST syndrome (limited form), but can also occur in a diffuse form involving the skin as well as the GI, GU,"]]},"1": {"question": "An 8-year-old boy is brought to the pediatrician because his mother is concerned about recent behavioral changes. His mother states that she has started to notice that he is slurring his speech and seems to be falling more than normal. On exam, the pediatrician observes the boy has pes cavus, hammer toes, and kyposcoliosis. Based on these findings, the pediatrician is concerned the child has a trinucleotide repeat disease. Which of the following trinucleotide repeats is this child most likely to possess?", "options": {"A": "CGG", "B": "GAA", "C": "CAG", "D": "GCC"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Friedreich's ataxia symptoms and trinucleotide repeat", "log": "The symptoms presented by the boy, including slurred speech, falling more than normal, pes cavus, hammer toes, and kyphoscoliosis, suggest a possible trinucleotide repeat disorder. The most common trinucleotide repeat disorders include Fragile X syndrome (CGG), Friedreich's ataxia (GAA), Huntington's disease (CAG), and possibly others. The combination of neurological symptoms and skeletal deformities points towards Friedreich's ataxia, which is associated with GAA repeats. \n\nAction: search_docs  \nAction Input: \"Friedreich's ataxia symptoms and trinucleotide repeat\"  ", "type": "AgentAction"}}, "Friedreich ataxia is a relentlessly progressive, autosomalrecessive disorder. Children present in the late elementary yearswith ataxia, dysmetria, dysarthria, diminished proprioceptionand vibration, absent deep tendon reflexes, and nystagmus,and many develop hypertrophic cardiomyopathy and\n\nthe shared clinical features with Friedreich ataxia are unmistakable and create diagnostic confusion before genetic testing.\n\nMore than 50% of human DNA appears as repeat sequences, two or three bases repeated over and over again. Disorders caused by expansion of trinucleotide repeats include Fragile X syndrome, Huntington disease, myotonic dystrophy, Friedreich ataxia, and the spinocerebellar ataxias. Although an"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "trinucleotide repeat disorders overview", "log": "The information confirms that Friedreich's ataxia is associated with the GAA trinucleotide repeat. The symptoms noted in the boy, such as ataxia (falling), dysarthria (slurred speech), and skeletal deformities (pes cavus, hammer toes, kyphoscoliosis), align with those typically seen in Friedreich's ataxia. \n\nAction: search_docs  \nAction Input: \"trinucleotide repeat disorders overview\"  ", "type": "AgentAction"}}, "More than 50% of human DNA appears as repeat sequences, two or three bases repeated over and over again. Disorders caused by expansion of trinucleotide repeats include Fragile X syndrome, Huntington disease, myotonic dystrophy, Friedreich ataxia, and the spinocerebellar ataxias. Although an\n\nFragile X syndrome is the prototype of diseases in which the causative mutation occurs in a long repeating sequence of three nucleotides. Other examples of diseases associated with trinucleotide repeat mutations are Huntington disease and myotonic dystrophy. This type of mutation is now known to\n\nfeatures of trinucleotide repeat mutations, described later, are responsible for the atypical pattern of inheritance of the associated diseases."]]},"2": {"question": "A 36-year-old man is brought to the emergency department by his wife 20 minutes after having a seizure. Over the past 3 days, he has had a fever and worsening headaches. This morning, his wife noticed that he was irritable and demonstrated strange behavior; he put the back of his fork, the salt shaker, and the lid of the coffee can into his mouth. He has no history of serious illness and takes no medications. His temperature is 39\u00b0C (102.2\u00b0F), pulse is 88/min, and blood pressure is 118/76 mm Hg. Neurologic examination shows diffuse hyperreflexia and an extensor response to the plantar reflex on the right. A T2-weighted MRI of the brain shows edema and areas of hemorrhage in the left temporal lobe. Which of the following is most likely the primary mechanism of the development of edema in this patient?", "options": {"A": "Release of vascular endothelial growth factor", "B": "Cellular retention of sodium", "C": "Breakdown of endothelial tight junctions", "D": "Increased hydrostatic pressure"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for information on the mechanisms of edema formation in the brain, particularly in relation to infections or inflammatory conditions.", "tool_input": "mechanisms of brain edema formation in infections or inflammation\" \n", "log": "To answer the question, I need to analyze the clinical scenario provided. The patient has a fever, worsening headaches, strange behavior, and neurological signs such as hyperreflexia and an extensor plantar response. The MRI findings of edema and hemorrhage in the left temporal lobe suggest a possible infectious or inflammatory process, which could lead to the breakdown of the blood-brain barrier and edema formation.\n\nGiven the options, I need to identify which mechanism is most likely responsible for the edema development in this context. \n\nAction: I will search for information on the mechanisms of edema formation in the brain, particularly in relation to infections or inflammatory conditions. \n\nAction Input: \"mechanisms of brain edema formation in infections or inflammation\" \n", "type": "AgentAction"}}, "I will search for information on the mechanisms of edema formation in the brain, particularly in relation to infections or inflammatory conditions. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "mechanisms of brain edema formation in infections or inflammation\" \n", "log": "I need to perform a search using the available tool to gather relevant information about the mechanisms of brain edema formation, especially in the context of infections or inflammatory conditions. \n\nAction: search_docs \nAction Input: \"mechanisms of brain edema formation in infections or inflammation\" \n", "type": "AgentAction"}}, "and hemorrhages. As mentioned earlier, edema is the main element in the genesis of brain swelling and of raised ICP in most head-injured patients (Marmarou et al). This reflects a failure of autoregulatory vascular mechanisms, with resulting transudative edema in damaged areas of the brain. The\n\nMarmarou A, Fatouros PP, Barzo P, et al: Contribution of edema and cerebral blood volume to traumatic brain swelling in head-injured patients. J Neurosurg 93:183, 2000.\n\nCerebral edema is the accumulation of excess fluid within the brain parenchyma. There are two types, which often occur together, particularly after generalized injury."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "cerebral edema mechanisms breakdown of endothelial tight junctions\" \n", "log": "The observation provides some insights into the mechanisms of cerebral edema but does not directly address the specific options given in the question. The context suggests that the edema is likely related to a breakdown of the blood-brain barrier due to an infectious or inflammatory process, which aligns with option C: \"Breakdown of endothelial tight junctions.\" \n\nI need to further clarify the mechanisms of edema formation to confirm this hypothesis. \n\nAction: search_docs \nAction Input: \"cerebral edema mechanisms breakdown of endothelial tight junctions\" \n", "type": "AgentAction"}}, "cross rapidly cell tight junctions \u2022 vasogenic edema.\n\nlevel, disruption of end-capillary pressure causes increased hydrostatic pressure, hyperperfusion, and extravasation of plasma and red cells through endothelial tight-junction openings. his leads to vasogenic edema. he recent description of a central nervous system lymphatic vasculature lends\n\nFigure 30-1.\u2002A. Schematic representation of the astrocytes and endothelial cells of the capillary wall in the normal state (above) and in vasogenic edema (below). Heightened permeability in vasogenic edema is partly the result of a defect in tight endothelial junctions, but mainly a result of"]]},"3": {"question": "A 35-year-old woman presents to the ER with shortness of breath, cough, and severe lower limb enlargement. The dyspnea was of sudden onset, started a week ago, and increased with exercise but did not disappear with rest. Her cough was dry, persistent, and non-productive. She has a family history of maternal hypertension. Her vital signs include heart rate 106/min, respiratory rate 28/min, and blood pressure 140/90 mm Hg. On physical examination, thoracic expansion was diminished on the right side with rhonchi and crackles on the lower two-thirds of both sides, with left predominance. A systolic murmur was heard on the tricuspid foci, which increased in intensity with inspiration. There was jugular engorgement when the bed was placed at 50\u00b0. Palpation of the abdomen was painful on the right hypochondrium, with hepatomegaly 4 cm below the lower coastal edge. Hepatojugular reflux was present. Soft, painless, pitting edema was present in both lower limbs up until the middle third of both legs. Lung computed tomography (CT) and transthoracic echocardiogram were performed and detected right heart failure and severe pulmonary fibrosis. What is the most likely diagnosis?", "options": {"A": "Left-sided heart failure", "B": "Coronary artery disease", "C": "Budd-chiari syndrome", "D": "Cor pulmonale"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Budd-chiari syndrome symptoms and diagnosis", "log": "The clinical presentation suggests a case of right heart failure with associated pulmonary issues. The sudden onset of dyspnea, cough, and significant lower limb edema, along with the physical examination findings such as jugular engorgement, hepatomegaly, and hepatojugular reflux, point towards a diagnosis related to right heart function. The echocardiogram findings of right heart failure and the presence of severe pulmonary fibrosis also support a diagnosis linked to pulmonary vascular issues.\n\nGiven the options, I need to consider which condition aligns best with the symptoms and findings:\n\n- **A: Left-sided heart failure** typically presents with pulmonary congestion and is less likely to cause the specific right-sided symptoms observed here.\n- **B: Coronary artery disease** usually leads to ischemic heart disease and does not directly explain the pulmonary and right heart failure findings.\n- **C: Budd-chiari syndrome** involves hepatic venous obstruction, which can lead to right heart failure due to increased venous pressure, and the presence of hepatomegaly and abdominal pain supports this diagnosis.\n- **D: Cor pulmonale** is right heart failure secondary to lung disease, which fits with the pulmonary fibrosis noted.\n\nI need to determine which of these is the most likely diagnosis based on the symptoms and findings presented.\n\nAction: search_docs  \nAction Input: \"Budd-chiari syndrome symptoms and diagnosis\"  ", "type": "AgentAction"}}, "testicular atrophy, and peripheral edema. Budd-Chiari syndrome can occur due to HCC invasion of the hepatic veins, with tense ascites and a large tender liver (Chap. 365).\n\nblood flow. This is the first test ordered in patients suspected of having Budd-Chiari syndrome.\n\nAspergillus). May lead to Budd-Chiari syndrome."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "cor pulmonale symptoms and diagnosis", "log": "The information gathered from the search indicates that Budd-Chiari syndrome is associated with hepatic venous obstruction, which can lead to symptoms like abdominal pain, hepatomegaly, and peripheral edema. The presence of right heart failure and the symptoms observed in the patient, such as jugular engorgement and hepatojugular reflux, align with this diagnosis.\n\nHowever, I also need to consider the other options in light of the findings from the search. While Budd-Chiari syndrome is a strong candidate due to the abdominal symptoms and right heart failure, I should also evaluate the possibility of cor pulmonale, given the severe pulmonary fibrosis noted in the echocardiogram results.\n\nTo make a more informed decision, I will search for more specific information regarding cor pulmonale and its relationship with pulmonary fibrosis.\n\nAction: search_docs  \nAction Input: \"cor pulmonale symptoms and diagnosis\"  ", "type": "AgentAction"}}, "CLINICAL MANIFESTATIONS Symptoms The symptoms of chronic cor pulmonale generally are related to the underlying pulmonary disorder. Dyspnea, the most common symptom, is usually the result of the increased work of breathing secondary to changes in elastic recoil of the lung (fibrosing lung diseases),\n\nApproach to the Patient with Disease of the Respiratory System 1662 the right side of the heart, patients may also present with symptoms of cor pulmonale, including abdominal bloating or distention and pedal edema (Chap. 279).\n\nCor pulmonale develops in response to acute or chronic changes in the pulmonary vasculature and/or the lung parenchyma that are sufficient to cause pulmonary hypertension. The true prevalence of cor pulmonale is difficult to ascertain. First, not all patients with chronic lung disease will develop"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Budd-chiari syndrome vs cor pulmonale clinical features", "log": "The information gathered about cor pulmonale indicates that it is characterized by right heart failure due to pulmonary issues, such as pulmonary fibrosis. The symptoms of dyspnea, abdominal distention, and pedal edema align with the patient's presentation. This suggests that cor pulmonale could indeed be a plausible diagnosis, especially considering the echocardiogram findings of right heart failure and the severe pulmonary fibrosis.\n\nNow I need to weigh the evidence for both Budd-Chiari syndrome and cor pulmonale. Budd-Chiari syndrome is characterized by hepatic venous obstruction leading to abdominal symptoms and peripheral edema, which fits the patient's symptoms. However, the presence of severe pulmonary fibrosis strongly suggests cor pulmonale as a more likely diagnosis due to the direct impact of lung disease on heart function.\n\nTo confirm the most likely diagnosis, I will conduct one more search to gather comparative insights regarding the two conditions and their clinical presentations.\n\nAction: search_docs  \nAction Input: \"Budd-chiari syndrome vs cor pulmonale clinical features\"  ", "type": "AgentAction"}}, "Like chronic constrictive pericarditis, cor pulmonale (Chap. 279) may be associated with severe systemic venous hypertension but little pulmonary congestion; the heart is usually not enlarged, and a paradoxical pulse may be present. However, in cor pulmonale, advanced parenchymal pulmonary disease\n\n(cor pulmonale) Unrepaired or palliated congenital heart disease Cardiomyopathy\n\nApproach to the Patient with Disease of the Respiratory System 1662 the right side of the heart, patients may also present with symptoms of cor pulmonale, including abdominal bloating or distention and pedal edema (Chap. 279)."]]},"4": {"question": "A 5-year-old boy is brought in by his parents for recurrent abdominal pain. The child has been taken out of class 5 times this past week for abdominal pain that resulted in him being sent home. The mother reports that her son's stools have remained unchanged during this time and are brown in color, without blood, and with normal consistency and scent. She also notes that while at home he seems to be his usual self and does not complain of any symptoms. Of note she presents to you that she has been preparing her son's lunches which consist of couscous, vegetables, fried rice, and chicken. The patient denies difficulty with producing stool and does not complain of any functional pain. The child's vitals and labs including BMP and CBC are unremarkable and within normal limits. An abdominal exam is performed and there is no tenderness upon palpation, and the abdomen is soft and non-distended. After a conversation with the child exploring his symptoms, which of the following is the next step in management for this child?", "options": {"A": "Increase oral hydration and fiber intake", "B": "Check the stool for fecal red blood cells and leukocytes", "C": "Begin treatment with ciprofloxacin", "D": "Begin cognitive behavioral therapy"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'management of recurrent abdominal pain in children'", "log": "The case presents a 5-year-old boy with recurrent abdominal pain but no alarming signs such as blood in stool or tenderness on examination. The child's symptoms seem to be more related to stress or anxiety, especially since he is fine at home and has no issues with bowel movements. Given the context, cognitive behavioral therapy could be beneficial in addressing any psychological factors contributing to his abdominal pain. \n\nAction: search_docs  \nAction Input: 'management of recurrent abdominal pain in children'  ", "type": "AgentAction"}}, "Treatment of Recurrent Abdominal Pain\n\nRecurrent abdominal pain is a common problem, affecting more than 10% of all children. The peak incidence occurs between ages 7 and 12 years. Although the differential diagnosis of recurrent abdominal pain is fairly extensive (Table 126-4),most children do not have a serious (or even identifiable)\n\nTable 126-2 lists the differential diagnosis of acute abdominal pain in children. The urgent task of the clinician is to rule out surgical emergencies. In young children, malrotation with volvulus, incarcerated hernia, congenital anomalies, and intussusception are common concerns. In older children"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'cognitive behavioral therapy for children with abdominal pain'", "log": "The information gathered indicates that recurrent abdominal pain in children is common and often not associated with serious medical conditions. The management approach should consider the child's psychological state, especially given that the child is asymptomatic at home. Cognitive behavioral therapy may be appropriate to address any underlying stress or anxiety contributing to the symptoms.\n\nAction: search_docs  \nAction Input: 'cognitive behavioral therapy for children with abdominal pain'  ", "type": "AgentAction"}}, "in treating IBS. In difficult and persistent cases, cognitive behavioral\n\nSJ, Pituch K, Orr DP, Dittus RS. Clinical outcomes of children with acute abdominal pain. Pediatrics. 1996;98(4 pt 1): 680-685.\t61.\tReynolds SL, Jaffe DM. Diagnosing abdominal pain in a pediatric emergency department. Pediatr Emerg Care. 1992;8(3):126-128.\t62.\tLee SL, Stark R, Yaghoubian A,\n\nTable 126-3 Distinguishing Features of Abdominal Pain in Children DISEASE ONSET LOCATION REFERRAL QUALITY COMMENTS Functional: irritable bowel syndrome Recurrent Periumbilical, splenic and hepatic flexures None Dull, crampy, intermittent; duration 2 h Family stress, school phobia, diarrhea and"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'management options for recurrent abdominal pain in children'", "log": "The gathered information suggests that cognitive behavioral therapy (CBT) can be an effective treatment for children experiencing recurrent abdominal pain, particularly when psychological factors such as stress or anxiety are involved. Given that the child in this scenario has no significant medical findings and appears fine at home, CBT may help address the underlying issues contributing to his symptoms.\n\nAction: search_docs  \nAction Input: 'management options for recurrent abdominal pain in children'  ", "type": "AgentAction"}}, "Treatment of Recurrent Abdominal Pain\n\nRecurrent abdominal pain is a common problem, affecting more than 10% of all children. The peak incidence occurs between ages 7 and 12 years. Although the differential diagnosis of recurrent abdominal pain is fairly extensive (Table 126-4),most children do not have a serious (or even identifiable)\n\nTable 126-2 lists the differential diagnosis of acute abdominal pain in children. The urgent task of the clinician is to rule out surgical emergencies. In young children, malrotation with volvulus, incarcerated hernia, congenital anomalies, and intussusception are common concerns. In older children"]]},"5": {"question": "A 5-day-old male newborn is brought to the emergency department 1 hour after having a seizure. It lasted approximately 1 minute, and involved blinking and lip-smacking movements as well as left-sided jerking of the hand and foot. His mother says she measured a temperature of 38.2\u00b0C (100.7\u00b0F) at that time. He has had increasing difficulty feeding since yesterday. He was born at 39 weeks' gestation and weighed 3189 g (7 lb, 1 oz); he currently weighs 2980 g (6 lb, 9 oz). The mother's prenatal course was significant for gonorrhea infection diagnosed early in pregnancy and treated with ceftriaxone and azithromycin combination therapy. The boy appears irritable and lethargic. His temperature is 36.0\u00b0C (96.8\u00b0F). Examination shows clusters of vesicular lesions with an erythematous base on the patient's face and trunk. There is profuse lacrimation. Laboratory studies show:\nLeukocyte count 16,200/mm3\nSegmented neutrophils 25%\nBands 5%\nLymphocytes 65%\nMonocytes 3%\nEosinophils 2%\nSerum\nGlucose 80 mg/dL\nA lumbar puncture is performed. Cerebrospinal fluid analysis shows a leukocyte count of 117/\u03bcL, a protein concentration of 52 mg/dL, and a glucose concentration of 58 mg/dL. Results of blood cultures are pending. Which of the following is the most appropriate pharmacotherapy?\"", "options": {"A": "IV ganciclovir", "B": "Pyrimethamine", "C": "IV acyclovir", "D": "IV vancomycin"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "neonatal seizures herpes simplex virus treatment\" \n", "log": "The clinical presentation of the newborn suggests a viral infection, particularly given the presence of vesicular lesions and the lumbar puncture results indicating pleocytosis (elevated leukocyte count) in the cerebrospinal fluid. The most common viral infections in neonates that present with similar symptoms include herpes simplex virus (HSV) infection. The presence of irritability, lethargy, and seizures also points towards a central nervous system infection. \n\nAcyclovir is the standard treatment for HSV infections, especially in cases of encephalitis or meningitis. Ganciclovir is used for cytomegalovirus (CMV) infections, pyrimethamine is used for toxoplasmosis, and vancomycin is typically used for bacterial infections. Given the signs of viral infection and the likely diagnosis of HSV, the most appropriate pharmacotherapy would be IV acyclovir.\n\nAction: search_docs\nAction Input: \"neonatal seizures herpes simplex virus treatment\" \n", "type": "AgentAction"}}, "Treatment of Seizures in the Neonate and Young Child\n\nThe treatment of neonatal seizures may be specific, such as treatment of meningitis or the correction of hypoglycemia, hypocalcemia, hypomagnesemia, hyponatremia, or vitamin B6 deficiency or dependency. In the absence of an identifiable cause, therapy should involve an anticonvulsant agent, such as\n\nJames SH, Kimberlin DW: Neonatal herpes simplex virus infection: epidemiology and treatment. Clin PerinatoIt42(1):47, 2015\n\nJamieson OJ, ReadJS, KourtisAP, et al: Cesaren delivery for HIV-infected women: recommendations nd controversies. Am J Obstet Gynecol 197: S96, 2007"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "neonatal herpes simplex virus IV acyclovir treatment guidelines\" \n", "log": "The information retrieved does not directly address the specific pharmacotherapy for a neonatal herpes simplex virus infection. However, based on my previous reasoning, IV acyclovir remains the most appropriate treatment for suspected HSV infection in neonates. \n\nAction: search_docs\nAction Input: \"neonatal herpes simplex virus IV acyclovir treatment guidelines\" \n", "type": "AgentAction"}}, "III. Neonatal HSV infections: Oral acyclovir (60 mg/kg per day, divided into 3 doses) is given. The recommended duration of IV treatment is 21 days. Monitoring for relapse should be undertaken. Continued suppression with oral acyclovir suspension should be given for 3\u20134 months.\n\nherpes should be treated with IV acyclovir and then placed on maintenance oral antiviral therapy for the first 6\u201312 months of life. Antiviral chemotherapy with high-dose IV acyclovir (60 mg/kg per day) has reduced the mortality rate from neonatal herpes to ~15%. However, rates of morbidity,\n\nParenteral acyclovir is the treatment of choice for neonatal HSV infections. Acyclovir should be administered to all infants suspected to have infection or diagnosed with HSV. The most benign outcome with regard to morbidity and mortality is observed in infants with disease limited to the skin,"]]},"6": {"question": "A 30-year-old woman presents to the clinic for a 3-month history of painful hair loss. She was in her usual state of health until about 3 months ago when she started to develop some painfully itchy spots across her scalp. Since that time these spots have lost hair and scarred, with new spots continuing to form. On further questioning, she shares that, for the last couple of years, she has generally felt poorly, specifically noting intermittent fevers, muscle and joint pains, and fatigue. On physical exam, she has several erythematous and scaly plaques across her scalp. These areas have no hair growth, but some do demonstrate hyperpigmentation. Which of the following is the most likely diagnosis?", "options": {"A": "Alopecia areata", "B": "Discoid lupus erythematosus (DLE)", "C": "Tinea capitis", "D": "Trichotillomania"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Discoid lupus erythematosus symptoms diagnosis'\n", "log": "I need to analyze the symptoms and clinical presentation of the patient to determine the most likely diagnosis among the options provided. The key details include painful hair loss, itchy spots on the scalp, scarring, intermittent fevers, muscle and joint pains, and erythematous and scaly plaques.\n\n- Alopecia areata typically presents as non-scarring hair loss without the associated systemic symptoms noted in this case.\n- Discoid lupus erythematosus (DLE) can cause scarring hair loss and is associated with systemic symptoms like fatigue and joint pain.\n- Tinea capitis usually presents with scaling and hair loss but is not typically associated with systemic symptoms or scarring.\n- Trichotillomania involves hair pulling and does not present with scaly plaques or systemic symptoms.\n\nGiven the combination of scarring, systemic symptoms, and skin findings, DLE seems to fit best.\n\nAction: search_docs\nAction Input: 'Discoid lupus erythematosus symptoms diagnosis'\n", "type": "AgentAction"}}, "Chronic discoid lupus erythematosus is a disease in which the skin manifestations may mimic SLE, but systemic manifestations are rare. It is characterized by the presence of skin plaques, most often on the face and scalp, showing varying degrees of edema, erythema, scaliness, follicular plugging,\n\n5.\n\nB. Systemic diseases 1.\n\nDiscoid lesions in the setting of systemic lupus erythematosusb 2.\n\n3.\n\nwith only discoid lesions usually have the form of lupus that is limited to the skin. However, up to 10% of these patients eventually develop systemic lupus. Direct immunofluorescence of involved skin, in particular discoid lesions, shows deposits of IgG or IgM and C3 in a granular distribution"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Discoid lupus erythematosus diagnosis criteria'\n", "log": "The observation indicates that Discoid lupus erythematosus (DLE) is characterized by skin plaques, especially on the face and scalp, which aligns with the patient's symptoms of scarring and erythematous plaques. Although systemic manifestations are rare in chronic DLE, the patient's history of intermittent fevers, muscle and joint pains, and fatigue suggests a possible connection to systemic lupus erythematosus (SLE). \n\nGiven the evidence, DLE remains the most likely diagnosis due to the combination of scarring hair loss and the systemic symptoms presented.\n\nAction: search_docs\nAction Input: 'Discoid lupus erythematosus diagnosis criteria'\n", "type": "AgentAction"}}, "*These are the 1997 revised criteria for diagnosing systemic lupus erythematosus (SLE). A patient must have 4 of the 11 criteria to establish the diagnosis of SLE. These criteria may be present at the same or at different times during the patient\u2019s illness. Additional, less specific diagnostic\n\n5.\n\nB. Systemic diseases 1.\n\nDiscoid lesions in the setting of systemic lupus erythematosusb 2.\n\n3.\n\na Most patients with trichotillomania, pressure-induced alopecia, or early stages of traction alopecia. b While the majority of patients with discoid lesions have only cutaneous disease, these lesions do represent one of the 11 American College of Rheumatology criteria (1982) for systemic lupus"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Discoid lupus erythematosus clinical features'\n", "log": "The observation indicates that discoid lesions can be associated with systemic lupus erythematosus (SLE) but that most patients with discoid lupus erythematosus (DLE) typically have only cutaneous disease. However, the presence of systemic symptoms in the patient raises the possibility of an underlying systemic condition. \n\nGiven the combination of symptoms, including scarring hair loss, erythematous and scaly plaques, and systemic symptoms like intermittent fevers and joint pain, DLE is still the most fitting diagnosis among the options provided. \n\nAction: search_docs\nAction Input: 'Discoid lupus erythematosus clinical features'\n", "type": "AgentAction"}}, "5.\n\nB. Systemic diseases 1.\n\nDiscoid lesions in the setting of systemic lupus erythematosusb 2.\n\n3.\n\nChronic discoid lupus erythematosus is a disease in which the skin manifestations may mimic SLE, but systemic manifestations are rare. It is characterized by the presence of skin plaques, most often on the face and scalp, showing varying degrees of edema, erythema, scaliness, follicular plugging,\n\nFIguRE 76e-60 Discoid lupus erythematosus. Atrophic, depigmented plaques and patches surrounded by hyperpigmentation and erythema in association with scarring and alopecia are characteristic of this cutaneous form of lupus."]]},"7": {"question": "A 68-year-old man is admitted to the intensive care unit after open abdominal aortic aneurysm repair. The patient has received 4 units of packed red blood cells during the surgery. During the first 24 hours following the procedure, he has only passed 200 mL of urine. He has congestive heart failure and hypertension. Current medications include atenolol, enalapril, and spironolactone. He appears ill. His temperature is 37.1\u00b0C (98.8\u00b0F), pulse is 110/min, respirations are 18/min, and blood pressure is 110/78 mm Hg. Examination shows dry mucous membranes and flat neck veins. The remainder of the examination shows no abnormalities. Laboratory studies show a serum creatinine level of 2.0 mg/dL and a BUN of 48 mg/dL. His serum creatinine and BUN on admission were 1.2 mg/dL and 18 mg/dL, respectively. Further evaluation of this patient is most likely to reveal which of the following findings?", "options": {"A": "Decreased urine osmolarity", "B": "Leukocyte casts", "C": "Low urine sodium", "D": "Proteinuria"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "acute kidney injury pre-renal azotemia findings", "log": "To answer the question, I need to analyze the clinical scenario presented. The patient has undergone abdominal aortic aneurysm repair and is experiencing reduced urine output, elevated creatinine and BUN levels, and signs of dehydration (dry mucous membranes, flat neck veins). This suggests the possibility of acute kidney injury (AKI), likely due to pre-renal causes given his history of congestive heart failure and the context of surgery.\n\nIn pre-renal azotemia, we typically see low urine sodium and high urine osmolarity due to the kidneys conserving water and sodium in response to perceived low blood volume. Therefore, I should look for findings consistent with pre-renal azotemia.\n\nI will now look for relevant information regarding the expected findings in acute kidney injury, particularly focusing on pre-renal causes.\n\nAction: search_docs  \nAction Input: \"acute kidney injury pre-renal azotemia findings\"  ", "type": "AgentAction"}}, "The most common causes of intrinsic AKI are sepsis, ischemia, and nephrotoxins, both endogenous and exogenous (Fig. 334-3). In many cases, prerenal azotemia advances to tubular injury. Although classically termed \u201cacute tubular necrosis,\u201d human biopsy confirmation of tubular necrosis is, in\n\nProlonged renal hypoperfusion may lead to acute tubular necrosis (ATN), an intrinsic renal disease that is discussed below. The urinalysis and urinary electrolyte measurements can be useful in distinguishing prerenal azotemia from ATN (Table 61-2). The urine Na and osmolality of patients with\n\nand these patients are usually undergoing dialysis. The urinalysis and renal ultrasound can facilitate distinguishing acute from chronic renal failure. An approach to the evaluation of azotemic patients is shown in Fig. 61-1. Patients with advanced chronic renal insufficiency often have some"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "urine sodium levels in prerenal azotemia", "log": "The observation provided information about the progression from prerenal azotemia to acute tubular necrosis (ATN) and emphasized the importance of urinalysis and urinary electrolyte measurements in distinguishing between prerenal azotemia and intrinsic renal disease. \n\nIn prerenal azotemia, we typically expect low urine sodium (due to renal conservation of sodium) and high urine osmolality (due to concentrated urine). The patient's clinical scenario, including his history of congestive heart failure, suggests that he is experiencing prerenal azotemia rather than intrinsic renal failure at this point.\n\nTo confirm this, I will look for more specific information about the expected urine sodium levels and osmolality in prerenal azotemia.\n\nAction: search_docs  \nAction Input: \"urine sodium levels in prerenal azotemia\"  ", "type": "AgentAction"}}, "osmolality of patients with prerenal azotemia can be predicted from the stimulatory actions of norepinephrine, angiotensin II, ADH, and low tubule fluid flow rate. In prerenal conditions, the tubules are intact, leading to a concentrated urine (>500 mosmol), avid Na retention (urine Na\n\non the balance ofsodium and free water losses. The measured serum sodium concentration is artificially low, however, because of hyperglycemia. Hyperlipidemia also contributes to the decrease inmeasured serum sodium. The level of blood urea nitrogen(BUN) can be elevated with prerenal azotemia\n\nProlonged renal hypoperfusion may lead to acute tubular necrosis (ATN), an intrinsic renal disease that is discussed below. The urinalysis and urinary electrolyte measurements can be useful in distinguishing prerenal azotemia from ATN (Table 61-2). The urine Na and osmolality of patients with"]]},"8": {"question": "A 44-year-old with a past medical history significant for human immunodeficiency virus infection presents to the emergency department after he was found to be experiencing worsening confusion. The patient was noted to be disoriented by residents and staff at the homeless shelter where he resides. On presentation he reports headache and muscle aches but is unable to provide more information. His temperature is 102.2\u00b0F (39\u00b0C), blood pressure is 112/71 mmHg, pulse is 115/min, and respirations are 24/min. Knee extension with hips flexed produces significant resistance and pain. A lumbar puncture is performed with the following results:\n\nOpening pressure: Normal\nFluid color: Clear\nCell count: Increased lymphocytes\nProtein: Slightly elevated\n\nWhich of the following is the most likely cause of this patient's symptoms?", "options": {"A": "Cryptococcus", "B": "Group B streptococcus", "C": "Herpes simplex virus", "D": "Neisseria meningitidis"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Cryptococcus meningitis in HIV patients symptoms CSF findings", "log": "The patient presents with confusion, fever, headache, muscle aches, and signs of meningeal irritation (indicated by resistance and pain during knee extension with hips flexed). The lumbar puncture results show increased lymphocytes, normal opening pressure, clear fluid, and slightly elevated protein. This presentation is suggestive of viral or fungal meningitis rather than bacterial meningitis, which typically presents with cloudy fluid and a neutrophilic predominance.\n\nGiven the patient's history of HIV infection, he is at increased risk for opportunistic infections. Cryptococcus is a common cause of meningitis in immunocompromised patients, particularly those with HIV. The presence of increased lymphocytes in the cerebrospinal fluid (CSF) also supports a diagnosis of cryptococcal meningitis. \n\nI need to confirm the details regarding the likelihood of the other options in the context of the patient's immunocompromised state and CSF findings.\n\nAction: search_docs  \nAction Input: \"Cryptococcus meningitis in HIV patients symptoms CSF findings\"", "type": "AgentAction"}}, "Cryptococcal infection\u2002Meningitis with this fungus and less often, solitary cryptococcoma are the most frequent fungal complications of HIV infection. Flagrant symptoms of meningitis or meningoencephalitis may be lacking and the CSF may show little abnormality with respect to cells, protein, and\n\npatients with HIV are particularly vulnerable to cryptococcal infection; estimates are that 6 to 12 percent of HIV patients are subject to meningoencephalitis with the organism.\n\nhowever, it is rare following the development of AIDS. This suggests that clinical aseptic meningitis in the context of HIV infection is an immune-mediated disease. Cryptococcus is the leading infectious cause of meningitis in patients with AIDS (Chap. 239). While the vast majority of these are due"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Group B streptococcus meningitis HIV symptoms CSF findings", "log": "The information gathered from the search confirms that cryptococcal meningitis is indeed a frequent complication in patients with HIV. The CSF findings of increased lymphocytes, normal opening pressure, and slightly elevated protein are consistent with cryptococcal meningitis. The data also indicates that patients with HIV are particularly susceptible to this type of infection, reinforcing the likelihood of this diagnosis over the other options.\n\nI should also consider the other options briefly to ensure that there are no better alternatives. \n\nAction: search_docs  \nAction Input: \"Group B streptococcus meningitis HIV symptoms CSF findings\"  ", "type": "AgentAction"}}, "and particularly by influenza. There is often accompanying neck pain and slight stiffness. The suspicion of meningitis is raised, even subarachnoid hemorrhage, but there is no reaction in the CSF (\u201cmeningism\u201d). The mild aseptic meningitis that accompanies HIV seroconversion may also be accompanied\n\nand HIV-related CSF abnormalities has been demonstrated.\n\nwith the virus. This is evidenced by the fact that CSF findings are abnormal in ~90% of patients, even during the asymptomatic phase of HIV infection. CSF abnormalities include pleocytosis (50\u201365% of patients), detection of viral RNA (~75%), elevated CSF protein (35%), and evidence of intrathecal"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Herpes simplex virus meningitis HIV symptoms CSF findings", "log": "The search did not yield specific information directly linking Group B streptococcus with the CSF findings in the context of HIV. However, I know that Group B streptococcus is more commonly associated with meningitis in neonates and is less likely to be the cause of meningitis in adults, especially in the context of HIV.\n\nNext, I will explore the other remaining options, particularly focusing on Herpes simplex virus and Neisseria meningitidis, to see if they could be more likely causes given the patient's symptoms and CSF findings.\n\nAction: search_docs  \nAction Input: \"Herpes simplex virus meningitis HIV symptoms CSF findings\"  ", "type": "AgentAction"}}, "and particularly by influenza. There is often accompanying neck pain and slight stiffness. The suspicion of meningitis is raised, even subarachnoid hemorrhage, but there is no reaction in the CSF (\u201cmeningism\u201d). The mild aseptic meningitis that accompanies HIV seroconversion may also be accompanied\n\nIt has already been mentioned that HIV infection may present as an acute asymptomatic meningitis with a mild lymphocytic pleocytosis and modest elevation of CSF protein. The acute illness may also take the form of a meningoencephalitis or even a myelopathy or neuropathy (see Myelopathy, Peripheral\n\nand HIV-related CSF abnormalities has been demonstrated."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Neisseria meningitidis meningitis HIV symptoms CSF findings", "log": "The search did not provide specific information linking Herpes simplex virus with the CSF findings in the context of HIV. However, I know that Herpes simplex virus can cause viral meningitis, but it typically presents with a more pronounced pleocytosis (increased white blood cell count) and a predominance of lymphocytes, which may not align with the patient's CSF findings.\n\nNext, I will check the last option, Neisseria meningitidis, to confirm its association with the patient's symptoms and CSF findings.\n\nAction: search_docs  \nAction Input: \"Neisseria meningitidis meningitis HIV symptoms CSF findings\"  ", "type": "AgentAction"}}, "and particularly by influenza. There is often accompanying neck pain and slight stiffness. The suspicion of meningitis is raised, even subarachnoid hemorrhage, but there is no reaction in the CSF (\u201cmeningism\u201d). The mild aseptic meningitis that accompanies HIV seroconversion may also be accompanied\n\nand HIV-related CSF abnormalities has been demonstrated.\n\nIt has already been mentioned that HIV infection may present as an acute asymptomatic meningitis with a mild lymphocytic pleocytosis and modest elevation of CSF protein. The acute illness may also take the form of a meningoencephalitis or even a myelopathy or neuropathy (see Myelopathy, Peripheral"]]},"9": {"question": "A 8-month-old boy is brought to the physician for the evaluation of shortening of his arms and legs. The parents report that they have also noticed that their son's head is progressively enlarging. The patient was born at term via vaginal delivery. There is no personal or family history of serious illness. His immunizations are up-to-date. He is at the 3rd percentile for height, 25th percentile for weight, and 95th percentile for head circumference. Examination shows macrocephaly and prominent brow bones. The extremities are short and plump. Muscle strength is 3/5 in all muscle groups. Deep tendon reflexes are 4+ bilaterally. An x-ray of the lateral skull shows midfacial hypoplasia and frontal prominence. X-rays of the spine shows abnormally narrow interpedicular distance. Which of the following is the most appropriate next step in management?", "options": {"A": "Growth hormone therapy", "B": "Levothyroxine therapy", "C": "CT scan of the head", "D": "Bisphosphonate therapy\n\""}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "next step in management for 8-month-old boy with macrocephaly and short limbs", "log": "The clinical presentation suggests a possible diagnosis of achondroplasia or another form of skeletal dysplasia, given the macrocephaly, short limbs, and specific x-ray findings. The next step in management should be aimed at further evaluating the patient's condition to confirm the diagnosis and assess any potential complications. A CT scan of the head would provide detailed imaging to evaluate the brain and skull structure, which is crucial given the macrocephaly and prominent brow bones.\n\nAction: search_docs  \nAction Input: \"next step in management for 8-month-old boy with macrocephaly and short limbs\"  ", "type": "AgentAction"}}, "As a particular guide to the pediatrician and neurologist who assume responsibility for the diagnosis and management of children harboring a wide array of diseases and maldevelopments of the nervous system, the following clinical approach is suggested. First, as already described, there is an\n\nTreatment of Infantile and Childhood Hydrocephalus\n\nNeonates with myelomeningocele must undergo operative closure of the open spinal defects (fetal or postnatal surgery) and often require treatment of hydrocephalus by placement of a ventriculoperitoneal shunt. Toddlers and children with lower spinal cord dysfunction require physical therapy, bracing"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of achondroplasia in infants", "log": "The information returned does not seem to directly address the next step in management for the specific case presented. However, the mention of hydrocephalus in neonates could be relevant given the macrocephaly observed in the patient. This suggests that further imaging may be necessary to assess for conditions such as hydrocephalus that could be contributing to the symptoms.\n\nAction: search_docs  \nAction Input: \"management of achondroplasia in infants\"  ", "type": "AgentAction"}}, "that cause achondroplasia. It occurs in about 1 of every 20,000 live births. Affected individuals have micromelic shortening of the limbs, frontal bossing, relative macrocephaly, a small chest cavity, and a bell-shaped abdomen. The underdeveloped thoracic cavity leads to respiratory insufficiency,\n\nCaused by a defect in cartilage-derived bone, achondroplasia (ACH) is the most common skeletal dysplasia in humans. The bony abnormalities lead to short stature, macrocephaly, a flat midface with a prominent forehead, and rhizomelic shortening of the limbs. The disorder occurs in approximately 1 in\n\nI. ACHONDROPLASIA\n\nA. Impaired cartilage proliferation in the growth plate; common cause of dwarfism\n\nB. Due to an activating mutation in fibroblast growth factor receptor 3 (FGFR3); autosomal dominant 1.\n\nOverexpression of FGFR3 inhibits growth.\n\n2."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "next steps in management for macrocephaly and short stature in infants", "log": "The information retrieved provides an overview of achondroplasia, including its causes and clinical features. However, it does not directly address the next step in management for the specific case of the 8-month-old boy. Given the clinical presentation, it appears that imaging studies may be necessary to rule out associated complications, such as hydrocephalus or other structural anomalies.\n\nAction: search_docs  \nAction Input: \"next steps in management for macrocephaly and short stature in infants\"  ", "type": "AgentAction"}}, "B. Growth Hormone Treatment of Pediatric Patients with Short Stature\n\nEnlargement of the Head (Macrocephaly)\n\nManagement of Mild Developmental Delay"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "imaging studies for macrocephaly in infants", "log": "The output does not seem to provide a clear next step in management for the case in question. However, it indicates that macrocephaly can be associated with various conditions, and that further evaluation is necessary. Given the clinical presentation of the boy, including macrocephaly and short stature, imaging studies such as a CT scan may be warranted to assess for underlying issues.\n\nAction: search_docs  \nAction Input: \"imaging studies for macrocephaly in infants\"  ", "type": "AgentAction"}}, "Dubois ], Dehaene-Lambertz G, Kulilova S, et al: he early development of brain white matter: a review of imaging studies in fetuses, newborns and infants. Neuroscience 12:276,s2014\n\nImaging studies of cerebral palsy have increasingly appeared and it has even been suggested, perhaps with excessive enthusiasm, that all such children undergo scanning. Cowan and colleagues (2003) used MRI to determine the proportion of infants with a neonatal encephalopathy who had antenatal brain\n\noptic tracts (Fig. 10-55). In other fetuses, MR imaging can also assist with identiying agenesis or dysgenesis of the corpus callosum and characterizing migrational abnormalities (Benacerraf, 2007; Li, 2012; Twickler, 2003)."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "appropriate management for macrocephaly in infants", "log": "The information retrieved discusses imaging studies in infants but does not provide a definitive next step in management for the specific case. However, it reinforces the idea that imaging, such as a CT scan or MRI, is important for evaluating macrocephaly and potential associated conditions.\n\nGiven the clinical details of macrocephaly, short stature, and the need to rule out conditions like hydrocephalus, it seems that a CT scan of the head would be the most appropriate next step in management.\n\nAction: search_docs  \nAction Input: \"appropriate management for macrocephaly in infants\"  ", "type": "AgentAction"}}, "Treatment of Infantile and Childhood Hydrocephalus\n\nEnlargement of the Head (Macrocephaly)\n\nShinnar S, Gammon K, Bergman EW Jr, et al: Management of hydrocephalus in infancy: Use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts. J Pediatr 107:31, 1985."]]},"10": {"question": "A 70-year-old woman, gravida 5, para 5, comes to the physician for the evaluation of sensation of vaginal fullness for the last six months. During this period, she has had lower back and pelvic pain that is worse with prolonged standing or walking. The patient underwent a hysterectomy at the age of 35 years because of severe dysmenorrhea. She has type 2 diabetes mellitus and hypercholesterolemia. Medications include metformin and atorvastatin. Vital signs are within normal limits. Pelvic examination elicits a feeling of pressure on the perineum. Pelvic floor muscle and anal sphincter tone are decreased. Pelvic examination shows protrusion of posterior vaginal wall with Valsalva maneuver and vaginal discharge. Which of the following is the most likely diagnosis?", "options": {"A": "Bartholin gland cyst", "B": "Atrophic vaginitis", "C": "Infectious vulvovaginitis", "D": "Enterocele"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "vaginal fullness pelvic pain decreased muscle tone protrusion posterior vaginal wall diagnosis\"  \n", "log": "I need to analyze the symptoms and medical history of the patient to determine the most likely diagnosis. The patient is experiencing vaginal fullness, pelvic pain, decreased muscle tone, protrusion of the posterior vaginal wall, and vaginal discharge. These symptoms suggest a condition related to pelvic organ prolapse or dysfunction. \n\nAction: search_docs  \nAction Input: \"vaginal fullness pelvic pain decreased muscle tone protrusion posterior vaginal wall diagnosis\"  \n", "type": "AgentAction"}}, "215.\n\nMaher C, Baessler K. Surgical management of posterior vaginal wall prolapse: an evidence-based literature review. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:84\u201388.\n\n216.\n\nTable 16.3 Differential Diagnosis of Chronic Pelvic Pain\n\nVaginal Support The salient points of pelvic organ prolapse (see Chapter 27 for patients with defecatory dysfunction are the support of the vaginal apex, posterior wall, and perineal body, although some experts believe anterior wall defects can also affect defecatory dysfunction. The posterior wall"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "pelvic organ prolapse posterior vaginal wall enterocele diagnosis\"  \n", "log": "The observation provides some literature references but does not directly answer the question. I need to focus on the symptoms related to pelvic organ prolapse, particularly the posterior vaginal wall. The protrusion of the posterior vaginal wall with Valsalva maneuver indicates a potential issue with the pelvic support structures, which could correlate with an enterocele.\n\nAction: search_docs  \nAction Input: \"pelvic organ prolapse posterior vaginal wall enterocele diagnosis\"  \n", "type": "AgentAction"}}, "of prolapse and pelvic \ufb02oor descent is quantified in relation to the pubococcygeal line. Pelvic \ufb02uoroscopy is superior to physical examination for diagnosing enterocele, and this technique has the advantage of being able to distinguish enteroceles from sigmoidoceles (90). Rectosphincteric\n\nFigure 27.3 A: Posterior enterocele without eversion. B: Enterocele with eversion.\n\nFigure 27.4 Uterine prolapse with apical detachment from the uterosacral ligament complex and lateral wall detachment from the endopelvic connective tissue.\n\nFigure 27.5 Procidentia of the uterus and vagina.\n\nwall of the vagina to facilitate defecation (suggestive of anterior rectocele), or prior pelvic surgery that may be complicated by enterocele."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "enterocele symptoms diagnosis pelvic organ prolapse\"  \n", "log": "The observations indicate that posterior vaginal wall prolapse is associated with enterocele, especially when considering the symptoms of vaginal fullness and protrusion during Valsalva maneuver. The patient\u2019s history of hysterectomy and symptoms such as pelvic pain and decreased muscle tone further support the diagnosis of an enterocele. \n\nAction: search_docs  \nAction Input: \"enterocele symptoms diagnosis pelvic organ prolapse\"  \n", "type": "AgentAction"}}, "to superior breaks in the rectovaginal and pubocervical fascia. Patients with rectocele and enterocele may have similar symptoms, including pelvic pressure, vaginal protrusion, obstipation, fecal incontinence, and sexual dysfunction. Although associations have been made between defecatory\n\nof prolapse and pelvic \ufb02oor descent is quantified in relation to the pubococcygeal line. Pelvic \ufb02uoroscopy is superior to physical examination for diagnosing enterocele, and this technique has the advantage of being able to distinguish enteroceles from sigmoidoceles (90). Rectosphincteric\n\nand rectocele can result from chronic straining and increased intra-abdominal pressure due to other etiologies of defecatory dysfunction. Defecatory dysfunction related to pelvic organ prolapse can result from rectocele, enterocele, or perineal descent, either individually or in combination."]]},"11": {"question": "A 1-year-old boy is brought to the physician by his parents for the evaluation of recurrent seizures. He is at the 5th percentile for height and 10th percentile for weight. Examination shows coarse pale hair, inelastic hypopigmented skin, and generalized hypotonia. Laboratory studies show low serum ceruloplasmin levels. Decreased activity of which of the following enzymes is most likely responsible for this patient's condition?", "options": {"A": "Prolyl hydroxylase", "B": "Lysyl oxidase", "C": "Glucocerebrosidase", "D": "Homogentisate oxidase"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "1-year-old boy recurrent seizures low serum ceruloplasmin coarse pale hair inelastic skin hypotonia enzyme deficiency\"  \n", "log": "To answer the question, I need to analyze the symptoms and laboratory findings of the 1-year-old boy. The key points are recurrent seizures, growth percentiles indicating failure to thrive, coarse pale hair, inelastic hypopigmented skin, generalized hypotonia, and low serum ceruloplasmin levels. These symptoms suggest a possible metabolic or genetic disorder.\n\nThe low serum ceruloplasmin indicates a deficiency in copper metabolism, which is often seen in conditions like Menkes disease. Menkes disease is caused by a deficiency of the enzyme ATP7A, which is involved in copper transport. However, none of the options directly mention ATP7A. \n\nThe symptoms of inelastic skin and hypotonia can also be associated with connective tissue disorders, which could point towards lysyl oxidase deficiency, as lysyl oxidase is important for collagen and elastin formation. \n\nNow, I need to find out which enzyme deficiency aligns best with the symptoms presented, particularly focusing on the options provided.\n\nAction: search_docs  \nAction Input: \"1-year-old boy recurrent seizures low serum ceruloplasmin coarse pale hair inelastic skin hypotonia enzyme deficiency\"  \n", "type": "AgentAction"}}, "microcephaly, seizures, hypotonia, and megaloblastic anemia.\n\nThe authors thank Dr. James Dowling for his generous help in preparing Chapter 182 on weakness and hypotonia.\n\nFenichel GM: Clinical Pediatric Neurology: a Signs and Symptoms Approach, ed 6, Philadelphia, 2009, Saunders\n\nOf course, epilepsy is a component of many genetic syndromes that are defined by their dysmorphic appearance, neurocutaneous disorder, or maldevelopment of the cerebra with or without mental retardation. What we consider first the few idiopathic seizure disorders that are inherited by a simple"]]},"12": {"question": "A 2-year-old boy is presented to the pediatrician due to poor weight gain and easy fatigability. His mother states that the patient barely engages in any physical activity as he becomes short of breath easily. The prenatal and birth histories are insignificant. Past medical history includes a few episodes of upper respiratory tract infection that were treated successfully. The patient is in the 10th percentile for weight and 40th percentile for height. The vital signs include: heart rate 122/min and respirations 32/min. Cardiac auscultation reveals clear lungs and a grade 2/6 holosystolic murmur loudest at the left lower sternal border. The remainder of the physical examination is negative for clubbing, cyanosis, and peripheral edema. Which of the following is the most likely diagnosis in this patient?", "options": {"A": "Atrial septal defect (ASD)", "B": "Ventricular septal defect (VSD)", "C": "Coarctation of aorta", "D": "Tetralogy of Fallot (TOF)"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Ventricular septal defect symptoms and diagnosis in children'", "log": "I need to analyze the symptoms and findings presented in the case to determine the most likely diagnosis. The key points include the patient's age, poor weight gain, easy fatigability, shortness of breath during physical activity, and the presence of a holosystolic murmur. The murmur's location is also important, as it is loudest at the left lower sternal border.\n\nAtrial septal defect (ASD) typically presents with a systolic murmur and is associated with right heart volume overload, but the murmur is not holosystolic. Ventricular septal defect (VSD) usually presents with a holosystolic murmur and can cause symptoms of heart failure, which aligns with the patient's presentation. Coarctation of the aorta often presents with differential blood pressures and may not necessarily present with a murmur. Tetralogy of Fallot (TOF) usually has a characteristic murmur and presents with cyanosis, which is not noted here.\n\nGiven the presence of a holosystolic murmur and the symptoms of easy fatigability and poor weight gain, I suspect that the most likely diagnosis is Ventricular septal defect (VSD).\n\nAction: search_docs\nAction Input: 'Ventricular septal defect symptoms and diagnosis in children' ", "type": "AgentAction"}}, "defects develop signs of congestive heart failure within the first few months of life.Physical examination may reveal a right ventricular heave and a systolic murmur. Children may also present with endo-carditis or paradoxical emboli as a result of the intracardiac communication. Chest radiography\n\nFigure 143-1 Ventricular septal defect. AO, Aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery; RA, right atrium; RV, right ventricle.\n\nDefects in the ventricular septum allow left-to-right shunting and constitute the most common congenital cardiac anomaly at birth (see\n\nTable 11.1"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Ventricular septal defect clinical features in children'", "log": "The information retrieved confirms that ventricular septal defects (VSD) are indeed associated with symptoms of congestive heart failure, which aligns with the patient's presentation of poor weight gain and easy fatigability. The presence of a holosystolic murmur is characteristic of VSD, further supporting this diagnosis. \n\nSince the findings correlate well with VSD, I can confidently conclude that this is the most likely diagnosis for the patient.\n\nAction: search_docs\nAction Input: 'Ventricular septal defect clinical features in children' ", "type": "AgentAction"}}, "Figure 143-1 Ventricular septal defect. AO, Aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery; RA, right atrium; RV, right ventricle.\n\nDefects in the ventricular septum allow left-to-right shunting and constitute the most common congenital cardiac anomaly at birth (see\n\nTable 11.1\n\nin 393 children with double-outlet right ventricle. J Thorac Cardiovasc Surg. 2007;134(4):967-973.e6.\t151.\tBelli E, Serraf A, Lacour-Gayet F, et al. Double-outlet right ventricle with non-committed ventricular septal defect. Eur J Cardiothorac Surg. 1999;15(6):747-752.\t152.\tKawashima Y, Matsuda H,"]]},"13": {"question": "A 13-month-old girl is brought to the physician because of a pruritic rash for 2 days. The girl's mother says she noticed a few isolated skin lesions on her trunk two days ago that appear to be itching. The girl received her routine immunizations 18 days ago. Her mother has been giving her ibuprofen for her symptoms. The patient has no known sick contacts. She is at the 71st percentile for height and the 64th percentile for weight. She is in no acute distress. Her temperature is 38.1\u00b0C (100.6\u00b0F), pulse is 120/min, and respirations are 26/min. Examination shows a few maculopapular and pustular lesions distributed over the face and trunk. There are some excoriation marks and crusted lesions as well. Which of the following is the most likely explanation for these findings?", "options": {"A": "Antigen contact with presensitized T-lymphocytes", "B": "Reactivation of virus dormant in dorsal root ganglion", "C": "Crosslinking of preformed IgE antibodies", "D": "Replication of the attenuated vaccine strain"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "maculopapular rash vaccine 18 days after immunization", "log": "To determine the most likely explanation for the findings in this 13-month-old girl, I need to consider the context of her recent immunizations and the nature of her rash. The timeline of the rash appearing 18 days after receiving routine immunizations suggests a possible connection to a vaccine, particularly if she received a live attenuated vaccine.\n\nThe options provided include:\n- A: Antigen contact with presensitized T-lymphocytes (more related to allergic reactions).\n- B: Reactivation of virus dormant in dorsal root ganglion (more associated with herpes zoster or similar conditions).\n- C: Crosslinking of preformed IgE antibodies (related to allergic reactions).\n- D: Replication of the attenuated vaccine strain (likely if she received a live vaccine, such as the varicella or MMR vaccines).\n\nGiven that the rash is maculopapular and pustular and considering the timing post-immunization, the most plausible explanation is that the lesions are due to the replication of the attenuated vaccine strain.\n\nAction: search_docs\nAction Input: \"maculopapular rash vaccine 18 days after immunization\"", "type": "AgentAction"}}, "nodosum, sied 4\u20136 weeks after injection. If noncaseating maculopapular lesions granulomas are seen, this is highly specific for the\n\nmaculopapular rash evolves rapidly into vesicular lesions (Fig. 217-2). In the normal host, these lesions may remain few in number and continue to form for only 3\u20135 days. The total duration of disease is generally 7\u201310 days; however, it may take as long as 2\u20134 weeks for the skin to return to\n\n12 Therefore, a cold chain must be maintained before and after reconstitution. Antibodies first appear 12\u201315 days after vaccination, and titers peak at 1\u20133 months. Measles vaccines are often combined with other live attenuated virus vaccines, such as those for mumps and rubella (MMR) and for mumps,"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "live attenuated vaccine rash timing symptoms", "log": "The search results provide information about maculopapular rashes evolving into vesicular lesions and the timing of antibody appearance after vaccination. This supports the idea that the rash could be related to a live attenuated vaccine, as the lesions may develop in a normal host after such vaccination. The timing of the rash appearing 18 days post-immunization aligns with the expected response to a live vaccine.\n\nGiven that the lesions are maculopapular and pustular, and considering the context of recent immunizations, the most plausible explanation remains that the rash is due to the replication of the attenuated vaccine strain, particularly if the girl received vaccines like MMR or varicella.\n\nAction: search_docs\nAction Input: \"live attenuated vaccine rash timing symptoms\"", "type": "AgentAction"}}, "response to live virus vaccines if administered before the recommended interval.\n\nthe prodromal illness; (2) when the rash is attenuated by passively acquired antibodies or prior immunization; (3) when the rash is absent or delayed in immunocompromised children or severely undernourished children with impaired cellular immunity; and (4) in regions where the incidence of measles\n\nWhole-cell pertussis vaccine causes side-effects, typically redness, pain, and swelling at the site of the injection; less commonly, vaccination is followed by high temperature and persistent crying. Very rarely, fits and a short-lived sleepiness or a floppy unresponsive state ensue. During the"]]},"14": {"question": "A 65-year-old man was picked up by the security personnel for voiding urine and defecating at an inappropriate place in the community. On questioning, he was making offensive remarks and behaving inappropriately. On physical examination, the physician observed an ataxic gait and amnesia. Initial urine drug screen is negative for any drugs of abuse. Which is the most likely pathological finding present in this patient?", "options": {"A": "Drug abuse", "B": "Lewy bodies", "C": "Pick bodies", "D": "Amyloid plaques"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "pathological findings Lewy bodies Pick bodies Amyloid plaques symptoms ataxic gait amnesia", "log": "To determine the most likely pathological finding in this case, I need to analyze the symptoms presented. The patient is a 65-year-old man exhibiting inappropriate behavior, ataxic gait, and amnesia. The negative urine drug screen suggests that drug abuse is unlikely. \n\nThe symptoms of ataxia and amnesia could indicate a neurodegenerative disorder. Given the options, Lewy bodies are associated with Lewy body dementia, which can cause similar behavioral changes and cognitive decline. Pick bodies are associated with frontotemporal dementia, which could also lead to inappropriate behavior but is less common than Lewy body dementia in older adults. Amyloid plaques are characteristic of Alzheimer's disease, but the ataxic gait and behavioral issues might not align as closely.\n\nI will search for more information on the pathological findings associated with the symptoms presented.\n\nAction: search_docs  \nAction Input: \"pathological findings Lewy bodies Pick bodies Amyloid plaques symptoms ataxic gait amnesia\"  ", "type": "AgentAction"}}, "Lewy body pathology frequently coexists with Alzheimer\u2019s disease and cerebrovascular disease pathology, particularly among the oldest age groups. In Alzheimer\u2019s disease, there is concomitant synuclein pathology in 60% of cases (if amygdala-restricted cases are in- cluded). In general, there is a\n\nand colleagues in 1961 (see review by Kosaka). The disease is defined by the diffuse involvement of cortical neurons with Lewy body inclusions and by an absence or inconspicuous number of neurofibrillary tangles and amyloid plaques. To some extent, increased recognition of this disorder is a result\n\nDisorder With Lewy Bodiesb"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Lewy body dementia symptoms ataxia amnesia pathological findings", "log": "The information gathered suggests that Lewy body pathology is associated with behavioral changes and cognitive decline, which aligns with the symptoms presented in the case. The presence of ataxic gait and amnesia further supports the likelihood of a neurodegenerative disorder, particularly Lewy body dementia, as it is common in older adults. \n\nI still need to confirm the relationship between the symptoms and the pathological findings more explicitly before making a final decision. \n\nAction: search_docs  \nAction Input: \"Lewy body dementia symptoms ataxia amnesia pathological findings\"  ", "type": "AgentAction"}}, "Possible major neurocognitive disorder due to Alzheimer\u2019s disease\n\nPossible major neurocognitive disorder with Lewy bodies\n\nAutosomal dominant cerebellar ataxia, deafness, and narcolepsy\n\nAutosomal dominant narcolepsy, obesity, and type 2 diabetes\n\nLennox G: Lewy body dementia. Baillieres Clin Neurol 1:653, 1993.\n\nLeverenz J, Sumi SM: Parkinson\u2019s disease in patients with Alzheimer\u2019s disease. Arch Neurol 43:662, 1986.\n\nIn our experience with Lewy body disease, the parkinsonian symptoms have been more prominent than they are in progressive supranuclear palsy, and the most characteristic feature besides the movement disorder and a slowly advancing dementia has been a vacuous, anxious state with intermittent"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Lewy body dementia pathological findings ataxic gait amnesia behavioral changes", "log": "The observations indicate that Lewy body dementia is characterized by a combination of movement disorders (such as ataxia), cognitive decline (evidenced by amnesia), and behavioral changes. This aligns well with the symptoms presented in the case. Given that the other options (Pick bodies and amyloid plaques) are less consistent with the combination of ataxic gait and inappropriate behavior in an older adult, it seems that the most likely pathological finding in this patient is related to Lewy bodies.\n\nAction: search_docs  \nAction Input: \"Lewy body dementia pathological findings ataxic gait amnesia behavioral changes\"  ", "type": "AgentAction"}}, "Lennox G: Lewy body dementia. Baillieres Clin Neurol 1:653, 1993.\n\nLeverenz J, Sumi SM: Parkinson\u2019s disease in patients with Alzheimer\u2019s disease. Arch Neurol 43:662, 1986.\n\nprocess as Lewy body dementia and not Parkinson disease.\n\nThe majority of the demented Parkinson patients show some Alzheimer-type changes but there are some in whom few plaques or neurofibrillary changes can be found and instead display cortical neuronal loss accompanied by widespread distribution of Lewy bodies, marking the process as Lewy body dementia"]]},"15": {"question": "A 58-year-old man is brought to the emergency department after a witnessed tonic-clonic seizure. His wife says he has had a persistent dry cough for 6 months. During this time period, he has also had fatigue and a 4.5-kg (10-lb) weight loss. The patient has no history of serious illness and does not take any medications. He has smoked 1 pack of cigarettes daily for 35 years. He is confused and oriented only to person. Laboratory studies show a serum sodium concentration of 119 mEq/L and glucose concentration of 102 mg/dL. An x-ray of the chest shows an irregular, poorly demarcated density at the right hilum. Microscopic examination of this density is most likely to confirm which of the following diagnoses?", "options": {"A": "Squamous cell lung carcinoma", "B": "Small cell lung carcinoma", "C": "Large cell lung carcinoma", "D": "Bronchial carcinoid tumor"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for the most relevant information regarding the relationship between the patient's symptoms and the types of lung cancer, particularly focusing on small cell lung carcinoma and its association with hyponatremia.", "tool_input": "search_docs(query='small cell lung carcinoma hyponatremia symptoms') \n", "log": "The clinical presentation of the patient, including the history of smoking, persistent cough, weight loss, confusion, and the findings from the chest X-ray, suggests a possible lung malignancy. The serum sodium concentration of 119 mEq/L indicates hyponatremia, which can be associated with certain types of lung cancer, particularly small cell lung carcinoma (SCLC) due to the potential for paraneoplastic syndromes like the syndrome of inappropriate antidiuretic hormone secretion (SIADH). \n\nGiven the options, I need to consider the characteristics of each type of lung cancer. Squamous cell carcinoma is also known for causing paraneoplastic syndromes but is more commonly associated with hypercalcemia. Large cell carcinoma does not have specific paraneoplastic associations. Bronchial carcinoid tumors are typically less aggressive and may not cause such severe symptoms in a 58-year-old heavy smoker.\n\nAction: I will search for the most relevant information regarding the relationship between the patient's symptoms and the types of lung cancer, particularly focusing on small cell lung carcinoma and its association with hyponatremia.\n\nAction Input: search_docs(query='small cell lung carcinoma hyponatremia symptoms') \n", "type": "AgentAction"}}, "I will search for the most relevant information regarding the relationship between the patient's symptoms and the types of lung cancer, particularly focusing on small cell lung carcinoma and its association with hyponatremia. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for the most relevant information regarding the relationship between the patient's symptoms and small cell lung carcinoma.", "tool_input": "search_docs(query='small cell lung carcinoma hyponatremia symptoms') \n", "log": "I need to gather relevant information about small cell lung carcinoma and its associations with symptoms like hyponatremia in order to confirm the most likely diagnosis for this patient.\n\nAction: I will search for the most relevant information regarding the relationship between the patient's symptoms and small cell lung carcinoma.\n\nAction Input: search_docs(query='small cell lung carcinoma hyponatremia symptoms') \n", "type": "AgentAction"}}, "I will search for the most relevant information regarding the relationship between the patient's symptoms and small cell lung carcinoma. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for information specifically about small cell lung carcinoma and its association with hyponatremia to support my diagnosis.", "tool_input": "search_docs(query='small cell lung carcinoma hyponatremia') \n", "log": "It seems there was an error in the previous attempts to search for information. I need to ensure that I formulate the search query correctly.\n\nAction: I will search for information specifically about small cell lung carcinoma and its association with hyponatremia to support my diagnosis.\n\nAction Input: search_docs(query='small cell lung carcinoma hyponatremia') \n", "type": "AgentAction"}}, "I will search for information specifically about small cell lung carcinoma and its association with hyponatremia to support my diagnosis. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for general information about small cell lung carcinoma and its symptoms, particularly focusing on hyponatremia.", "tool_input": "search_docs(query='small cell lung carcinoma') \n", "log": "It appears that I am encountering an issue with conducting the search. I should try to rephrase or simplify my query to ensure I can retrieve relevant documents.\n\nAction: I will search for general information about small cell lung carcinoma and its symptoms, particularly focusing on hyponatremia.\n\nAction Input: search_docs(query='small cell lung carcinoma') \n", "type": "AgentAction"}}, "I will search for general information about small cell lung carcinoma and its symptoms, particularly focusing on hyponatremia. is not a valid tool, try one of [search_docs]."]]},"16": {"question": "A 55-year-old man presents to the physician with tiredness, lethargy, bone pain, and colicky right abdominal pain for 1 month. He has no comorbidities. He does not have any significant past medical history. His height is 176 cm (5 ft 7 in), weight is 88 kg (194 lb), and his BMI is 28.47 kg/m2. The physical examination is normal, except for mild right lumbar region tenderness. Laboratory studies show:\nHemoglobin 13.5 g/dL\nSerum TSH 2.2 mU/L\nSerum calcium 12.3 mg/dL\nSerum phosphorus 1.1 mg/dL\nSerum sodium 136 mEq/L\nSerum potassium 3.5 mEq/L\nSerum creatinine 1.1 mg/dL\nUrine calcium Elevated\nAn ultrasound of the abdomen reveals a single stone in the right ureter without hydroureteronephrosis. Clinically, no evidence of malignancy was observed. An X-ray of the long bones reveals diffuse osteopenia with subperiosteal bone resorption. The serum parathyroid hormone level is tested and it is grossly elevated. What is the most appropriate next step in his management?", "options": {"A": "99mTc sestamibi scan with ultrasound of the neck", "B": "CT scan of the neck", "C": "Bone scan (DEXA)", "D": "Sestamibi scan only"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of primary hyperparathyroidism imaging options", "log": "To determine the most appropriate next step in the management of this patient, we need to consider his clinical presentation and laboratory findings. The patient presents with symptoms and signs suggestive of primary hyperparathyroidism, including elevated serum calcium, low serum phosphorus, elevated urine calcium, and a significantly elevated serum parathyroid hormone level. The ultrasound findings of a stone in the ureter and the X-ray findings of osteopenia with subperiosteal bone resorption further support this diagnosis.\n\nIn cases of primary hyperparathyroidism, it is essential to localize any potential parathyroid adenomas that may be causing the hypersecretion of parathyroid hormone. The options provided include imaging studies that can help identify such adenomas.\n\nOption A (99mTc sestamibi scan with ultrasound of the neck) is a common approach for localizing parathyroid adenomas. Option B (CT scan of the neck) can also be used but is not the first-line imaging study. Option C (Bone scan (DEXA)) is not appropriate for this situation, as it is primarily used to assess bone density rather than locate parathyroid glands. Option D (Sestamibi scan only) is incomplete without neck ultrasound, which is often done in conjunction with the sestamibi scan.\n\nGiven this reasoning, the most appropriate next step is likely to be the combination of a sestamibi scan with neck ultrasound to localize the parathyroid adenoma.\n\nAction: search_docs  \nAction Input: \"management of primary hyperparathyroidism imaging options\"  ", "type": "AgentAction"}}, "G, Biagini C, et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3595-3606.\t82.\tBilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary\n\nBilezikian JP, Cusano NE, Khan AA, et al: Primary hyperparathyroidism, Nat Rev Dis Primers 2:16033, 2016. [This review follows the format of other reviews in this journal that is heavy on summary figures and overviews written for a broad audience. The reader is encouraged to periodically browse the\n\nproceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism. J Clin Endocri-nol Metab. 2014;99:3607-3618.\t79.\tPasieka JL, Parsons L, Jones J. The long-term benefit of parathyroidectomy in primary hyperparathyroidism: a 10-year prospective surgical"]]},"17": {"question": "An 8-year-old boy is brought to the emergency department because of shortness of breath and dry cough for 2 days. His symptoms began after he helped his father clean the basement. He is allergic to shellfish. Respirations are 26/min. Physical examination shows diffuse end-expiratory wheezing and decreased inspiratory-to-expiratory ratio. This patient's symptoms are most likely being caused by inflammation of which of the following structures?", "options": {"A": "Pleural cavity", "B": "Alveoli", "C": "Distal trachea", "D": "Terminal bronchioles"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "inflammation of terminal bronchioles in children asthma symptoms\" \n", "log": "The symptoms presented by the boy, including shortness of breath, dry cough, wheezing, and the context of exposure to allergens (in this case, possibly mold or dust in the basement), suggest that there is inflammation in the airways. The wheezing and respiratory rate indicate that the issue is likely related to the bronchi or bronchioles rather than the alveoli or pleural cavity. Given the options, the terminal bronchioles are the most distal part of the conducting airways and are involved in the inflammatory response seen in asthma-like symptoms.\n\nAction: search_docs\nAction Input: \"inflammation of terminal bronchioles in children asthma symptoms\" \n", "type": "AgentAction"}}, "or family history of asthma are the major differential factors. Bronchiolitis occurs primarily in the first year of life and is accompanied by fever, whereas asthma usually presents in older children with previous wheezing episodes typically unaccompanied by fever unless a respiratory tract\n\nacute exposure: bronchiolitis obliterans in in children with lifelong residential 2\u20136 weeks exposure\n\nAvailable @ StudentConsult.com\n\nChildren with asthma have symptoms of coughing, wheezing, shortness of breath or rapid breathing, and chest tightness. The history should elicit the frequency, severity, and factors that worsen the child\u2019s symptoms as well as a family history of"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "asthma inflammation terminal bronchioles children symptoms\"\n", "log": "The information gathered from the observation indicates that children with asthma often present with symptoms such as coughing, wheezing, and shortness of breath. The context of the boy's exposure and his symptoms aligns with asthma, which is characterized by inflammation in the airways, particularly in the terminal bronchioles.\n\nAction: search_docs\nAction Input: \"asthma inflammation terminal bronchioles children symptoms\"\n", "type": "AgentAction"}}, "Available @ StudentConsult.com\n\nChildren with asthma have symptoms of coughing, wheezing, shortness of breath or rapid breathing, and chest tightness. The history should elicit the frequency, severity, and factors that worsen the child\u2019s symptoms as well as a family history of\n\nor family history of asthma are the major differential factors. Bronchiolitis occurs primarily in the first year of life and is accompanied by fever, whereas asthma usually presents in older children with previous wheezing episodes typically unaccompanied by fever unless a respiratory tract\n\ndisease (bronchitis, asthma, wheezing) in later childhood."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "asthma terminal bronchioles inflammation in children\"\n", "log": "The observations reinforce the idea that the boy's symptoms are consistent with asthma, which is characterized by inflammation of the airways, particularly the terminal bronchioles. The wheezing and respiratory distress are typical of this condition, especially following exposure to potential allergens like dust or mold in the basement.\n\nAction: search_docs\nAction Input: \"asthma terminal bronchioles inflammation in children\"\n", "type": "AgentAction"}}, "or family history of asthma are the major differential factors. Bronchiolitis occurs primarily in the first year of life and is accompanied by fever, whereas asthma usually presents in older children with previous wheezing episodes typically unaccompanied by fever unless a respiratory tract\n\nacute exposure: bronchiolitis obliterans in in children with lifelong residential 2\u20136 weeks exposure\n\nThe incidence of asthma seems to be higher for children hospitalized for bronchiolitis as infants, but it is unclear whether this is causal or whether children prone to asthma are more likely to be hospitalized with bronchiolitis. There is a 1% to 2% mortality rate, highest among infants with"]]},"18": {"question": "A 79-year-old man is brought to the emergency department after he noted the abrupt onset of weakness accompanied by decreased sensation on his left side. His symptoms developed rapidly, peaked within 1 minute, and began to spontaneously resolve 10 minutes later. Upon arrival in the emergency room 40 minutes after the initial onset of symptoms, they had largely resolved. The patient has essential hypertension, type 2 diabetes mellitus, chronic obstructive pulmonary disease, and a 50 pack-year smoking history. He also had an ST-elevation myocardial infarction 3 years ago. His brain CT scan without contrast is reported as normal. Carotid duplex ultrasonography reveals 90% stenosis of the right internal carotid. His transthoracic echocardiogram does not reveal any intracardiac abnormalities. Which of the following interventions is most appropriate for this patient's condition?", "options": {"A": "Aspirin and clopidogrel", "B": "Warfarin", "C": "Carotid stenting", "D": "Hypercoagulability studies"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "appropriate intervention for TIA with carotid artery stenosis", "log": "The patient presents with abrupt onset of weakness and decreased sensation on one side, which spontaneously resolved. This suggests a transient ischemic attack (TIA), given the rapid onset and resolution of symptoms. The carotid duplex ultrasonography indicates significant stenosis (90%) in the right internal carotid artery. In cases of TIA with significant carotid artery stenosis, the most appropriate intervention typically involves antiplatelet therapy. Aspirin and clopidogrel are commonly used in such scenarios to reduce the risk of future strokes. \n\nAction: search_docs  \nAction Input: \"appropriate intervention for TIA with carotid artery stenosis\"  ", "type": "AgentAction"}}, "with asymptomatic carotid stenosis. As with atrial fibrillation, it is imperative to counsel the patient about TIAs so that therapy can be revised if symptoms develop.\n\nIf there is a reduction in diameter of greater than 70 percent when compared with an adjacent normal segment of vessel, and probably if there is a severely ulcerated but not critically stenotic plaque, carotid surgery (or angioplasty with stenting) is advisable. If a single TIA lasted more than 1 h\n\nThere is evidence that well-executed surgery or stenting in appropriately chosen cases arrests the TIAs and diminishes the risk of future strokes. These views initially received strong affirmation from two often-cited randomized studies\u2014the North American Symptomatic Carotid Endarterectomy Trial"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "TIA management guidelines antiplatelet therapy", "log": "The information gathered from the search indicates that in cases of transient ischemic attack (TIA) with significant carotid artery stenosis, interventions such as carotid surgery or stenting are considered. However, it also emphasizes the importance of antiplatelet therapy in reducing the risk of future strokes. Given that the patient has a 90% stenosis of the right internal carotid artery and has experienced a TIA, the most appropriate initial intervention would likely still be antiplatelet therapy.\n\nAction: search_docs  \nAction Input: \"TIA management guidelines antiplatelet therapy\"  ", "type": "AgentAction"}}, "transfusion. J Trauma. 2011;71(2 Suppl 3): S318-S328.\t24.\tEikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141 (2\n\nand stroke or TIA is uncommon beyond 2 weeks. Although there are no trials comparing anticoagulation to antiplatelet agents, many physicians treat acutely with anticoagulants and then convert to antiplatelet therapy after demonstration of satisfactory vascular recanalization.\n\nobtained from monitoring antiplatelet drug effect was used to alter therapy."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "current guidelines for TIA treatment antiplatelet therapy", "log": "The gathered information emphasizes the importance of antiplatelet therapy in managing transient ischemic attacks (TIA). It indicates that while there are interventions like carotid surgery or stenting for significant stenosis, the initial approach typically involves antiplatelet agents, particularly in the acute setting post-TIA. Given the patient's significant carotid stenosis and recent TIA, starting with antiplatelet therapy is consistent with current management guidelines.\n\nAction: search_docs  \nAction Input: \"current guidelines for TIA treatment antiplatelet therapy\"  ", "type": "AgentAction"}}, "transfusion. J Trauma. 2011;71(2 Suppl 3): S318-S328.\t24.\tEikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141 (2\n\nand stroke or TIA is uncommon beyond 2 weeks. Although there are no trials comparing anticoagulation to antiplatelet agents, many physicians treat acutely with anticoagulants and then convert to antiplatelet therapy after demonstration of satisfactory vascular recanalization.\n\nstroke or TIA and has no contraindication should be taking an antiplatelet agent regularly because the average annual risk of another stroke is 8\u201310%; another few percent will experience an MI or vascular death. Clearly, the likelihood of benefit far outweighs the risks of treatment."]]},"19": {"question": "A 65-year-old woman comes to the physician because of a 2-month history of persistent pain in her right shoulder. The pain is localized to the top of the shoulder and is worse with movement. She has stiffness in the right shoulder that is worse in the morning and usually lasts 20 minutes. The patient reports that she is unable to brush her hair and has stopped going to her regular tennis lessons because of the pain. She does not recall any fall or trauma. When her right arm is passively abducted in an arc, there is pain between 60 and 120 degrees of abduction. When asked to lower the right arm slowly from 90 degrees of abduction, she is unable to hold her arm up and it drops to her side. Passive range of motion is normal. Injection of 5 mL of 1% lidocaine into the right subacromial space does not relieve the pain or improve active range of motion of the right arm. Which of the following is the most likely diagnosis?", "options": {"A": "Cervical radiculopathy", "B": "Rotator cuff tear", "C": "Subacromial bursitis", "D": "Biceps tendinitis"}, "output": "C (Subacromial bursitis) is not the most likely diagnosis given the lack of response to lidocaine. The symptoms align more closely with adhesive capsulitis, but this option is not listed. Therefore, the best alternative based on the options provided would be B (Rotator cuff tear), as it is a common cause of similar symptoms in elderly patients.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "shoulder pain diagnosis in elderly woman with stiffness and limited movement", "log": "To determine the most likely diagnosis for the patient's symptoms, I need to analyze the details provided in the case. The patient is a 65-year-old woman with persistent shoulder pain, stiffness, and difficulty with movement, especially in the morning. The pain is localized to the top of the shoulder and is exacerbated by movement. The passive range of motion is normal, which suggests that the issue may not be structural but rather related to soft tissue or inflammation. The lack of relief from lidocaine injection into the subacromial space indicates that the pain may not be due to subacromial bursitis.\n\nGiven these considerations, I will search for relevant medical literature or guidelines that could help clarify the diagnosis based on the symptoms described.\n\nAction: search_docs  \nAction Input: \"shoulder pain diagnosis in elderly woman with stiffness and limited movement\"  ", "type": "AgentAction"}}, "A 45-year-old man came to his physician complaining of pain and weakness in his right shoulder. The pain began after a fall on his outstretched hand approximately 6 months previously. The patient recalled having some minor shoulder tenderness but no other specific symptoms. He was otherwise fit and\n\nencountered. The condition is observed in elderly persons, in some series mainly men, but our experience has included as many women. There is severe but relatively nonprogressive weakness of the neck extensors and only mild weakness of shoulder girdle and proximal arm muscles. Katz and colleagues\n\nshoulders, signs that exclude disease of muscle."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "elderly woman shoulder pain stiffness diagnosis differential", "log": "The information retrieved does not directly address the specific case of the 65-year-old woman with shoulder pain. However, it does suggest that certain conditions can be observed in elderly patients. I need to refine my search to focus on the specific symptoms and the differential diagnosis for shoulder pain in elderly women.\n\nAction: search_docs  \nAction Input: \"elderly woman shoulder pain stiffness diagnosis differential\"  ", "type": "AgentAction"}}, "A 45-year-old man came to his physician complaining of pain and weakness in his right shoulder. The pain began after a fall on his outstretched hand approximately 6 months previously. The patient recalled having some minor shoulder tenderness but no other specific symptoms. He was otherwise fit and\n\nWith reference to the most common of these symptoms, the neck and shoulder pain, in any sizable group of patients older than 50 years of age, approximately 40 percent will be found at times to have some clinical abnormality of the neck, usually crepitus or pain, with restriction of lateral flexion\n\nshoulder pain, or hemodynamic compromise."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "shoulder pain in elderly women differential diagnosis stiffness movement", "log": "The retrieved information is still not addressing the specific case of the 65-year-old woman with shoulder pain and stiffness. I need to conduct another search that is more focused on the specific symptoms described, including the nature of the pain, the age of the patient, and the differential diagnosis related to shoulder issues in elderly women.\n\nAction: search_docs  \nAction Input: \"shoulder pain in elderly women differential diagnosis stiffness movement\"  ", "type": "AgentAction"}}, "shoulder pain, or hemodynamic compromise.\n\nencountered. The condition is observed in elderly persons, in some series mainly men, but our experience has included as many women. There is severe but relatively nonprogressive weakness of the neck extensors and only mild weakness of shoulder girdle and proximal arm muscles. Katz and colleagues\n\nAdhesive capsulitis occurs more commonly in women after age 50. Pain and stiffness usually develop gradually but progress rapidly in some patients. Night pain is often present in the affected shoulder, and pain may interfere with sleep. The shoulder is tender to palpation, and both active and"]]},"20": {"question": "A 72-year-old man presents to the emergency department after a fall. The patient was found lying down on the floor in his room in his retirement community. The patient has a past medical history of Alzheimer dementia and a prosthetic valve. His current medications include donepezil and warfarin. His temperature is 97.7\u00b0F (36.5\u00b0C), blood pressure is 85/50 mmHg, pulse is 160/min, respirations are 13/min, and oxygen saturation is 97% on room air. That patient is started on IV fluids and a type and screen is performed. Laboratory values are ordered as seen below.\n\nHemoglobin: 13 g/dL\nHematocrit: 39%\nLeukocyte count: 5,500 cells/mm^3 with normal differential\nPlatelet count: 225,000/mm^3\n\nINR: 2.5\nAST: 10 U/L\nALT: 12 U/L\n\nA chest radiograph and EKG are performed and are within normal limits. A full physical exam is within normal limits. The patient\u2019s vitals are repeated. His temperature is 99.5\u00b0F (37.5\u00b0C), blood pressure is 110/70 mmHg, pulse is 90/min, respirations are 10/min, and oxygen saturation is 98% on room air. Which of the following is the best next step in management?", "options": {"A": "CT scan", "B": "Exploratory laparoscopy", "C": "Exploratory laparotomy", "D": "Fresh frozen plasma"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of elevated INR in patients on warfarin\"  \n", "log": "The patient has a history of a fall, is on warfarin, and has an elevated INR of 2.5, indicating an increased risk of bleeding. His vital signs have stabilized with IV fluids, but given the elevated INR, it is important to address the potential risk of bleeding. Fresh frozen plasma (FFP) is commonly used to reverse the effects of warfarin in cases of elevated INR, especially when there is a concern for bleeding.\n\nAction: search_docs  \nAction Input: \"management of elevated INR in patients on warfarin\"  \n", "type": "AgentAction"}}, "Do not give warfarin until the platelet count returns to its baseline level. If warfarin was administered, give vitamin K to restore the INR to normal.\n\nEvaluate for thrombosis, particularly deep vein thrombosis.\n\nAbbreviation: INR, international normalized ratio.\n\nCan increase warfarin levels. Monitor INR closely if drugs are given concomitantly. Increased effect of warfarin. Monitor levels closely if drugs are given concomitantly.\n\nrecommended range of 2.5\u20133.5. While a prolonged INR is widely used as an indication of integrity of the coagulation system in liver disease and other disorders, it has been validated only in patients in steady state on chronic warfarin therapy."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "fresh frozen plasma indications warfarin INR\"  \n", "log": "The observation suggests that in cases where a patient on warfarin has an elevated INR, especially in the context of a fall or potential bleeding, fresh frozen plasma (FFP) is indicated to reverse the anticoagulation effects. Since the patient's INR is 2.5 and he has a history of a fall, administering FFP would be the appropriate next step in management to mitigate the risk of bleeding.\n\nAction: search_docs  \nAction Input: \"fresh frozen plasma indications warfarin INR\"  \n", "type": "AgentAction"}}, "(e.g., myocardial ischemia, hemorrhage). It is not necessary to use fresh frozen plasma to correct INR abnormalities in the absence of bleeding. Consider prophylactic transfusion of platelets when counts are less than 10,000/mL in the absence of bleeding, <20,000/mL if there is a risk of bleeding,\n\n2.\n\nFresh frozen plasma therapy is indicated if the prothrombin or activated partial thromboplastin time values exceed 1.5 times the normal value.\n\n3.\n\nCryoprecipitate transfusion is indicated if fibrinogen concentrations decrease to less than 80 to 100 mg/dL.\n\nFor reversal of warfarin, give vitamin K.\n\nFor rapid reversal, give fresh frozen plasma (FFP) or PCC."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "warfarin reversal guidelines emergency management\"  \n", "log": "The observation confirms that fresh frozen plasma (FFP) is indeed indicated for the rapid reversal of warfarin, particularly when there is an elevated INR and potential risk of bleeding, as in this case following a fall. Given the patient's INR of 2.5 and the context of his fall, administering FFP is the best next step in management.\n\nAction: search_docs  \nAction Input: \"warfarin reversal guidelines emergency management\"  \n", "type": "AgentAction"}}, "concentration then checked.64 Rapid reversal of anticoagulation can be accom-plished with plasma or prothrombin complex concentrates in the emergent situation. An example of a warfarin reversal guideline using four-factor prothrombin complex concentrate for patients with major or life-threatening\n\nFor reversal of warfarin, give vitamin K.\n\nFor rapid reversal, give fresh frozen plasma (FFP) or PCC.\n\nconsultation is obtained (Chap. 330). Reversal of coagulopathy and consideration of surgical evacuation of the hematoma (detailed below) are two other principal aspects of initial emergency management."]]},"21": {"question": "A 42-year-old man presents for evaluation of vitamin D deficiency with possible osteomalacia. The patient had a pathologic fracture 3 weeks ago and was found to have dangerously low levels of vitamin D with normal serum calcium levels. Bone density has been drastically affected, leading to the fracture this patient experienced. The lack of what compound is most responsible for the formation of this disease?", "options": {"A": "Calcifediol", "B": "Calcitriol", "C": "Vitamin D binding protein", "D": "PTH"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'osteomalacia vitamin D deficiency calcitriol role'", "log": "To answer the question, I need to identify the compound that is most responsible for the formation of osteomalacia, particularly in the context of vitamin D deficiency. Osteomalacia is primarily caused by a deficiency in vitamin D, which is crucial for calcium absorption and bone mineralization. \n\nIn this case, the patient has low vitamin D levels, which suggests that the active form of vitamin D, calcitriol, is likely the key compound that is deficient. Calcifediol is a precursor to calcitriol, and while vitamin D binding protein and PTH are also important in bone health, they are not the primary compounds responsible for the disease formation in this context.\n\nI will search for more information to confirm my thoughts about the role of calcitriol in osteomalacia.\n\nAction: search_docs\nAction Input: 'osteomalacia vitamin D deficiency calcitriol role' ", "type": "AgentAction"}}, "D. Osteomalacia is due to low vitamin D in adults.\n\n1.\n\nInadequate mineralization results in weak bone with an increased risk for fracture.\n\n2.\n\nLaboratory findings include --1.-serum calcium, --1.-serum phosphate, t PTH, and t alkaline phosphatase.\n\nV.\n\nA. Reduction in trabecular bone mass\n\nAlthough vitamin D deficiency is the most common cause of rickets and osteomalacia, many disorders lead to inadequate mineralization of the growth plate and bone. Calcium deficiency without vitamin D deficiency, the disorders of vitamin D metabolism previously discussed, and hypophosphatemia can\n\nto the osteomalacia observed in this disease. These patients gen-erally are treated medically with a low-phosphate diet, phos-phate binders, adequate intake of calcium and 1, 25-dihydroxy  vitamin D, and a high-calcium, low-aluminum dialysis bath. Calcimimetics have been shown to control"]]},"22": {"question": "A 22-year-old man comes to the physician because of headaches and blurry vision for the past 6 months. He also reports frequent episodes of vomiting over the last month. His father has died of renal cell carcinoma at the age of 37 years. Examination shows 20/40 vision bilaterally. Fundoscopic examination shows bilateral optic disc swelling and growth of capillary vessels in the temporal peripheral retina. An MRI of the brain shows an infratentorial mass. The patient undergoes surgical resection of the mass. A photomicrograph of the resected specimen is shown. Which of the following is the most likely diagnosis?", "options": {"A": "Medulloblastoma", "B": "Oligodendroglioma", "C": "Hemangioblastoma", "D": "Ependymoma"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'infratentorial mass diagnosis symptoms medulloblastoma hemangioblastoma ependymoma' \n", "log": "To determine the most likely diagnosis based on the provided clinical details, I need to consider the symptoms, family history, and MRI findings. The patient has headaches, blurry vision, vomiting, and optic disc swelling, which suggests increased intracranial pressure. The infratentorial mass seen on MRI is significant, as certain tumors are more common in that location.\n\nGiven the age of the patient and the family history of renal cell carcinoma, I should also consider hereditary syndromes that may predispose to specific brain tumors. \n\nThe options provided include:\n- Medulloblastoma: Common in children and often presents in the cerebellum.\n- Oligodendroglioma: Typically found in adults and usually presents with seizures or focal neurological deficits.\n- Hemangioblastoma: Often associated with von Hippel-Lindau syndrome and can appear in the cerebellum or brainstem.\n- Ependymoma: Can occur in the infratentorial region, especially in children.\n\nGiven the symptoms and the location of the mass, I suspect that either medulloblastoma or hemangioblastoma could be the most likely diagnoses. However, the family history may lean towards hemangioblastoma due to its association with von Hippel-Lindau syndrome.\n\nI will search for more information regarding the characteristics of these tumors, particularly focusing on the infratentorial mass and associated symptoms.\n\nAction: search_docs\nAction Input: 'infratentorial mass diagnosis symptoms medulloblastoma hemangioblastoma ependymoma' \n", "type": "AgentAction"}}, "astrocytoma, ependymoma, and medulloblastoma.\n\nThe tumors that most often produce these unique intracranial syndromes are the ones listed above as well as a number of other erosive tumors at the base of the skull. The aforementioned medulloblastoma, hemangioblastoma, and ependymoma of the fourth ventricle may have a similar regional clinical\n\nPatients Who Present Primarily With Signs of Increased Intracranial Pressure (Medulloblastoma, Ependymoma of the Fourth Ventricle, Hemangioblastoma of the Cerebellum, Pinealoma, Colloid Cyst of the Third Ventricle and Rare Related Tumors)"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'hemangioblastoma infratentorial mass symptoms von Hippel-Lindau syndrome' \n", "log": "The search results indicate that medulloblastoma, ependymoma, and hemangioblastoma are tumors that can present with signs of increased intracranial pressure, which aligns with the symptoms described in the case (headaches, blurry vision, vomiting). The infratentorial location of the mass is particularly relevant as it is common for these tumors to arise in that area.\n\nGiven the age of the patient and the family history of renal cell carcinoma, the association with von Hippel-Lindau syndrome becomes more significant. Hemangioblastoma is known to be associated with this syndrome, which could explain the symptoms and the infratentorial mass.\n\nI will further refine my search to see if there are more specific characteristics or distinguishing features of hemangioblastoma, especially in the context of infratentorial masses and associated symptoms.\n\nAction: search_docs\nAction Input: 'hemangioblastoma infratentorial mass symptoms von Hippel-Lindau syndrome' \n", "type": "AgentAction"}}, "VON HIPPEL-LINDAU DISEASE (SEE ALSO CHAP. 407) Clinical Manifestations von Hippel-Lindau (VHL) disease is an autosomal dominant disorder characterized by hemangioblastomas of the retina and CNS; cysts involving the kidneys, pancreas, and epididymis; renal cell carcinomas; pheochromocytomas; and\n\ni. Von Hippel-Lindau disease is an autosomal dominant disorder associated with inactivation of the VHL gene leading to increased risk for hemangioblastoma of the cerebellum and renal cell carcinoma.\n\nF. Staging 1.\n\nbeen from ependymoma. With von Hippel-Lindau disease, the diagnosis hinges on the finding of the characteristic hereditary hemangioblastoma in the syrinx and retinal and cerebellar vascular malformations. In posttraumatic cases, necrosis of the spinal cord that has been stable for months or years"]]},"23": {"question": "A 53-year-old woman presents to her primary care physician with joint pain. She reports a 6-month history of progressive pain in her hands that is worse around her knuckles. The pain is symmetric bilaterally and seems to improve after she starts working in the morning at her job in a local grocery store. She has also lost 10 pounds over the past 6 months despite no changes in her weight or exercise regimen. Her past medical history is notable for seasonal allergies, hypertension, and intermittent constipation. She takes losartan and a laxative as needed. She had adolescent idiopathic scoliosis as a child and underwent a spinal fusion at the age of 14. She does not smoke or drink alcohol. Her temperature is 98.6\u00b0F (37\u00b0C), blood pressure is 135/75 mmHg, pulse is 92/min, and respirations are 16/min. On examination, she appears well and is appropriately interactive. Strength is 5/5 and sensation to light touch is intact in the bilateral upper and lower extremities. An examination of her hands demonstrates symmetric swelling of the metacarpophalangeal joints bilaterally. This patient\u2019s condition is most strongly characterized by which of the following?", "options": {"A": "HLA-B27", "B": "HLA-DR2", "C": "HLA-DR3", "D": "HLA-DR4"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "HLA-DR4 association with rheumatoid arthritis\" \n", "log": "I need to analyze the patient's symptoms and medical history to determine which HLA type is most strongly associated with her condition. The patient's presentation includes symmetric joint pain, particularly in the hands, which is a characteristic of rheumatoid arthritis (RA). RA is commonly associated with HLA-DR4. \n\nAction: search_docs \nAction Input: \"HLA-DR4 association with rheumatoid arthritis\" \n", "type": "AgentAction"}}, "rheumatoid arthritis (RA) and HLA-DR4 to 100 or more for ankylosing spondylitis and HLA-B27. However, how MHC genes influence the development of autoimmunity is still not clear. Notably, most individuals with a susceptibility-related MHC allele never develop disease, and, conversely, individuals\n\nextends across large segments of the MHC region, it is quite possible that combinations of genes may account for the particular associations of HLA haplotypes with disease. For example, on some haplotypes associated with rheumatoid arthritis, both HLA-DRB1 alleles and a particular polymorphism\n\nRheumatoid Arthritis The HLA genes associated with rheumatoid arthritis (RA) (Chap."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "HLA-DR4 rheumatoid arthritis association details\" \n", "log": "The information retrieved confirms that HLA-DR4 is indeed associated with rheumatoid arthritis. The patient's symptoms align well with RA, including symmetric joint pain and swelling in the metacarpophalangeal joints. \n\nAction: search_docs \nAction Input: \"HLA-DR4 rheumatoid arthritis association details\" \n", "type": "AgentAction"}}, "Rheumatoid Arthritis The HLA genes associated with rheumatoid arthritis (RA) (Chap.\n\nrheumatoid arthritis (RA) and HLA-DR4 to 100 or more for ankylosing spondylitis and HLA-B27. However, how MHC genes influence the development of autoimmunity is still not clear. Notably, most individuals with a susceptibility-related MHC allele never develop disease, and, conversely, individuals\n\nDessen, A., Lawrence, C.M., Cupo, S., Zaller, D.M., and Wiley, D.C.: X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 1997, 7:473\u2013481."]]},"24": {"question": "A 34-year-old man presents to a clinic with complaints of abdominal discomfort and blood in the urine for 2 days. He has had similar abdominal discomfort during the past 5 years, although he does not remember passing blood in the urine. He has had hypertension for the past 2 years, for which he has been prescribed medication. There is no history of weight loss, skin rashes, joint pain, vomiting, change in bowel habits, and smoking. On physical examination, there are ballotable flank masses bilaterally. The bowel sounds are normal. Renal function tests are as follows:\nUrea 50 mg/dL\nCreatinine 1.4 mg/dL\nProtein Negative\nRBC Numerous\nThe patient underwent ultrasonography of the abdomen, which revealed enlarged kidneys and multiple anechoic cysts with well-defined walls. A CT scan confirmed the presence of multiple cysts in the kidneys. What is the most likely diagnosis?", "options": {"A": "Autosomal dominant polycystic kidney disease (ADPKD)", "B": "Autosomal recessive polycystic kidney disease (ARPKD)", "C": "Medullary cystic disease", "D": "Acquired cystic kidney disease"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Autosomal dominant polycystic kidney disease (ADPKD) symptoms and diagnosis\" \n", "log": "The patient's symptoms and imaging findings suggest a renal condition characterized by multiple cysts in the kidneys. The age of the patient, the presence of hypertension, and the history of abdominal discomfort are important factors to consider. Autosomal dominant polycystic kidney disease (ADPKD) is known to present with multiple renal cysts, abdominal pain, and hypertension, typically in adults. On the other hand, autosomal recessive polycystic kidney disease (ARPKD) usually presents in childhood. Medullary cystic disease and acquired cystic kidney disease are less likely given the patient's age and presentation. \n\nGiven these considerations, I will search for more information to confirm the most likely diagnosis.\n\nAction: search_docs\nAction Input: \"Autosomal dominant polycystic kidney disease (ADPKD) symptoms and diagnosis\" \n", "type": "AgentAction"}}, "C. Autosomal Dominant Polycystic Kidney Disease\n\nClinical Manifestations ADPKD is characterized by the progressive bilateral formation of renal cysts. Focal renal cysts are typically detected in affected subjects before 30 years of age. Hundreds to thousands of cysts are usually present in the kidneys of most patients in the fifth decade (Fig.\n\nAutosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease, occurring in about 1 in 1000 people. Approximately 12.5 million people worldwide have ADPKD, which is caused primarily by mutations in PKD1 (85%\u201390% of cases) or PKD2 (\u224815% of cases). The major"]]},"25": {"question": "A 40-year-old woman comes to the physician because of a 2-week history of anal pain that occurs during defecation and lasts for several hours. She reports that she often strains during defecation and sees bright red blood on toilet paper after wiping. She typically has 3 bowel movements per week. Physical examination shows a longitudinal, perianal tear. This patient's symptoms are most likely caused by tissue injury in which of the following locations?", "options": {"A": "Posterior midline of the anal canal, distal to the pectinate line", "B": "Anterior midline of the anal canal, distal to the pectinate line", "C": "Posterior midline of the anal canal, proximal to the pectinate line", "D": "Lateral aspect of the anal canal, distal to the pectinate line"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "anal fissure location symptoms", "log": "To answer the question, I need to analyze the symptoms and the physical examination findings. The patient has anal pain during defecation, bright red blood on toilet paper, and a longitudinal perianal tear. These symptoms suggest a condition such as an anal fissure, which commonly occurs in specific locations. \n\nIn adults, anal fissures typically occur at the posterior midline of the anal canal, especially distal to the pectinate line. The pectinate line is significant because it separates the areas of the anal canal that are innervated by different nerves and have different blood supplies. Given that the patient has a tear and is experiencing pain during defecation, it is likely that this is a classic case of a posterior anal fissure.\n\nNow, I will proceed to search for more information to confirm this reasoning.\n\nAction: search_docs  \nAction Input: \"anal fissure location symptoms\"  ", "type": "AgentAction"}}, "off midline.Symptoms and Findings.\u2002Anal fissure is extremely common. Characteristic symptoms include tearing pain with defecation and hematochezia (usually described as blood on the toilet paper). Patients may also complain of a sensation of intense and painful anal spasm lasting for several hours\n\ncycle of pain, spasm, and ischemia contributes to development of a poorly healing wound that becomes a chronic fissure. The vast major-ity of anal fissures occur in the posterior midline. Ten percent to 15% occur in the anterior midline. Less than 1% of fissures occur off midline.Symptoms and\n\nwith hemorrhoids. On examination, most fissures are located in either the posterior or anterior position. A lateral fissure is worrisome because it may have a less benign nature, and systemic disorders should be ruled out. A chronic fissure is indicated by the presence of a hypertrophied anal"]]},"26": {"question": "A 40-year-old G1P0010 presents to the clinic with nausea and vomiting 8 weeks after a spontaneous abortion at 10 weeks gestation. She admits to heavy drinking (7\u20138 glasses of wine per day) for the last 20 years; however, after the pregnancy loss, she increased her drinking to 8\u20139 glasses per day. Hepatomegaly, right upper quadrant pain, and jaundice are noted on abdominal examination. The lungs are clear to auscultation with no abnormalities on chest X-ray. Liver function tests are obtained and a biopsy is performed. Which of the following findings is most likely to be true in her condition?", "options": {"A": "\u2191 NADH/NAD+; AST:ALT \u2265 2:1; \u00df-oxidation \u2193; \u00df-hydroxybutyrate \u2191; lactic acid \u2191", "B": "\u2191 NAD+/NADH; ALT:AST \u2265 2:1; \u00df-oxidation \u2191; \u00df-hydroxybutyrate, no change; lactic acid \u2193", "C": "\u2191 NAD+/NADH; AST:ALT \u2265 2:1; \u00df-oxidation \u2191; \u00df-hydroxybutyrate \u2193; lactic acid \u2193", "D": "\u2191 NADH/NAD+; ALT:AST \u2265 2:1; \u00df-oxidation \u2193; \u00df-hydroxybutyrate \u2193; lactic acid \u2191"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'metabolic changes alcoholic liver disease'", "log": "To answer the question, I need to analyze the clinical scenario presented. The patient has a history of heavy alcohol consumption and presents with symptoms and signs suggestive of liver disease, likely alcoholic hepatitis or liver dysfunction due to alcohol. Given the context, I should look for specific metabolic changes associated with alcoholic liver disease.\n\nKey points to consider:\n- In alcoholic liver disease, there's often an increase in the NADH/NAD+ ratio due to alcohol metabolism.\n- The AST:ALT ratio is typically greater than or equal to 2:1 in alcoholic liver disease.\n- There may be decreased \u03b2-oxidation due to the toxic effects of alcohol on liver metabolism.\n- Increased levels of \u03b2-hydroxybutyrate and lactic acid are also common due to altered metabolic processes.\n\nBased on this reasoning, I should search for relevant documents that confirm these metabolic changes in alcoholic liver disease.\n\nAction: search_docs  \nAction Input: 'metabolic changes alcoholic liver disease'  ", "type": "AgentAction"}}, "to ethanol, especially daily heavy drinking, more severe changes in the liver occur, including alcohol-induced hepatitis, perivenular sclerosis, and cirrhosis, with the latter observed in an estimated 15% of alcoholics (Chap. 363). Perhaps through an enhanced vulnerability to infections, alcoholics\n\nThe pathogenesis of alcoholic liver disease is a multifactorial process involving metabolic repercussions of ethanol oxidation in the liver, dysregulation of fatty acid oxidation and synthesis, and activation of the innate immune system by a combination of direct effects of ethanol and its\n\nentire spectrum of hepatic changes associated with alcohol abuse. Since the morphologic changes of alcoholic and NAFLD are indistinguishable, they are discussed together, followed by the pathogenesis and distinctive clinical features of each entity."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'alcoholic liver disease metabolic changes NADH AST ALT \u03b2-oxidation'", "log": "The search result did not provide specific metabolic changes related to alcoholic liver disease. However, I can summarize the key points I know. Given the patient's history of heavy drinking, symptoms, and clinical findings, the condition is likely alcoholic hepatitis. \n\nKey findings to consider:\n- Increased NADH/NAD+ ratio.\n- AST:ALT ratio typically \u2265 2:1.\n- Decreased \u03b2-oxidation due to alcohol's effects on liver metabolism.\n- Increased \u03b2-hydroxybutyrate and lactic acid levels.\n\nI need to check if any of the options align with these findings.\n\nOptions to analyze:\n- A: \u2191 NADH/NAD+; AST:ALT \u2265 2:1; \u00df-oxidation \u2193; \u00df-hydroxybutyrate \u2191; lactic acid \u2191\n- B: \u2191 NAD+/NADH; ALT:AST \u2265 2:1; \u00df-oxidation \u2191; \u00df-hydroxybutyrate, no change; lactic acid \u2193\n- C: \u2191 NAD+/NADH; AST:ALT \u2265 2:1; \u00df-oxidation \u2191; \u00df-hydroxybutyrate \u2193; lactic acid \u2193\n- D: \u2191 NADH/NAD+; ALT:AST \u2265 2:1; \u00df-oxidation \u2193; \u00df-hydroxybutyrate \u2193; lactic acid \u2191\n\nGiven the known changes in alcoholic liver disease, I will analyze the options further.\n\nAction: search_docs  \nAction Input: 'alcoholic liver disease metabolic changes NADH AST ALT \u03b2-oxidation'  ", "type": "AgentAction"}}, "During conversion of ethanol by ADH to acetaldehyde, hydrogen ion is transferred from ethanol to the cofactor nicotinamide adenine dinucleotide (NAD+) to form NADH. As a net result, alcohol oxidation generates an excess of reducing equivalents in the liver, chiefly as NADH. The excess NADH\n\nRQ1. Many of the metabolic consequences of chronic excessive alcohol consumption seen in AK are the result of an increase in the ratio of reduced nicotinamide adenine dinucleotide (NADH) to its oxidized form (NAD+) in both the cytoplasm and mitochondria. Which of the following statements concerning\n\nChronic alcohol consumption can also result in alcoholic fatty liver because of increased hepatic synthesis of TAG coupled with impaired formation or release of VLDL. This occurs as a result of decreased FA oxidation because of a fall in the NAD+/NADH ratio and increased lipogenesis because of the"]]},"27": {"question": "A 24-year-old professional athlete is advised to train in the mountains to enhance his performance. After 5 months of training at an altitude of 1.5 km (5,000 feet), he is able to increase his running pace while competing at sea-level venues. Which of the following changes would produce the same effect on the oxygen-hemoglobin dissociation curve as this athlete's training did?", "options": {"A": "Decreased pH", "B": "Decreased temperature", "C": "Decreased 2,3-bisphosphoglycerate", "D": "Increased partial pressure of oxygen"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "oxygen-hemoglobin dissociation curve effects of pH temperature 2,3-bisphosphoglycerate partial pressure of oxygen", "log": "To answer this question, I need to understand how altitude training affects the oxygen-hemoglobin dissociation curve. Training at high altitudes typically leads to physiological adaptations that enhance oxygen delivery to tissues. This is often associated with increased levels of 2,3-bisphosphoglycerate (2,3-BPG), which shifts the curve to the right, facilitating oxygen release to tissues. \n\nNow, I need to identify which of the options would produce a similar rightward shift in the oxygen-hemoglobin dissociation curve.\n\nAction: search_docs  \nAction Input: \"oxygen-hemoglobin dissociation curve effects of pH temperature 2,3-bisphosphoglycerate partial pressure of oxygen\"  ", "type": "AgentAction"}}, "Figure 58-1 Hemoglobin-oxygen dissociation curves. The position of the adult curve depends on the binding of adult hemoglobin to 2,3-diphosphoglycerate (DPG), temperature, PCO2, and hydrogen ion concentration (pH).\n\nHgb (Fig. 24.4 ). The S shape of the curve demonstrates the dependence of Hgb saturation on PO2, especially at partial pressures lower than 60 mm Hg. The clinical significance of the flat portion of the oxyhemoglobin dissociation curve (>60 mm Hg) is that a drop in PO2 over a wide range of partial\n\ncan oxidize the \u2022Fig. 24.4 Oxyhemoglobin Dissociation Curve Showing the Relationship Between the Partial Pressure of Oxygen (Po2) in Blood and the Percentage of Hemoglobin (Hgb) Binding Sites That Are Occupied by Oxygen Molecules (Percentage Saturation)."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "oxygen-hemoglobin dissociation curve right shift causes", "log": "The search results provided information about the factors affecting the oxygen-hemoglobin dissociation curve, such as 2,3-bisphosphoglycerate (2,3-BPG), temperature, pH, and partial pressure of oxygen (PO2). A rightward shift in the curve, which enhances oxygen delivery, can be caused by decreased pH (increased acidity), increased temperature, or increased levels of 2,3-BPG. Conversely, an increased partial pressure of oxygen typically shifts the curve to the left, making it harder for oxygen to be released from hemoglobin.\n\nNext, I need to analyze the options given in relation to these factors and determine which one would produce a similar rightward shift in the oxygen-hemoglobin dissociation curve as altitude training.\n\nOptions:\n- A: Decreased pH (would shift the curve to the right)\n- B: Decreased temperature (would shift the curve to the left)\n- C: Decreased 2,3-bisphosphoglycerate (would shift the curve to the left)\n- D: Increased partial pressure of oxygen (would shift the curve to the left)\n\nGiven that altitude training typically leads to adaptations that enhance oxygen delivery, I need to identify the option that would have a similar effect.\n\nAction: search_docs  \nAction Input: \"oxygen-hemoglobin dissociation curve right shift causes\"  ", "type": "AgentAction"}}, "Physiological Factors That Shift the Oxyhemoglobin Dissociation Curve\n\nThe oxyhemoglobin dissociation curve can shift in numerous clinical conditions, either to the right or to the left (\n\nFig.\n\n24.5 ). The curve is shifted to the right when the affinity of\n\noxygen dissociation portion representing the tissue-capillary environment. Shifts of the curve have their greatest efect at the steep portion because they afect oxygen delivery. A rightward shit is associated with decreased hemoglobin ainity for oxygen and hence increased tissue-capillary oxygen :0\n\nOxygen-dissociation curve shift: Hemoglobin from which 2,3-BPG has been removed has high oxygen affinity. However, as seen in the RBC, the presence of 2,3-BPG significantly reduces the oxygen affinity of hemoglobin, shifting the oxygen-dissociation curve to the right (Fig. 3.12). This reduced"]]},"28": {"question": "A 35-year-old man presents to pulmonary function clinic for preoperative evaluation for a right pneumonectomy. His arterial blood gas at room air is as follows:\n\npH: 7.34\nPaCO2: 68 mmHg\nPaO2: 56 mmHg\nBase excess: +1\nO2 saturation: 89%\n\nWhat underlying condition most likely explains these findings?", "options": {"A": "Acute respiratory distress syndrome", "B": "Chronic obstructive pulmonary disease", "C": "Cystic fibrosis", "D": "Obesity"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'underlying condition for low pH high PaCO2 hypoxemia in adults' \n", "log": "To determine the underlying condition that explains the arterial blood gas findings, I need to analyze the results provided. The patient has a low pH (7.34), indicating acidosis, elevated PaCO2 (68 mmHg), suggesting respiratory acidosis, and low PaO2 (56 mmHg) with an O2 saturation of 89%, indicating hypoxemia. \n\nChronic obstructive pulmonary disease (COPD) is characterized by chronic respiratory acidosis and hypoxemia due to airflow limitation, which aligns with the findings. Other options like acute respiratory distress syndrome (ARDS) typically present with a different profile, cystic fibrosis usually has a different set of symptoms and complications, and obesity can lead to hypoventilation but is less likely to cause such severe gas exchange abnormalities.\n\nGiven this analysis, I will search for more information to confirm my reasoning regarding the most likely underlying condition.\n\nAction: search_docs\nAction Input: 'underlying condition for low pH high PaCO2 hypoxemia in adults' \n", "type": "AgentAction"}}, "the resting level of Paco2 in spontaneously breathing patients.\n\nThe clinical features vary according to the severity and duration of the respiratory acidosis, the underlying disease, and whether there is accompanying hypoxemia. A rapid increase in Paco2 may cause anxiety, dyspnea, confusion, psychosis, and hallucinations and may progress to coma. Lesser degrees\n\nrange. If the hypoxemia is severe, the increased respiratory drive secondary to the hypoxemia increases the ventilation and can decrease PaCO2 to below the normal range."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'COPD arterial blood gas findings respiratory acidosis hypoxemia' \n", "log": "The observation provided information about the clinical features of respiratory acidosis and hypoxemia but did not directly address the specific underlying conditions associated with the given arterial blood gas results. Given the context, I should consider the characteristics of the options provided.\n\nChronic obstructive pulmonary disease (COPD) typically presents with chronic respiratory acidosis and hypoxemia due to airflow limitation, which aligns with the patient's arterial blood gas findings. The other conditions listed (ARDS, cystic fibrosis, and obesity) do not fit as well with the combination of low pH, high PaCO2, and hypoxemia in this particular case.\n\nI will search again to find more specific references that directly link these arterial blood gas findings to the most likely underlying condition.\n\nAction: search_docs\nAction Input: 'COPD arterial blood gas findings respiratory acidosis hypoxemia' \n", "type": "AgentAction"}}, "Arterial blood gas To determine severity of respiratory compromise, hypoxemia, and hypercapnia and type of acidosis; severity determines treatment strategy\n\nChronic obstructive pulmonary disease such as emphysema, fibrosing lung disease, neuromuscular weakness, and, in some instances, inadequacy of the medullary respiratory centers each may lead to persistent respiratory acidosis, with elevated Pco2 and reduced arterial Po2. The complete clinical\n\nArterial blood gas testing is often helpful in assessing respiratory 1663 disease. Hypoxemia, while usually apparent with pulse oximetry, can be further evaluated with the measurement of arterial PO2 and the calculation of an alveolar gas and arterial blood oxygen tension difference ([A\u2013a]DO2)."]]},"29": {"question": "A 48-year old man comes to the physician for the evaluation of an 8-month history of fatigue and profuse, watery, odorless diarrhea. He reports that he has had a 10.5-kg (23-lb) weight loss during this time. Physical examination shows conjunctival pallor and poor skin turgor. Laboratory studies show:\nHemoglobin 9.8 g/dl\nSerum\nGlucose (fasting) 130 mg/dl\nK+ 2.5 mEq/L\nCa2+ 12 mg/dl\nA CT scan of the abdomen with contrast shows a 3.0 \u00d7 3.2 \u00d7 4.4 cm, well-defined, enhancing lesion in the pancreatic tail. Further evaluation of this patient is most likely to show which of the following findings?\"", "options": {"A": "Achlorhydria", "B": "Cholelithiasis", "C": "Deep vein thrombosis", "D": "Episodic hypertension"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'pancreatic tail lesion achlorhydria VIPoma symptoms'  \n", "log": "The patient presents with symptoms that suggest a pancreatic condition, particularly given the well-defined enhancing lesion in the pancreatic tail. The combination of fatigue, diarrhea, weight loss, and electrolyte imbalances (notably hypokalemia) raises the suspicion of a pancreatic endocrine tumor, such as a VIPoma, which can cause watery diarrhea and may lead to achlorhydria due to the effects on gastric secretions.\n\nAction: search_docs  \nAction Input: 'pancreatic tail lesion achlorhydria VIPoma symptoms'  \n", "type": "AgentAction"}}, "and electrolytes. VIPomas are more commonly located in the distal pancreas and most have spread outside the pancreas. Palliative debulking operations can some-times improve symptoms for a period, along with somatostatin analogues. Hepatic artery embolization also has been reported as a potentially\n\nsymptoms. These phenomena and other features of parietal lobe lesions are, as mentioned, considered further in Chap. 21.\n\ntumors, which may involve extra-adrenal sites in VHL disease. The most frequent pancreatic lesions in VHL are multiple cyst-adenomas, which rarely cause clinical disease. However, nonsecreting pancreatic islet cell tumors occur in <10% of VHL patients, who are usually asymptomatic. The pancreatic"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'VIPoma achlorhydria symptoms pancreatic tumor'  \n", "log": "The information retrieved does not provide a clear answer to the question. However, it supports the notion that a pancreatic lesion, particularly a VIPoma, can lead to achlorhydria due to its effects on gastric secretions. This aligns with the patient's symptoms, including watery diarrhea and electrolyte imbalances.\n\nAction: search_docs  \nAction Input: 'VIPoma achlorhydria symptoms pancreatic tumor'  \n", "type": "AgentAction"}}, "and electrolytes. VIPomas are more commonly located in the distal pancreas and most have spread outside the pancreas. Palliative debulking operations can some-times improve symptoms for a period, along with somatostatin analogues. Hepatic artery embolization also has been reported as a potentially\n\nIn adults, 80\u201390% of VIPomas are pancreatic in location, with the rest due to VIP-secreting pheochromocytomas, intestinal carcinoids, and rarely ganglioneuromas. These tumors are usually solitary, 50\u201375% are in the pancreatic tail, and 37\u201368% have hepatic metastases at diagnosis. In children <10\n\nVasoactive Intestinal Peptide (VIP) Tumors (VIPomas) VIPomas have been reported in only a few patients with MEN 1. This clinical syndrome is characterized by watery diarrhea, hypokalemia, and achlorhydria and is also referred to as the Verner-Morrison syndrome, the WDHA (watery diarrhea,"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'VIPoma achlorhydria diagnosis findings'  \n", "log": "The retrieved information confirms that VIPomas are associated with a clinical syndrome characterized by watery diarrhea, hypokalemia, and achlorhydria. The patient's symptoms and findings are consistent with this condition. Achlorhydria is a likely finding in this case due to the effects of the VIPoma on gastric secretions.\n\nAction: search_docs  \nAction Input: 'VIPoma achlorhydria diagnosis findings'  \n", "type": "AgentAction"}}, "Vasoactive Intestinal Peptide (VIP) Tumors (VIPomas) VIPomas have been reported in only a few patients with MEN 1. This clinical syndrome is characterized by watery diarrhea, hypokalemia, and achlorhydria and is also referred to as the Verner-Morrison syndrome, the WDHA (watery diarrhea,\n\nthe WDHA (watery diarrhea, hypokalemia, and achlorhydria) syndrome, or the VIPoma syndrome. The diagnosis is established by excluding laxative and diuretic abuse, by confirming a stool volume in excess of 0.5\u20131.0 L/d during a fast, and by documenting a markedly increased plasma VIP concentration.\n\nThe vasoac-tive intestinal peptide-secreting tumor (VIPoma) syndrome is also called WDHA syndrome due to the presence of watery diarrhea, hypokalemia, and achlorhydria. The massive (5 L/d) and episodic nature of the diarrhea associated with the appropriate electrolyte abnormalities should raise"]]},"30": {"question": "A 74-year-old man presents to the emergency department with sudden-onset abdominal pain that is most painful around the umbilicus. The pain began 16 hours ago and has no association with meals. He has not been vomiting, but he has had several episodes of bloody loose bowel movements. He was hospitalized 1 week ago for an acute myocardial infarction. He has had diabetes mellitus for 35 years and hypertension for 20 years. He has smoked 15\u201320 cigarettes per day for the past 40 years. His temperature is 36.9\u00b0C (98.42\u00b0F), blood pressure is 95/65 mm Hg, and pulse is 95/min. On physical examination, the patient is in severe pain, there is mild periumbilical tenderness, and a bruit is heard over the epigastric area. Which of the following is the definitive test to assess the patient condition?", "options": {"A": "Mesenteric angiography", "B": "CT scanning", "C": "Plain abdominal X-rays", "D": "Colonoscopy"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "definitive test for mesenteric ischemia", "log": "To determine the definitive test for this patient's condition, I need to analyze the symptoms and clinical presentation. The patient has sudden-onset abdominal pain, bloody loose bowel movements, and a history of significant cardiovascular risk factors. The presence of a bruit over the epigastric area suggests possible vascular involvement, which could indicate mesenteric ischemia. \n\nGiven this context, mesenteric angiography would be a key diagnostic test to visualize blood flow to the intestines and identify any blockages or ischemia. While CT scanning can also be useful in this scenario, mesenteric angiography is often considered the definitive test for assessing mesenteric blood supply.\n\nAction: search_docs\nAction Input: \"definitive test for mesenteric ischemia\"", "type": "AgentAction"}}, "during the test. This tool is frequently used as a screening test for patients with symptoms suggestive of chronic mesenteric ischemia. The gold standard for confirmation of mesenteric arterial occlusion is mesenteric angiography. Evaluation with mesenteric angiography allows for identification and\n\nvalue of mesenteric ischemia. More significantly, a negative duplex scan virtually precludes the diagnosis of mesenteric ischemia. Duplex imaging serves as a screening test; further investigations with angiography are needed. The biggest limitation of duplex scanning is body habitus; in obese\n\nF. Surgical management of mesenteric ischemia. Tech Vasc Interv Radiol. 2004;7(3):151-154.\t90.\tMitchell EL, Moneta GL. Mesenteric duplex scanning. Per-spect Vasc Surg Endovasc Ther. 2006;18(2):175-183.\t91.\tMoneta GL, Lee RW, Yeager RA, Taylor LM Jr, Porter JM. Mesenteric duplex scanning: a blinded"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "definitive test for mesenteric ischemia diagnosis", "log": "The search results confirm that mesenteric angiography is indeed considered the gold standard for confirming mesenteric arterial occlusion and is the definitive test for assessing mesenteric ischemia. This aligns with my initial thought regarding the patient's presentation and symptoms, which strongly suggest a vascular issue related to the intestines.\n\nAction: search_docs\nAction Input: \"definitive test for mesenteric ischemia diagnosis\"", "type": "AgentAction"}}, "during the test. This tool is frequently used as a screening test for patients with symptoms suggestive of chronic mesenteric ischemia. The gold standard for confirmation of mesenteric arterial occlusion is mesenteric angiography. Evaluation with mesenteric angiography allows for identification and\n\nvalue of mesenteric ischemia. More significantly, a negative duplex scan virtually precludes the diagnosis of mesenteric ischemia. Duplex imaging serves as a screening test; further investigations with angiography are needed. The biggest limitation of duplex scanning is body habitus; in obese\n\nspectroscopy can be used in the diagnosis of chronic ischemia. When suspecting mesenteric ischemia involving the colon, performing an endoscopy to evaluate up to the splenic"]]},"31": {"question": "An investigator is studying the principles of cell-to-cell signaling of the autonomic nervous system. It is found that the adrenal medulla has receptors that, when activated, result in the immediate opening of Na+, Ca2+, and K+ channels, which subsequently leads to the secretion of epinephrine and norepinephrine. These receptors are structurally most similar to which of the following receptors?", "options": {"A": "H2 receptors of the stomach", "B": "M2 receptors of heart", "C": "D2 receptors of the basal ganglia", "D": "NM receptors of the quadriceps femoris muscle"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "adrenal medulla receptors structural similarities ionotropic G-protein coupled receptors H2 M2 D2 NM\"\n", "log": "To determine which receptor type the adrenal medulla receptors are structurally most similar to, I need to consider the characteristics of the receptors mentioned in the options. Given that the adrenal medulla receptors are involved in the activation of ion channels and the secretion of catecholamines (epinephrine and norepinephrine), they are likely to be ionotropic receptors or G-protein coupled receptors that have a fast response mechanism.\n\nAction: search_docs\nAction Input: \"adrenal medulla receptors structural similarities ionotropic G-protein coupled receptors H2 M2 D2 NM\"\n", "type": "AgentAction"}}, "All four receptor types have been cloned and belong to the large superfamily of G protein-coupled receptors (GPCR). The structures of the H1 and H2 receptors differ significantly and appear to be more closely related to muscarinic and 5-HT1 receptors, respectively, than to each other. The H4\n\nwhich is called the adrenal medulla (see\n\n6.12\u2003Neurotransmitter\u2003receptors.\u2003The\u2003basic\u2003structure\u2003and\u2003mechanism\u2003of\u2003action\u2003are\u2003shown\u2003for\u2003ligand-gated\u2003ion\u2003channels\u2003(ionotropic\u2003receptors)\u2003(A)\u2003and\u2003G\u2003protein\u2013coupled\u2003(metabotropic)\u2003receptors\u2003(B).\u2003Detailed\u2003structures\u2003of\u2003cys-loop\u2003and\u2003glutamate\u2003ionotropic\u2003receptors\u2003are\u2003shown\u2003in\u2003C\u2003and\u2003D,\u2003respectively."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "H2 receptors M2 receptors D2 receptors NM receptors structure function comparison\"\n", "log": "The information retrieved indicates that all four receptor types belong to the superfamily of G protein-coupled receptors (GPCR). However, the adrenal medulla receptors are involved in the immediate activation of ion channels, which suggests they might be more similar to ionotropic receptors. Given the options, I need to analyze the structural similarities further, focusing on which receptor type among the options is more aligned with the characteristics of the adrenal medulla receptors.\n\nAction: search_docs\nAction Input: \"H2 receptors M2 receptors D2 receptors NM receptors structure function comparison\"\n", "type": "AgentAction"}}, "and H2 receptors, and several other receptor systems.\n\nreceptors within these groups (see Chapter 2).\n\nTABLE 9\u20132 Relative receptor affinities.\n\n1See text."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "M2 receptors D2 receptors NM receptors structural characteristics comparison\"\n", "log": "The previous search did not yield sufficient information to make a clear comparison between the receptor types. I need to refine my search to specifically focus on the structural characteristics and functional similarities of the M2, D2, and NM receptors, as well as their relationship to ionotropic and metabotropic receptors.\n\nAction: search_docs\nAction Input: \"M2 receptors D2 receptors NM receptors structural characteristics comparison\"\n", "type": "AgentAction"}}, "receptors within these groups (see Chapter 2).\n\nTABLE 9\u20132 Relative receptor affinities.\n\n1See text.\n\nreceptors?"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "structural similarities M2 D2 NM receptors ionotropic metabotropic function comparison\"\n", "log": "The retrieved documents are not providing specific structural comparisons or detailed functional characteristics of the M2, D2, and NM receptors in relation to the adrenal medulla receptors. I need to search for more targeted information regarding the structural and functional similarities of these receptor types, particularly focusing on their roles in cell signaling and their ion channel interactions.\n\nAction: search_docs\nAction Input: \"structural similarities M2 D2 NM receptors ionotropic metabotropic function comparison\"\n", "type": "AgentAction"}}, "One important difference between ionotropic and metabotropic receptors is that the kinetics of ionotropic receptor effects are fast (generally <1 ms) because 444e-3 neurotransmitter binding directly alters the electrical properties of the postsynaptic cell, whereas metabotropic receptors function\n\nThe metabotropic glutamate receptors are G protein-coupled receptors that act indirectly on ion channels via G proteins. Metabotropic receptors (mGluR1\u2013mGluR8) have been divided into three groups (I, II, and III). A variety of agonists and antagonists have been developed that interact selectively\n\ninteract with G proteins, stimulating production of second messengers and activating protein kinases, which modulate a variety of cellular events. Ionotropic receptors are multiple subunit structures, whereas metabotropic receptors are composed of single subunits only. One important difference"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "H2 M2 D2 NM receptor types ionotropic metabotropic classification\"\n", "log": "The information retrieved highlights the key differences between ionotropic and metabotropic receptors. Ionotropic receptors are characterized by their fast response times, as they directly alter the electrical properties of the postsynaptic cell, while metabotropic receptors, which include G protein-coupled receptors, act indirectly via second messengers. This suggests that the adrenal medulla receptors, which activate ion channels quickly, are more similar to ionotropic receptors. \n\nNow, I need to determine which of the options (H2, M2, D2, NM) are classified as ionotropic or have structural similarities to ionotropic receptors.\n\nAction: search_docs\nAction Input: \"H2 M2 D2 NM receptor types ionotropic metabotropic classification\"\n", "type": "AgentAction"}}, "The metabotropic glutamate receptors are G protein-coupled receptors that act indirectly on ion channels via G proteins. Metabotropic receptors (mGluR1\u2013mGluR8) have been divided into three groups (I, II, and III). A variety of agonists and antagonists have been developed that interact selectively\n\nThe second class of neurotransmitter receptor is referred to as metabotropic receptors (Figure 21\u20132C). These are seventransmembrane G protein-coupled receptors of the type described in Chapter 2. The binding of neurotransmitter to this type of receptor does not result in the direct gating of a\n\nGlutamate has both ionotropic and metabotropic receptors. Based on pharmacological properties and subunit composition, several distinct ionotropic receptor subtypes are recognized: AMPA, kainate, and NMDA. Overall, there are 18 known genes that code for glutamate subunits for the ionotropic"]]},"32": {"question": "A 27-year-old G1P0 presents to her obstetrician for her normal 30-week obstetric appointment. She reports that she feels well and has no complaints. Her past medical history is notable for intermittent asthma. Her only medications are prenatal vitamins. She has gained 10 pounds, more than expected given her current stage of pregnancy. Abdominal ultrasound reveals the presence of twins with separate amniotic sacs that share a common chorion and placenta. During which time interval following fertilization did the morula divide into two in this mother?", "options": {"A": "Days 4-8", "B": "Days 9-12", "C": "Days 13-15", "D": "Day 16+"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "morula division timing twins pregnancy", "log": "To answer the question, I need to determine the timing of the morula's division into two separate entities in the context of twin pregnancies. The options provided correspond to different time frames following fertilization. I will search for relevant information regarding the timing of morula division in relation to twin pregnancies.\n\nAction: search_docs  \nAction Input: \"morula division timing twins pregnancy\"  ", "type": "AgentAction"}}, "Rayburn WF, Lavin]P Jr, Miodovnik M, et al: Multiple gestation: time interval between delivery of the irst and second twins. Obstet Gynecol 63:502, 1984\n\nEaster SR, Robinson ]N, Lieberman E, et a1: Association of intended route of delivery and maternal morbidiry in twin pregnancy. Obstet Gynecol 129(2):305,t2017\n\nHernandez ]S, Twickler DM, McIntire DO, et al: Hydramnios in twin gestations. Obstet Gynecol 120(4):759,t2012\n\nHerranz G: he timing of monozygotic twinning: a criticism of the common model. Zygote 23(1):27, 2015"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "timing of morula division monozygotic twins", "log": "The search did not yield direct information about the timing of morula division in twin pregnancies, but it did provide references that could potentially contain relevant information. I will refine my search to focus more specifically on the timing of morula division in the context of monozygotic (identical) twins, as this is pertinent to understanding the timing of division.\n\nAction: search_docs  \nAction Input: \"timing of morula division monozygotic twins\"  ", "type": "AgentAction"}}, "The outcome of the monozygotic twinning process depends on when division oCCuts. If zygotes divide within the irst 72 hours after fertilization, two embryos, two amnions, and two chorions develop, and a diamnionic, dichorionic twin pregnancy evolves (Fig. 45-1). Two distinct placentas or a single,\n\nFIGURE 45-1 Mechanism of monozygotic twinning. Black boxing and blue arrows in columns A, B, and C indicates timing of division.\n\nHerranz (2015) ofered a provocative alternative hypothesis, which posits that monozygotic twinning occurs with splitting at the postzygotic twocell stage. Notably, data are not robust in support of either the traditional or the newly proposed model (Denker, 2015)."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "morula division timing pregnancy days 4-8 days 9-12 days 13-15 day 16+", "log": "The information gathered indicates that if division occurs within the first 72 hours after fertilization, it leads to a diamniotic, dichorionic twin pregnancy. However, the specific time frame needs to be clarified further. Given that the options for morula division timing are provided, I will continue to refine my search to pinpoint the exact timing of morula division in relation to the options given.\n\nAction: search_docs  \nAction Input: \"morula division timing pregnancy days 4-8 days 9-12 days 13-15 day 16+\"  ", "type": "AgentAction"}}, "This calculation has been termed the Naegele rule. The period of gestation can also be divided into three units of approximately 14 weeks each. These three trimesters are important obstetrical milestones.\n\nIt has become customary to divide pregnancy into three equal epochs or trimesters of approximately 3 calendar months. Historically, the irst trimester extends through completion of 14 weeks, the second through 28 weeks, and the third includes the 29th through 42nd weeks of pregnancy. Thus, there\n\nweeks,\" as pregnancies between 41 weeks 1 day and 41 weeks 6 days, although in the 42nd week, do not complete 42 weeks until the seventh day has elapsed. The method that we use widely in this book is to divide the 42nd week into 7 days, that is, 42\u00b0/7 through 426' weeks."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "embryo development morula stage timing of division monozygotic twins", "log": "The previous search did not provide specific information about the timing of morula division in relation to twin pregnancies and the specified options. I need to focus on the developmental stages of the embryo, particularly the morula stage, and when it typically divides to form monozygotic twins. \n\nAction: search_docs  \nAction Input: \"embryo development morula stage timing of division monozygotic twins\"  ", "type": "AgentAction"}}, "The outcome of the monozygotic twinning process depends on when division oCCuts. If zygotes divide within the irst 72 hours after fertilization, two embryos, two amnions, and two chorions develop, and a diamnionic, dichorionic twin pregnancy evolves (Fig. 45-1). Two distinct placentas or a single,\n\n\u2022 Genesis of Monozygotic Twins\n\nFIGURE 45-1 Mechanism of monozygotic twinning. Black boxing and blue arrows in columns A, B, and C indicates timing of division."]]},"33": {"question": "A 72-year-old man is brought to the emergency department with increasing fever and abdominal pain over the past week. The pain is constant and limited to the lower right part of his abdomen. He has nausea but no vomiting or diarrhea. His past medical history is unremarkable for any serious illnesses. He takes acetaminophen for knee arthritis. He is fully alert and oriented. His temperature is 39.5\u00b0C (103.1\u00b0F), pulse is 89/min, respirations are 15/min, and blood pressure is 135/70 mm Hg. Abdominal examination shows a tender mass in the right lower quadrant. CT shows obstruction of the appendiceal neck with a fecalith and the appendiceal tip leading to an irregular walled-off fluid collection. Stranding of the surrounding fat planes is also noted. Intravenous hydration is initiated. Which of the following is the most appropriate next step in management?", "options": {"A": "Antibiotics + CT-guided drainage", "B": "Antibiotics + interval appendectomy", "C": "Appendectomy within 12 hours", "D": "Early surgical drainage + interval appendectomy"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "management of appendiceal abscess in adults\" \n", "log": "The clinical presentation and CT findings suggest that the patient has an appendiceal abscess due to appendicitis complicated by a fecalith. In such cases, the standard management involves initiating antibiotics and considering drainage of the abscess, especially if it is significant. Surgical intervention can be delayed after initial management with antibiotics and drainage. Therefore, I need to find the most appropriate next step in management based on current guidelines for such cases.\n\nAction: search_docs\nAction Input: \"management of appendiceal abscess in adults\" \n", "type": "AgentAction"}}, "or conservative treatment for appendiceal abscess in adults? A randomized controlled trial. Ann Surg. 2015;262(2):237-242.\t19.\tThe American Board of Surgery. American Board of Surgery CME requirements for recertification. Available at: http://www.absurgery.org/default.jsp? Accessed June 15,\n\nManage-ment of perforated appendicitis with abscess is similar to adults, although no adverse effects of an early laparoscopic appendec-tomy have been seen even in this setting.39,72,73,74Nonoperative management of appendicitis has also been studied in children.75-77 It may be safe for children\n\nand cohort studies have examined the role of nonopera-tive management of adult patients with appendicitis.23,24,25 In each of these well-designed studies with noninferiority as the endpoint, patients were randomized to either receiving antibiot-ics or undergoing an appendectomy, which was"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "appendiceal abscess management guidelines\" \n", "log": "The search did not yield specific guidelines or recommendations directly addressing the management of appendiceal abscess in adults. However, the information suggests that nonoperative management, including antibiotics and possible drainage, is a common approach for such cases. I need to refine my search to find more detailed management protocols specifically for appendiceal abscesses.\n\nAction: search_docs\nAction Input: \"appendiceal abscess management guidelines\" \n", "type": "AgentAction"}}, "or conservative treatment for appendiceal abscess in adults? A randomized controlled trial. Ann Surg. 2015;262(2):237-242.\t19.\tThe American Board of Surgery. American Board of Surgery CME requirements for recertification. Available at: http://www.absurgery.org/default.jsp? Accessed June 15,\n\nversus initial nonoperative management Brunicardi_Ch30_p1331-p1344.indd   134101/03/19   7:05 PM 1342SPECIFIC CONSIDERATIONSPART\u2008IIand interval appendectomy for perforated appendicitis with abscess: a prospective, randomized trial. J Pediatr Surg. 2010;45(1):236-240.\t44.\tDixon MR, Haukoos JS, Park\n\nAbscess: Treat with broad-spectrum antibiotics and percutaneous drainage; an elective appendectomy should be performed 6\u20138 weeks later."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "appendiceal abscess treatment guidelines\" \n", "log": "The search results indicate that the management of an appendiceal abscess typically involves treating with broad-spectrum antibiotics and considering percutaneous drainage. An elective appendectomy is often recommended to be performed 6\u20138 weeks later. This aligns with the options provided, particularly option A, which suggests \"Antibiotics + CT-guided drainage.\" \n\nGiven this information, I will proceed with the most appropriate next step in management.\n\nAction: search_docs\nAction Input: \"appendiceal abscess treatment guidelines\" \n", "type": "AgentAction"}}, "or conservative treatment for appendiceal abscess in adults? A randomized controlled trial. Ann Surg. 2015;262(2):237-242.\t19.\tThe American Board of Surgery. American Board of Surgery CME requirements for recertification. Available at: http://www.absurgery.org/default.jsp? Accessed June 15,\n\nAbscess: Treat with broad-spectrum antibiotics and percutaneous drainage; an elective appendectomy should be performed 6\u20138 weeks later.\n\ntreatment of uncomplicated acute appendicitis: the APPAC randomized clinical trial. JAMA. 2015;313(23):2340-2348.\t28.\tHarnoss JC, Zelienka I, Probst P, et al. Antibiotics versus surgical therapy for uncomplicated appendicitis: system-atic review and meta-analysis of controlled trials (PROS-PERO"]]},"34": {"question": "A 29-year-old man comes to the physician because of a 3-month history of fatigue, weight loss, and multiple painless swellings on his neck and axilla. He reports that his swellings become painful after he drinks alcohol. Physical examination shows nontender cervical and axillary lymphadenopathy. A lymph node biopsy specimen shows giant binucleate cells. Which of the following is the most likely diagnosis?", "options": {"A": "Hodgkin lymphoma", "B": "Diffuse large B-cell lymphoma", "C": "Adult T-cell lymphoma", "D": "Acute lymphocytic leukemia"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Hodgkin lymphoma symptoms diagnosis giant binucleate cells' \n", "log": "The symptoms presented, including painless lymphadenopathy, fatigue, weight loss, and the presence of giant binucleate cells in the biopsy, are characteristic of Hodgkin lymphoma. Additionally, the fact that the lymphadenopathy becomes painful after alcohol consumption is also a classic sign associated with Hodgkin lymphoma. I need to confirm this by searching for more information related to the diagnosis of Hodgkin lymphoma and its typical presentations.\n\nAction: search_docs\nAction Input: 'Hodgkin lymphoma symptoms diagnosis giant binucleate cells' \n", "type": "AgentAction"}}, "Hodgkin lymphoma Contains Reed-Sternberg cells: distinctive tumor giant cells; binucleate or bilobed with the 2 halves as mirror images (\u201cowl eyes\u201d A ). RS cells are CD15+ and CD30+ B-cell origin. 2 owl eyes \u00d7 15 = 30.\n\ncommon forms of classical Hodgkin lymphoma, the nodular sclerosis and mixed-cellularity types, are discussed next.\n\nThe diagnosis of lymphoma is established by tissue biopsy orexamination of pleural or peritoneal fluid. Systemic symptoms,such as fever and weight loss, may be present and are particularly prominent in patients with anaplastic large cell lymphoma,which can be insidious in onset. If the bone marrow"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Hodgkin lymphoma symptoms alcohol pain lymphadenopathy' \n", "log": "The information confirms that Hodgkin lymphoma is characterized by the presence of Reed-Sternberg cells, which are giant binucleate cells. The symptoms described in the case, including painless lymphadenopathy that becomes painful after alcohol consumption, align well with Hodgkin lymphoma. This reinforces my initial thought that the most likely diagnosis is indeed Hodgkin lymphoma.\n\nAction: search_docs\nAction Input: 'Hodgkin lymphoma symptoms alcohol pain lymphadenopathy' \n", "type": "AgentAction"}}, "The most common clinical presentation of Hodgkin disease is painless, firm lymphadenopathy often confined to one or two lymph node areas, usually the supraclavicular and cervical nodes. Mediastinal lymphadenopathy producing cough or shortness of breath is another frequent initial presentation. The\n\nClinical Features. Hodgkin lymphoma, like NHL, usually manifests as painless lymphadenopathy. Although a definitive distinction from NHL can be made only by\n\nTable 12.9 Clinical Differences Between Hodgkin and Non-Hodgkin Lymphomas\n\nFever of unknown origin, weight loss, Lymphoreticular malignancy Hodgkin disease, non-Hodgkin lymphoma night sweats\n\nPainless lymphadenopathy Lymphoreticular malignancy, Leukemia, Hodgkin disease, non-Hodgkin lymphoma, metastatic solid tumor Burkitt lymphoma, thyroid carcinoma"]]},"35": {"question": "A 33-year-old primigravid visits the clinic at the 22 weeks\u2019 gestation with concerns about several episodes of loose watery stool over the past 4 months, which are sometimes mixed with blood. Use of over-the-counter antidiarrheal medications has not been helpful. She also reports having painful ulcers in her mouth for the last 2 months. Pregnancy has been otherwise uncomplicated so far. On physical examination, the blood pressure is 110/60 mm Hg, the pulse rate is 90/min, the respiratory rate is 19/min, and the temperature is 36.6\u00b0C (97.8\u00b0F). There is bilateral conjunctival redness. Abdominal examination shows minimal tenderness but no guarding or rebound tenderness. Fundal height is proportionate to 22 weeks of gestation, and fetal heart sounds are audible. Colonoscopy shows focal areas of inflammation in the ileum, separated by normal mucosa, with rectal sparing. Based on the colonoscopy results, which of the following complications is the patient at risk for?", "options": {"A": "Metastasis to the liver", "B": "Carcinoid syndrome", "C": "Intestinal obstruction", "D": "Paralytic ileus"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Crohn's disease complications intestinal obstruction\" \n", "log": "The patient's symptoms and colonoscopy findings suggest a diagnosis of Crohn's disease, particularly with the focal areas of inflammation in the ileum and rectal sparing. One of the common complications of Crohn's disease is intestinal obstruction due to strictures caused by inflammation and scarring. The other options listed are less likely to be directly associated with the findings presented.\n\nAction: search_docs \nAction Input: \"Crohn's disease complications intestinal obstruction\" \n", "type": "AgentAction"}}, "are com-mon. Symptoms of Crohn\u2019s disease depend on the severity of inflammation and/or fibrosis and the location of inflammation in the gastrointestinal tract. Acute inflammation may produce diarrhea, crampy abdominal pain, and fever. Strictures may pro-duce symptoms of obstruction. Weight loss is\n\nobstruction. Weight loss is common, both because of obstruction and from protein loss. Perianal Crohn\u2019s disease may present with pain, swelling, and drainage from fis-tulas or abscesses. Physical findings are also related to the site and severity of disease.In 15% of patients with colitis from\n\nDisorders associated with clinical presentations that resemble those of Crohn\u2019s dis-ease include ulcerative colitis, functional bowel disorders such as irritable bowel syndrome, mesenteric ischemia, collagen vascular diseases, carcinoma and lymphoma, diverticular dis-ease, and infectious"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Crohn's disease complications summary\" \n", "log": "The information retrieved confirms that intestinal obstruction is a common complication of Crohn's disease due to strictures caused by inflammation and scarring. This aligns with the patient's presentation and colonoscopy findings.\n\nAction: search_docs \nAction Input: \"Crohn's disease complications summary\" \n", "type": "AgentAction"}}, "Crohn disease was noted to be linked to excessive morbidity (Dominitz, 2002; Stephansson, 2010). But, according to Reddy (2008) and others, these adverse outcomes were in women with severe disease and multiple recurrences. Indeed, in the prospective European case-control ECCO-EpiCom study of 332\n\nmanifestation. Many of these complications can be seen with both Crohn\u2019s disease and ulcerative colitis, although they are more prevalent among patients with Crohn\u2019s disease. The most common extraintestinal manifestations are listed in Table 28-7. The clinical severity of some of these\n\nwith inflammatory bowel disease (especially Crohn\u2019s disease)."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Crohn's disease complications intestinal obstruction risk\" \n", "log": "The information retrieved does not provide additional insights specifically related to the complications of Crohn's disease. However, it reinforces that complications are more prevalent in Crohn's disease compared to ulcerative colitis. Given the context of the patient's symptoms and colonoscopy findings, I will proceed with the assumption that intestinal obstruction remains the most likely complication.\n\nAction: search_docs \nAction Input: \"Crohn's disease complications intestinal obstruction risk\" \n", "type": "AgentAction"}}, "are com-mon. Symptoms of Crohn\u2019s disease depend on the severity of inflammation and/or fibrosis and the location of inflammation in the gastrointestinal tract. Acute inflammation may produce diarrhea, crampy abdominal pain, and fever. Strictures may pro-duce symptoms of obstruction. Weight loss is\n\nwith inflammatory bowel disease (especially Crohn\u2019s disease).\n\nintervention. Less common complications that require surgical intervention are acute gastro-intestinal hemorrhage, perforations, and development of cancer.Although surgery for Crohn\u2019s disease is usually planned, an uncommon, but not rare, scenario is the intraoperative dis-covery of inflammation"]]},"36": {"question": "A 25-year-old woman has dysuria, pyuria, increased frequency of urination, and fever of 1-day duration. She is sexually active. Urine cultures show gram-positive bacteria in clusters that are catalase-positive and coagulase-negative. The patient is started on trimethoprim-sulfamethoxazole. Which of the following characteristics is used to identify the offending organism?", "options": {"A": "Beta hemolysis", "B": "Sensitivity to novobiocin", "C": "Sensitivity to bacitracin", "D": "Resistance to novobiocin"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'sensitivity to novobiocin in Staphylococcus saprophyticus'", "log": "To answer the question, I need to identify the characteristics used to identify the offending organism based on the provided clinical scenario. The patient has dysuria, pyuria, and urine cultures show gram-positive bacteria that are catalase-positive and coagulase-negative. This suggests the organism is likely a coagulase-negative staphylococcus, such as Staphylococcus saprophyticus, which is known to cause urinary tract infections in young sexually active women.\n\nOne key characteristic used to differentiate Staphylococcus saprophyticus from other coagulase-negative staphylococci is its sensitivity to novobiocin. Staphylococcus saprophyticus is resistant to novobiocin, while other coagulase-negative staphylococci are sensitive.\n\nNow, I will check the options to confirm which one aligns with this characteristic.\n\nAction: search_docs  \nAction Input: 'sensitivity to novobiocin in Staphylococcus saprophyticus'  ", "type": "AgentAction"}}, "predictable sensitivity of most isolates to specific antibiotics.\n\naeruginosa; S epidermidis = Staphylococcus epidermidis;  S pyogenes = Streptococcus pyogenes; VRE = vancomycin-resistant Enterococcus1 = reliable activity; +/\u2013 = variable activity; 0 = no activity.The sensitivities printed here are generalizations. The clinician should confirm sensitivity patterns\n\nGram \u2295, catalase \u2295, coagulase \u229d, urease \u2295 cocci in clusters. Novobiocin sensitive. Does not ferment mannitol (vs S aureus).\n\nNormal flora of skin; contaminates blood cultures.\n\nInfects prosthetic devices (eg, hip implant, heart valve) and IV catheters by producing adherent biofilms."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'Staphylococcus saprophyticus novobiocin resistance'", "log": "The observation did not provide specific information regarding novobiocin resistance or sensitivity in Staphylococcus saprophyticus, but it did mention that coagulase-negative staphylococci are typically sensitive to novobiocin, which is relevant. \n\nNow, I need to confirm the relationship between Staphylococcus saprophyticus and novobiocin resistance. Since I already have a hypothesis about the organism being Staphylococcus saprophyticus, I will proceed to search for specific information about its novobiocin resistance.\n\nAction: search_docs  \nAction Input: 'Staphylococcus saprophyticus novobiocin resistance'  ", "type": "AgentAction"}}, "contribute to resistance to macrolides in streptococci and resistance to macrolides, clindamycin, and dalfopristin in staphylococci. Plasmid-acquired drug-modifying enzymes in staphylococci can also cause resistance to quinupristin and dalfopristin. Macrolide resistance due to 23S rRNA mutations is\n\nWe have already observed the accumulation of new or unanticipated modes of resistance from ongoing evolutionary pressure caused by the widespread clinical use of antibiotics. Even with MRSA, perhaps the best-studied case of antibiotic resistance and a model of relative simplicity with a single\n\nof drug that occurs with inhibition of cell wall synthesis. Resistance to gentamicin rapidly emerges in staphylococci during monotherapy owing to selection of permeability mutants. Ribosomal resistance is rare. Among Gram-negative bacteria, resistance is most commonly due to plasmid-encoded"]]},"37": {"question": "A 9-year-old boy, otherwise healthy, presents with persistent bleeding following tooth extraction. The patient\u2019s mother states that yesterday, the patient had a tooth extracted that was complicated intraoperatively by persistent bleeding that continued postoperatively. She also says he has had no bleeding issues in the past. The past medical history is unremarkable. The patient is fully immunized and has been meeting all developmental milestones. The vital signs include: temperature 37.0\u00b0C (98.6\u00b0F), blood pressure 101/65 mm Hg, pulse 101/min, respirations 22/min, and oxygen saturation 98% on room air. The physical examination is significant for a wound consistent with the extraction of the second upper right molar, which is slowly oozing blood with no sign of a stable clot. There are no signs of infection. The laboratory findings are significant for the following:\nSodium 141 mEq/L\nPotassium 4.1 mEq/L\nChloride   101 mEq/L\nBicarbonate 25 mEq/L\nBUN 12 mg/dL\nCreatinine 1.0 mg/dL\nGlucose (fasting) 80 mg/dL\n   Bilirubin, conjugated 0.2 mg/dL\nBilirubin, total 1.0 mg/dL\nAST (SGOT) 11 U/L\nALT (SGPT) 12 U/L\nAlkaline Phosphatase 45 U/L\n   Prothrombin Time (PT) 14 s\nPartial Thromboplastin Time (PTT) 35 s\n  WBC 8,500/mm3\nRBC 4.00 x 106/mm3\nHematocrit 37.5%\nHemoglobin 13.1 g/dL\nPlatelet Count 225,000/mm3\nThis patient\u2019s condition would most likely also present with which of the following symptoms?", "options": {"A": "Epistaxis", "B": "Hemarthrosis", "C": "Purpura fulminans", "D": "Intracranial hemorrhage"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "persistent bleeding after tooth extraction symptoms", "log": "The case describes a 9-year-old boy with persistent bleeding following a tooth extraction, with no prior bleeding issues and normal laboratory findings except for the bleeding. This suggests a bleeding disorder, possibly related to a coagulopathy.\n\nTo determine which symptom might also be present in this scenario, I need to consider the options provided:\n\n- **A: Epistaxis** - This is a common symptom of bleeding disorders and can occur due to a variety of conditions.\n- **B: Hemarthrosis** - This refers to bleeding into joints and is typically associated with hemophilia or similar coagulopathies.\n- **C: Purpura fulminans** - This is a serious condition that involves widespread bleeding under the skin and is often associated with severe infections or coagulopathy.\n- **D: Intracranial hemorrhage** - This is a serious condition that can occur in severe bleeding disorders but is less common in mild cases.\n\nGiven the context of the case, I suspect that the patient might have a mild bleeding disorder that could lead to symptoms such as epistaxis or hemarthrosis. However, given the age and the presentation of bleeding after a dental procedure, epistaxis seems to be a more likely symptom that could also present alongside the bleeding from the extraction site.\n\nAction: search_docs  \nAction Input: \"persistent bleeding after tooth extraction symptoms\"  ", "type": "AgentAction"}}, "Hematologic and Nutritional Disease Internists are more likely to encounter patients with acquired, rather than congenital, bleeding disorders. Bleeding should stop 15 min after minor trauma and within an hour after tooth extraction if local pressure is applied. More prolonged bleeding, if not due\n\nthat appear to be more common in patients with bleeding disorders include prolonged bleeding with surgery, dental procedures and extractions, and/or trauma, menorrhagia or postpartum hemorrhage, and large bruises (often described with lumps).\n\nPatients have predominantly mucosal bleeding symptoms, although postoperative bleeding can also be seen. Bleeding symptoms are very uncommon in infancy and usually manifest later in childhood with excessive bruising and epistaxis. Because these symptoms occur commonly in childhood, the clinician"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "common symptoms of bleeding disorders in children", "log": "Based on the observation, it is noted that prolonged bleeding after dental procedures, such as tooth extractions, is a common symptom in patients with bleeding disorders. Additionally, mucosal bleeding symptoms, including epistaxis, are prevalent in children with such conditions. This reinforces the idea that epistaxis could be associated with the patient's bleeding disorder.\n\nGiven that the patient is presenting with persistent bleeding after a tooth extraction, and considering the common symptoms associated with bleeding disorders in children, it strengthens the likelihood that the patient may also present with epistaxis.\n\nAction: search_docs  \nAction Input: \"common symptoms of bleeding disorders in children\"  ", "type": "AgentAction"}}, "Patients have predominantly mucosal bleeding symptoms, although postoperative bleeding can also be seen. Bleeding symptoms are very uncommon in infancy and usually manifest later in childhood with excessive bruising and epistaxis. Because these symptoms occur commonly in childhood, the clinician\n\nFrom Scott JP: Bleeding and thrombosis. In Kliegman RM, editor: Practical Strategies in Pediatric Diagnosis and Therapy, Philadelphia, 1996, WB Saunders.\n\nDisorders of Platelets\n\nAvailable @ StudentConsult.com\n\nEpistaxis is a common symptom, particularly in children and in dry climates, and may not reflect an underlying bleeding disorder. However, it is the most common symptom in hereditary hemorrhagic telangiectasia and in boys with VWD. Clues that epistaxis is a symptom of an underlying bleeding"]]},"38": {"question": "A 74-year-old man presents to the emergency department with shortness of breath that started about 30 mins ago. He is also experiencing chest pain on deep inspiration. He has several significant medical conditions including obstructive pulmonary disease, hypertension, and dyslipidemia. He used to smoke about 3 packs of cigarettes every day until last year when he quit. He was in the emergency room 2 weeks ago for a hemorrhagic stroke which was promptly treated. He currently weighs 97.5 kg (215 lb). His respirations are 20/min, the blood pressure is 110/ 80 mm Hg, and the pulse is 105/min. On physical examination, Homan\u2019s sign is positive. An ECG and chest X-ray are performed. His current oxygen saturation is at 87% and D-dimer results are positive. He is wheeled in for a CT scan. Which of the following treatments would this patient be an ideal candidate for?", "options": {"A": "Greenfield filter", "B": "Unfractionated heparin", "C": "Subcutaneous fondaparinux", "D": "Warfarin"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "treatment for pulmonary embolism recent hemorrhagic stroke", "log": "I need to analyze the patient's symptoms and medical history to determine the most appropriate treatment option. The patient has shortness of breath, chest pain, a positive Homan's sign, positive D-dimer results, and has a history of hemorrhagic stroke. These details suggest a potential for a pulmonary embolism (PE), especially given the positive D-dimer and the recent medical history. \n\nIn terms of treatment options:\n- A Greenfield filter is typically used for patients with a high risk of deep vein thrombosis (DVT) who cannot receive anticoagulation.\n- Unfractionated heparin is often used in acute settings for PE, especially in hospitalized patients.\n- Subcutaneous fondaparinux is also an anticoagulant used for DVT/PE but may not be the first line in this acute scenario.\n- Warfarin is used for long-term anticoagulation but is not suitable for immediate treatment of an acute PE.\n\nGiven this context, I will search for specific guidelines or recommendations regarding the treatment of patients with suspected pulmonary embolism who have a history of recent hemorrhagic stroke.\n\nAction: search_docs  \nAction Input: \"treatment for pulmonary embolism recent hemorrhagic stroke\"  ", "type": "AgentAction"}}, "The treatment of pulmonary embolism is as follows: 1.\n\nImmediate anticoagulant therapy, identical to that outlined for the treatment of DVT, should be initiated.\n\n2.\n\nRespiratory support, including oxygen and bronchodilators and an intensive care setting, if necessary.\n\n3.\n\nImmediate treatment for pulmonary embolism is full anticoagulation similar to that for deep-vein thrombosis as discussed on page 1012. Several complementary procedures may be indicated.\n\n3.\n\nAlthough massive pulmonary emboli are usually quickly fatal, rarely pulmonary embolectomy is successful.\n\n4.\n\nPulmonary artery catheterization with the administration of thrombolytic agents bears further evaluation and may be important in patients with massive pulmonary embolism.\n\n5."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "pulmonary embolism treatment guidelines anticoagulation recent hemorrhagic stroke", "log": "The guidelines indicate that immediate anticoagulant therapy should be initiated for the treatment of pulmonary embolism, which is similar to that for deep vein thrombosis (DVT). Given the patient's recent hemorrhagic stroke, careful consideration is necessary when choosing the type of anticoagulant. \n\nUnfractionated heparin is commonly used in acute settings for pulmonary embolism and can be adjusted based on the patient's response and bleeding risk. Fondaparinux is also an option but is typically used for DVT/PE management in outpatient settings. Warfarin is not appropriate for immediate treatment of acute PE. \n\nGiven the patient's situation, the focus is on immediate management, and unfractionated heparin seems to be the most suitable choice, especially considering the acute nature of the presentation and the need for close monitoring due to the recent hemorrhagic stroke.\n\nAction: search_docs  \nAction Input: \"pulmonary embolism treatment guidelines anticoagulation recent hemorrhagic stroke\"  ", "type": "AgentAction"}}, "The treatment of pulmonary embolism is as follows: 1.\n\nImmediate anticoagulant therapy, identical to that outlined for the treatment of DVT, should be initiated.\n\n2.\n\nRespiratory support, including oxygen and bronchodilators and an intensive care setting, if necessary.\n\n3.\n\nImmediate treatment for pulmonary embolism is full anticoagulation similar to that for deep-vein thrombosis as discussed on page 1012. Several complementary procedures may be indicated.\n\nThis patient has pulmonary embolism secondary to a deep venous thrombosis (DVT). Options for treating this patient include unfractionated heparin or low-molecular-weight heparin followed by warfarin, with INR goal of 2\u20133; parenteral anticoagulation for 5\u20137 days followed by edoxaban; or rivaroxaban,"]]},"39": {"question": "An investigator performs a twin study to evaluate the effects of a novel drug that decreases serum glucose by inhibiting a transporter on the basolateral membrane of proximal convoluted tubule cells. The results of the study are shown.\nTest Control\nSerum glucose (mg/dL) 82.4 99\nDipstick urine glucose negative negative\nUrine anion gap positive negative\nThe drug most likely inhibits transport of which of the following substrates?\"", "options": {"A": "Glutamine", "B": "Sodium", "C": "Alanine", "D": "Leucine"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for more information on the specific transporters involved in glucose transport in the proximal convoluted tubule and how they relate to the substrates listed in the options.", "tool_input": "search_docs(\"proximal convoluted tubule glucose transporters\") \n", "log": "To determine which substrate the drug inhibits, I need to analyze the results of the twin study and understand the physiological roles of the substrates listed in the options. The drug decreases serum glucose and affects urine glucose and the urine anion gap. This suggests a relationship with glucose transport and possibly sodium transport, as sodium-glucose cotransporters are involved in glucose reabsorption in the kidneys. \n\nAction: I will search for more information on the specific transporters involved in glucose transport in the proximal convoluted tubule and how they relate to the substrates listed in the options.\n\nAction Input: search_docs(\"proximal convoluted tubule glucose transporters\") \n", "type": "AgentAction"}}, "I will search for more information on the specific transporters involved in glucose transport in the proximal convoluted tubule and how they relate to the substrates listed in the options. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(\"proximal convoluted tubule glucose transporters\")", "tool_input": "proximal convoluted tubule glucose transporters\"\n", "log": "Thought: I need to clarify the action I am taking. I will perform a search for information regarding the transporters in the proximal convoluted tubule that might be inhibited by the drug, particularly focusing on glucose transport and the substrates in the options.\n\nAction: search_docs(\"proximal convoluted tubule glucose transporters\") \n\nAction Input: \"proximal convoluted tubule glucose transporters\"\n", "type": "AgentAction"}}, "search_docs(\"proximal convoluted tubule glucose transporters\") is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "proximal convoluted tubule glucose transporters\"  \n", "log": "It seems there was an error in my previous attempts to perform the search. I need to ensure that I am using the correct format for the action input. I will try again to search for the relevant information about glucose transporters in the proximal convoluted tubule.\n\nAction: search_docs  \nAction Input: \"proximal convoluted tubule glucose transporters\"  \n", "type": "AgentAction"}}, "In the normal individual, the proximal convoluted tubule reabsorbs almost all of the glucose filtered by the glomeruli. Ninety percent of the glucose reabsorption occurs through SGLT2 (Figure 15\u20132), but inhibiting this transporter using the currently available drugs will result in glucose excretion\n\nThe proximal convoluted tubule also reabsorbs amino acids, sugars, and polypeptides.\n\n(Table 418-5) lower the blood glucose by selectively inhibiting this co-transporter, which is expressed almost exclusively in the proximal, convoluted tubule in the kidney. This inhibits glucose reabsorption, lowers the renal threshold for glucose, and leads to increased urinary glucose excretion."]]},"40": {"question": "A 24-year-old gravida 1 is admitted to the hospital after a tonic-clonic seizure at 37 weeks gestation. At the time of presentation, she complains of a severe headache, double vision, and nausea. Her vital signs are as follows: blood pressure, 165/90 mm Hg; heart rate, 91/min; respiratory rate, 9/min; and temperature, 37.0\u2103 (98.6\u2109). The rapid dipstick test performed on admission unit shows 3+ proteinuria. The fetal heart rate is 118/min. On examination, the patient is lethargic (GCS 12/15). There is 2+ pitting leg edema. The neurologic examination is significant for left eye deviation towards the nose, paralysis of the left conjugate gaze with a paralytic left eye, and right hemiplegia. Meningeal signs are negative. Which of the following findings would be expected if a head CT scan is performed?", "options": {"A": "Regions of hyperdensity within the cerebellar hemispheres", "B": "Hyperattenuating material in the subarachnoid space", "C": "Regions of hyperdensity in the left pons", "D": "Subcortical hypodense region with surrounding irregular hyperdense margins"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for relevant information about typical CT findings in patients with similar presentations, particularly focusing on potential hemorrhagic strokes or related findings in the context of a pregnant patient.", "tool_input": "CT findings in pregnant women with seizures and neurological deficits\" \n", "log": "I need to analyze the clinical scenario presented in the question. The patient is experiencing severe headache, double vision, nausea, hypertension, proteinuria, and neurological deficits, including left hemiplegia and eye deviation. These symptoms suggest a possible cerebrovascular accident (CVA) or hemorrhagic event, possibly related to her pregnancy.\n\nThe options provided relate to findings that might be seen on a head CT scan. \n\n- Option A suggests hyperdensity in the cerebellar hemispheres, which could indicate a hemorrhage but is less likely given the patient's symptoms.\n- Option B mentions hyperattenuating material in the subarachnoid space, which could indicate subarachnoid hemorrhage.\n- Option C indicates hyperdensity in the left pons, which may suggest a localized hemorrhage or infarct.\n- Option D describes a subcortical hypodense region with irregular hyperdense margins, which could indicate a more complex lesion or hemorrhagic transformation.\n\nGiven the patient's presentation of left-sided neurological deficits and the potential for a hemorrhagic stroke, I suspect that a finding consistent with a hemorrhagic event might be present.\n\nAction: I will search for relevant information about typical CT findings in patients with similar presentations, particularly focusing on potential hemorrhagic strokes or related findings in the context of a pregnant patient.\n\nAction Input: \"CT findings in pregnant women with seizures and neurological deficits\" \n", "type": "AgentAction"}}, "I will search for relevant information about typical CT findings in patients with similar presentations, particularly focusing on potential hemorrhagic strokes or related findings in the context of a pregnant patient. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "CT findings in pregnant women with seizures and neurological deficits\"  \n", "log": "I need to perform a search to find relevant information about CT findings in pregnant women who present with seizures and neurological deficits, as this could help clarify which of the options is most likely.\n\nAction: search_docs  \nAction Input: \"CT findings in pregnant women with seizures and neurological deficits\"  \n", "type": "AgentAction"}}, "Computed tomography (CT) and magnetic resonance (MR) imaging assist in the diagnosis, classification, and management of many neurological and psychiatric disorders. As discussed in Chapter 46 (p. 907), these imaging methods can be used safely during pregnancy. CT scanning is often used when rapid\n\nwithdrawals, cerebral infections, brain tumors, biochemical abnormalities, and arteriovenous malformations. A search for these is prudent with a new-onset seizure disorder in a pregnant woman. he diagnosis of idiopathic epilepsy is one of exclusion.\n\nCerebral imaging has come to play a major role in the diagnosis of seizures. CT is able to demonstrate many of the typical underlying causes of seizures in adults but MRI is more sensitive for the detection of small structural abnormalities underlying epilepsy including tumor, stroke and traumatic"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "CT scan findings hemorrhagic stroke pregnant women seizures\"  \n", "log": "The observation did not provide specific findings related to the CT scan in pregnant women with seizures and neurological deficits. However, it emphasized the importance of imaging in diagnosing underlying causes of seizures, such as stroke or hemorrhage. Given the patient's symptoms, including severe headache, neurological deficits, and the possibility of a cerebrovascular event, I need to refine my search to focus more specifically on CT findings associated with hemorrhagic strokes in pregnant women.\n\nAction: search_docs  \nAction Input: \"CT scan findings hemorrhagic stroke pregnant women seizures\"  \n", "type": "AgentAction"}}, "FIGURE 60-2 Illustrations of a brain showing various types of strokes seen in pregnancy: (1) subcortical infarction (preeclampsia), (2) hypertensive hemorrhage/ (3) aneurysm, (4) embolism or thrombosis in middle cerebral artery, (5) arteriovenous malformation, and (6) cortical vein thrombosis.\n\neclamptic seizures in women with gestational\n\nwithdrawals, cerebral infections, brain tumors, biochemical abnormalities, and arteriovenous malformations. A search for these is prudent with a new-onset seizure disorder in a pregnant woman. he diagnosis of idiopathic epilepsy is one of exclusion."]]},"41": {"question": "A 45-year-old male presents to your office following a diagnosis of an autosomal dominant disease. He has started therapy and has a strong family support system. He endorses a decrease in appetite over the last two weeks that he attributes to sadness surrounding his diagnosis and a depressed mood but denies any suicidal ideation. He continues to enjoy working in the yard and playing with his children. On physical examination you notice involuntary quick jerky movements of his hands and feet. Which of the following would you expect to see in this patient?", "options": {"A": "Caudate and putamen atrophy", "B": "Depigmentation of the substantia nigra pars compacta", "C": "Atrophy of the subthalamic nucleus", "D": "Lesion in the vermis"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "Huntington's disease brain changes caudate putamen atrophy\" \n", "log": "The patient presents with involuntary movements and a diagnosis of an autosomal dominant disease, which suggests a possible neurodegenerative condition. The symptoms of chorea-like movements (quick jerky movements) are characteristic of Huntington's disease, which is associated with atrophy of the caudate nucleus and putamen. Therefore, I should search for information regarding the expected brain changes in patients with Huntington's disease.\n\nAction: search_docs\nAction Input: \"Huntington's disease brain changes caudate putamen atrophy\" \n", "type": "AgentAction"}}, "predominantly affects the striatum. Progressive atrophy of the heads of the caudate nuclei, which form the lateral margins of the lateral ventricles, can be visualized by MRI (Fig. 449-8), but the putamen can be equally or even more severely affected. More diffuse cortical atrophy is seen in the\n\nHuntington disease (HD) is an autosomal dominant movement disorder associated with degeneration of the striatum (caudate and putamen). The disorder is characterized by involuntary jerky movements of all parts of the body; writhing movements of the extremities are typical. The disease is\n\nFIGURE 441e-22 Huntington\u2019s disease (Chap. 449). Axial noncontrast CT (A) demonstrates symmetric bilateral severe atrophy involving the caudate nuclei, putamen, and globus pallidi bilaterally with consequent enlargement of the frontal horns of the lateral ventricles (arrows). There is also diffuse"]]},"42": {"question": "A 69-year-old man with hypertension and congestive heart failure is brought to the emergency department because of a 9-day history of worsening shortness of breath and swelling of his legs. His respirations are 25/min, and blood pressure is 160/98 mm Hg. Pulse oximetry on 5 L O2 via nasal cannula shows an oxygen saturation of 92%. Examination shows 2+ pretibial edema bilaterally. Crackles are heard at both lung bases. The patient's symptoms are due in part to an increase in the rate of bradykinin breakdown. The substance responsible for bradykinin breakdown is primarily produced in which of the following?", "options": {"A": "Pulmonary endothelium", "B": "Liver", "C": "Atria", "D": "Zona glomerulosa"}, "output": "A", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "substance responsible for bradykinin breakdown production site\" \n", "log": "To answer the question, I need to determine where the substance responsible for the breakdown of bradykinin is primarily produced. Bradykinin is a peptide that plays a role in various physiological processes, and its breakdown is primarily facilitated by enzymes. I will search for information on the production of the substance that breaks down bradykinin.\n\nAction: search_docs\nAction Input: \"substance responsible for bradykinin breakdown production site\" \n", "type": "AgentAction"}}, "kininase. Bradykinin has been implicated as a mediator in some forms of allergic reaction, such as anaphylaxis.\n\nwith drugs that inhibit the formation or actions of bradykinin (see below).\n\nBradykinin is formed in other exocrine glands, such as the lacrimal and sweat glands. Its presence in sweat may be partly responsible for the dilation of cutaneous blood vessels."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "kininase bradykinin breakdown site of production\"\n", "log": "The search did not provide a clear answer regarding the primary production site of the substance responsible for bradykinin breakdown. However, I know that kininase, which breaks down bradykinin, is primarily produced in the pulmonary endothelium. I will confirm this knowledge to finalize my answer.\n\nAction: search_docs\nAction Input: \"kininase bradykinin breakdown site of production\"\n", "type": "AgentAction"}}, "kininase. Bradykinin has been implicated as a mediator in some forms of allergic reaction, such as anaphylaxis.\n\nThe pathway for the formation and metabolism of kinins is shown in Figure 17\u20134. The two major kinins in humans are bradykinin and Lys-bradykinin or kallidin. Bradykinin is released from HMW kininogen by plasma kallikrein, whereas kallidin is released from LMW kininogen by tissue kallikrein.\n\nelevated plasma levels of bradykinin, particularly in the venous effluent of an involvedextremity,andreducedlevelsofprekallikreinandhigh-molecular-weight kininogen, from which bradykinin is cleaved. The parallel decline in the complement substrates C4 and C2 reflects the action of activated C1"]]},"43": {"question": "An anxious mother brings her daughter into the clinic on her 5th birthday. She was forwarded a recent email by her aunt that stated that the pesticide-coated fruit in school lunches is the number one killer in children in the modern era. You assure her that that pesticides are not the number one killer, nor are they even in the top three killers of children in this age group. What are the top causes of death of American children aged 5-9, in order from most common to least?", "options": {"A": "Heart disease, malignant neoplasms, chronic lower respiratory disease", "B": "Unintentional injury, malignant neoplasms, congenital anomalies", "C": "Malignant neoplasms, heart disease, unintentional injury", "D": "Unintentional injury, suicide, malignant neoplasms"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "top causes of death American children aged 5-9\"  \n", "log": "To answer the question, I need to find the most recent and accurate statistics regarding the top causes of death for American children aged 5-9. The options provided list various causes of death, and I will need to verify which one aligns with the latest data.\n\nAction: search_docs  \nAction Input: \"top causes of death American children aged 5-9\"  \n", "type": "AgentAction"}}, "Cause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a\n\nthe principal causes of death in the United States by age group.\n\n2.\n\nThe leading causes of death in children are (1) accidents, (2) cancer, and (3) congenital defects.\n\nB. The most common cancers by incidence in adults are (1) breast/prostate, (2) lung, and (3) colorectal."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "current statistics causes of death American children aged 5-9 2023\"  \n", "log": "The observation indicates that the leading causes of death in children include accidents (unintentional injuries), cancer (malignant neoplasms), and congenital defects. This is consistent with the information I need to determine the correct answer from the options provided.\n\nAction: search_docs  \nAction Input: \"current statistics causes of death American children aged 5-9 2023\"  \n", "type": "AgentAction"}}, "Cause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a\n\nthe principal causes of death in the United States by age group.\n\n2.\n\nThe leading causes of death in children are (1) accidents, (2) cancer, and (3) congenital defects.\n\nB. The most common cancers by incidence in adults are (1) breast/prostate, (2) lung, and (3) colorectal."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "leading causes of death children aged 5-9 2023 statistics\"  \n", "log": "The observation did not provide updated statistics for 2023, but it did confirm that the leading causes of death in children include unintentional injuries, cancer (malignant neoplasms), and congenital defects. This aligns with the information I need to compare against the options provided.\n\nGiven the options:\n- A: Heart disease, malignant neoplasms, chronic lower respiratory disease\n- B: Unintentional injury, malignant neoplasms, congenital anomalies\n- C: Malignant neoplasms, heart disease, unintentional injury\n- D: Unintentional injury, suicide, malignant neoplasms\n\nI will now analyze the options based on the leading causes of death I have observed.\n\nThought: It seems that option B aligns well with the observed leading causes of death, which are unintentional injury, malignant neoplasms (cancer), and congenital anomalies. I need to confirm if this is indeed the correct answer.\n\nAction: search_docs  \nAction Input: \"leading causes of death children aged 5-9 2023 statistics\"  \n", "type": "AgentAction"}}, "2.\n\nThe leading causes of death in children are (1) accidents, (2) cancer, and (3) congenital defects.\n\nB. The most common cancers by incidence in adults are (1) breast/prostate, (2) lung, and (3) colorectal.\n\nTABLE 2.4-5. Leading Causes of Death by Age Group\n\nCause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "current leading causes of death children aged 5-9 2023\"  \n", "log": "The repeated observations indicate that the leading causes of death in children include unintentional injuries, cancer (malignant neoplasms), and congenital defects. This supports the understanding that option B is likely correct, as it lists unintentional injury, malignant neoplasms, and congenital anomalies.\n\nHowever, I still need to ensure that I am not overlooking any critical information that might suggest a different ranking or include other causes not mentioned in the previous observations.\n\nAction: search_docs  \nAction Input: \"current leading causes of death children aged 5-9 2023\"  \n", "type": "AgentAction"}}, "2.\n\nThe leading causes of death in children are (1) accidents, (2) cancer, and (3) congenital defects.\n\nB. The most common cancers by incidence in adults are (1) breast/prostate, (2) lung, and (3) colorectal.\n\nCause of death in U.S. children. The overall causes of death in all children (1 to 24 years of age) in the United States in 2010, in order of frequency, were accidents (unintentional injuries), assaults (homicide), suicide, malignant neoplasms, and congenital malformations (Table 1-1). There was a\n\nTABLE 2.4-5. Leading Causes of Death by Age Group"]]},"44": {"question": "A 3-year-old boy is brought to the emergency room by his mother with fever and difficulty breathing after receiving the BCG vaccine. He has never had a reaction to a vaccine before. He has a history of 2 salmonella infections over the past 2 years. He was born at 35 weeks\u2019 gestation and spent one day in the neonatal intensive care unit. His parents' family histories are unremarkable. His temperature is 101\u00b0F (38.3\u00b0C), blood pressure is 80/55 mmHg, pulse is 135/min, and respirations are 24/min. On examination, he appears acutely ill. He has increased work of breathing with intercostal retractions. A petechial rash is noted on his trunk and extremities. A serological analysis in this patient would most likely reveal decreased levels of which of the following cytokines?", "options": {"A": "Interferon alpha", "B": "Interferon gamma", "C": "Interleukin 1", "D": "Tumor necrosis factor alpha"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'cytokine levels BCG vaccine response immunocompromised'", "log": "The clinical scenario describes a 3-year-old boy presenting with fever, difficulty breathing, a petechial rash, and a history of salmonella infections. Given that he has received the BCG vaccine, which is a live attenuated vaccine, there is a concern for an immune response that may be inadequate due to an underlying immunocompromised state or deficiency. \n\nIn this case, the decreased levels of cytokines would likely be associated with the boy's immune response. Interferon gamma is crucial for the immune response to mycobacterial infections, and since he has had multiple salmonella infections, it suggests a potential defect in his immune system, particularly in the cell-mediated immunity pathway where interferon gamma plays a significant role.\n\nI will search for relevant documents that provide insight into cytokine levels associated with BCG vaccination responses, especially in immunocompromised patients.\n\nAction: search_docs  \nAction Input: 'cytokine levels BCG vaccine response immunocompromised'  ", "type": "AgentAction"}}, "BCG was derived from an attenuated strain of M. bovis and was first administered to humans in 1921. Many BCG vaccines are available worldwide; all are derived from the original strain, but the vaccines vary in efficacy, ranging from 80% to nil in randomized, placebo-controlled trials. A similar\n\nof infants and young children from serious disseminated forms of childhood TB, such as tuberculous meningitis and miliary TB. BCG vaccine is safe and rarely causes serious complications. The local tissue response begins 2\u20133 weeks after vaccination, with scar formation and healing within 3 months.\n\ninfection after vaccination with Mycobacterium bovis bacillus Calmette\u2013Gu\u00e9rin (BCG), the strain of M. bovis that is used as a live vaccine against M. tuberculosis. Because the IL12 p40 subunit is shared by IL12 and IL23, IL12 p40 deficiency results in a broader infectious disease risk due to"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "'interferon gamma levels BCG vaccine immunocompromised patients'", "log": "The search did not yield specific information on cytokine levels related to the BCG vaccine response in immunocompromised patients. However, it provided context about BCG vaccination and its safety. \n\nGiven the clinical scenario, the boy's presentation of fever, respiratory distress, and petechial rash may indicate a severe immune response or an infection due to an inadequate immune system, possibly linked to his history of salmonella infections. \n\nI need to refine my search to focus on cytokine levels, particularly interferon gamma, in relation to the immune response to BCG vaccination in patients with compromised immunity.\n\nAction: search_docs  \nAction Input: 'interferon gamma levels BCG vaccine immunocompromised patients'  ", "type": "AgentAction"}}, "interferon-gamma release in response to antigens present in M tuberculosis, but not bacille Calmette-Guerin (BCG) vaccine (Levison, 2010). he CDC (2005b, 2010b) recommends either skin testing or IGRA testing of gravidas who are in any of the high-risk groups. For those who have received BCG\n\nposing problems of interpretation for patients who have received BCG vaccine. Assays to measure the elaboration of IFN-\u03b3 in response to the relatively tuberculosis-specific proteins ESAT6 and CFP10 form the basis for IFN-\u03b3-release assays (IGRAs). These assays can be performed with whole blood or on\n\neffects on interferon gamma production. J. Exp. Med. 2001, 194:343\u2013354."]]},"45": {"question": "A 67-year-old man presents to the surgical clinic with swelling of his right leg, fever, and chills for 2 days. The maximum recorded temperature was 38.3\u00b0C (101.0\u00b0F) at home. His right leg is red and swollen from the dorsum of the foot to the thigh with an ill-defined edge. Venous stasis ulcers are present in both of his limbs, but those on the right have a yellow discharge. His vitals include the following: blood pressure is 120/78 mm Hg, heart rate is 94/min, temperature is 38.3\u00b0C (101.0\u00b0F), and respiratory rate is 16/min. On physical examination, there is tenderness and warmth compared with his normal leg. Dorsalis pedis pulses are present on both of the ankles. What is the most likely cause of the right shift of the hemoglobin dissociation curve for his condition?", "options": {"A": "Decrease in 2,3-DPG", "B": "Increase in temperature", "C": "Decrease in temperature", "D": "Increase in CO production"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "right shift hemoglobin dissociation curve causes\"\n", "log": "To determine the most likely cause of the right shift of the hemoglobin dissociation curve in this patient's condition, I need to consider the physiological factors that can lead to such a shift. A right shift typically indicates that hemoglobin has a decreased affinity for oxygen, which can occur due to increased temperature, increased levels of 2,3-DPG, or increased CO2 levels. Given the patient\u2019s fever (indicating increased temperature), it is likely that this is contributing to the right shift.\n\nAction: search_docs\nAction Input: \"right shift hemoglobin dissociation curve causes\"\n", "type": "AgentAction"}}, "Physiological Factors That Shift the Oxyhemoglobin Dissociation Curve\n\nThe oxyhemoglobin dissociation curve can shift in numerous clinical conditions, either to the right or to the left (\n\nFig.\n\n24.5 ). The curve is shifted to the right when the affinity of\n\noxygen dissociation portion representing the tissue-capillary environment. Shifts of the curve have their greatest efect at the steep portion because they afect oxygen delivery. A rightward shit is associated with decreased hemoglobin ainity for oxygen and hence increased tissue-capillary oxygen :0\n\nOxygen-dissociation curve shift: Hemoglobin from which 2,3-BPG has been removed has high oxygen affinity. However, as seen in the RBC, the presence of 2,3-BPG significantly reduces the oxygen affinity of hemoglobin, shifting the oxygen-dissociation curve to the right (Fig. 3.12). This reduced"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "hemoglobin dissociation curve right shift causes temperature 2,3-DPG CO\"\n", "log": "The observation indicates that a rightward shift of the oxyhemoglobin dissociation curve is associated with decreased hemoglobin affinity for oxygen, which can be influenced by several factors. The mention of temperature suggests that an increase in temperature can indeed contribute to this shift. Given that the patient has a fever, this aligns with the physiological response expected in such a scenario.\n\nAction: search_docs\nAction Input: \"hemoglobin dissociation curve right shift causes temperature 2,3-DPG CO\"\n", "type": "AgentAction"}}, "Oxygen-dissociation curve shift: Hemoglobin from which 2,3-BPG has been removed has high oxygen affinity. However, as seen in the RBC, the presence of 2,3-BPG significantly reduces the oxygen affinity of hemoglobin, shifting the oxygen-dissociation curve to the right (Fig. 3.12). This reduced\n\nFigure 58-1 Hemoglobin-oxygen dissociation curves. The position of the adult curve depends on the binding of adult hemoglobin to 2,3-diphosphoglycerate (DPG), temperature, PCO2, and hydrogen ion concentration (pH).\n\nPhysiological Factors That Shift the Oxyhemoglobin Dissociation Curve\n\nThe oxyhemoglobin dissociation curve can shift in numerous clinical conditions, either to the right or to the left (\n\nFig.\n\n24.5 ). The curve is shifted to the right when the affinity of"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "right shift hemoglobin dissociation curve increase temperature\"\n", "log": "The information retrieved reinforces the understanding that a rightward shift in the hemoglobin dissociation curve can occur due to several factors, including increased temperature. The patient\u2019s fever indicates an elevated temperature, which is likely contributing to the right shift, leading to decreased hemoglobin affinity for oxygen. \n\nGiven the options, the most relevant factor that correlates with the patient's condition and the physiological response observed is the increase in temperature.\n\nAction: search_docs\nAction Input: \"right shift hemoglobin dissociation curve increase temperature\"\n", "type": "AgentAction"}}, "Physiological Factors That Shift the Oxyhemoglobin Dissociation Curve\n\nThe oxyhemoglobin dissociation curve can shift in numerous clinical conditions, either to the right or to the left (\n\nFig.\n\n24.5 ). The curve is shifted to the right when the affinity of\n\nthe cold-induced shift of the oxyhemoglobin dissociation curve to the left (see\n\naddition to the increase in temperature in the contracting muscle, shifts the oxyhemoglobin dissociation curve to the right (see ). Therefore, at any given PO2, less O2 is held by the hemoglobin in the red blood cells, and consequently more O2 is available for the tissues. Oxygen consumption may"]]},"46": {"question": "A 75-year-old Caucasian man presents to the emergency department with abdominal pain. The patient states he was at home eating dinner when he began to experience severe abdominal pain. The patient has a past medical history of diabetes, hypertension, and atherosclerosis. He lives at home alone, smokes cigarettes, and drinks 1 to 2 alcoholic drinks per day. The patient is given IV morphine and an ultrasound is obtained demonstrating a dilated abdominal aorta. The patient states that his father died of a similar finding and is concerned about his prognosis. Which of the following is the greatest risk factor for this patient's presentation?", "options": {"A": "Atherosclerosis", "B": "Caucasian race", "C": "Cigarette smoking", "D": "Family history"}, "output": "C", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(query: 'greatest risk factor abdominal aortic aneurysm')", "tool_input": "'greatest risk factor abdominal aortic aneurysm'", "log": "To determine the greatest risk factor for the patient's presentation of a dilated abdominal aorta, I need to consider the options provided in relation to abdominal aortic aneurysm (AAA) risk factors. \n\n- Atherosclerosis is a significant risk factor for cardiovascular diseases, including AAA.\n- Caucasian race is known to have a higher prevalence of AAA compared to other races.\n- Cigarette smoking is a well-established risk factor for the development of AAA.\n- Family history can indicate a genetic predisposition to AAA.\n\nGiven that the patient has multiple risk factors, I need to evaluate which one is the most influential in this context.\n\nAction: search_docs(query: 'greatest risk factor abdominal aortic aneurysm')  \nAction Input: 'greatest risk factor abdominal aortic aneurysm'  ", "type": "AgentAction"}}, "search_docs(query: 'greatest risk factor abdominal aortic aneurysm') is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(query: 'risk factors for abdominal aortic aneurysm')", "tool_input": "'risk factors for abdominal aortic aneurysm'", "log": "To determine the greatest risk factor for this patient's presentation of a dilated abdominal aorta, I need to evaluate the options in the context of known risk factors for abdominal aortic aneurysm (AAA). \n\n- Atherosclerosis contributes to the risk of AAA due to its role in vascular disease.\n- Caucasian race is associated with a higher prevalence of AAA.\n- Cigarette smoking is a strong risk factor for AAA development.\n- Family history indicates a genetic predisposition, which can increase risk.\n\nGiven these considerations, I should search for more detailed information on the relative importance of these risk factors.\n\nAction: search_docs(query: 'risk factors for abdominal aortic aneurysm')  \nAction Input: 'risk factors for abdominal aortic aneurysm'  ", "type": "AgentAction"}}, "search_docs(query: 'risk factors for abdominal aortic aneurysm') is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs(query: 'risk factors for abdominal aortic aneurysm')", "tool_input": "'risk factors for abdominal aortic aneurysm'", "log": "To determine the greatest risk factor for the patient's presentation of a dilated abdominal aorta, I will analyze the options in relation to known risk factors for abdominal aortic aneurysm (AAA). \n\n- Atherosclerosis contributes to the risk of AAA due to its role in vascular disease.\n- Caucasian race is associated with a higher prevalence of AAA.\n- Cigarette smoking is a strong risk factor for AAA development.\n- Family history indicates a genetic predisposition, which can increase risk.\n\nGiven these considerations, I should search for more detailed information on the relative importance of these risk factors.\n\nAction: search_docs(query: 'risk factors for abdominal aortic aneurysm')  \nAction Input: 'risk factors for abdominal aortic aneurysm'  ", "type": "AgentAction"}}, "search_docs(query: 'risk factors for abdominal aortic aneurysm') is not a valid tool, try one of [search_docs]."]]},"47": {"question": "A 32-year-old woman presents to her primary care doctor complaining of increased fatigue and cold intolerance after her recent delivery. The patient delivered a healthy 39-week-old boy 3 weeks ago via spontaneous vaginal delivery. Delivery was complicated by postpartum hemorrhage requiring admission to the intensive care unit with blood transfusions. Pregnancy was otherwise uneventful, and the baby is healthy. The mother has had some difficulty with lactation, but is able to supplement her breast milk with formula feeds. On exam, her temperature is 97.7\u00b0F (36.5\u00b0C), blood pressure is 112/78 mmHg, pulse is 62/min, and respirations are 12/min. The patient does not have any neck masses or lymphadenopathy; however, her skin appears dry and rough. Which of the following serum lab abnormalities may be expected?", "options": {"A": "Decreased prolactin", "B": "Decreased thyroid releasing hormone", "C": "Increased follicle stimulating hormone", "D": "Increased luteinizing hormone"}, "output": "Agent stopped due to iteration limit or time limit.", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for relevant information regarding postpartum thyroiditis and its associated lab findings.", "tool_input": "search_docs(\"postpartum thyroiditis lab findings\") \n", "log": "Given the patient's symptoms of increased fatigue, cold intolerance, and physical exam findings of dry and rough skin, there is a strong suspicion of hypothyroidism, particularly postpartum thyroiditis. This condition can occur after delivery and may result in a variety of hormonal changes. \n\nThe options provided include various hormones, and I need to determine which one is likely to be increased or decreased in this scenario. \n\nAction: I will search for relevant information regarding postpartum thyroiditis and its associated lab findings.\n\nAction Input: search_docs(\"postpartum thyroiditis lab findings\") \n", "type": "AgentAction"}}, "I will search for relevant information regarding postpartum thyroiditis and its associated lab findings. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "search_docs(\"postpartum thyroiditis lab findings\") \n", "log": "I will search for relevant information regarding postpartum thyroiditis and its associated lab findings.\n\nAction: search_docs  \nAction Input: search_docs(\"postpartum thyroiditis lab findings\") \n", "type": "AgentAction"}}, "In clinical practice, postpartum thyroiditis is diagnosed infre quently because it typically develops months after delivery and causes vague and nonspeciic symptoms (Stagnaro-Green, 2004). he clinical presentation varies, and classically two clinical phases that may develop in succession are\n\n424.\n\nLucas A, Pizarro E, Granada ML, et al. Postpartum thyroiditis: long-term follow-up. Thyroid 2005;15:1177\u20131181.\n\n425.\n\nLazarus JH, Ammari F, Oretti R, et al. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997;47:305\u2013308.\n\n426.\n\nlymphocytic infiltration and in\ufb02ammation are found and anti-TPO antibodies are often present (419,420). The following are criteria for the diagnosis of postpartum thyroiditis: (i) no history of thyroid hormonal abnormalities either before or during pregnancy, (ii) documented abnormal TSH level"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "I will search for specific lab findings associated with postpartum thyroiditis to clarify which hormone is expected to be decreased or increased.", "tool_input": "search_docs(\"postpartum thyroiditis serum lab abnormalities\") \n", "log": "The information retrieved indicates that postpartum thyroiditis can lead to abnormal thyroid-stimulating hormone (TSH) levels, often presenting with symptoms such as fatigue and cold intolerance. The condition can also be associated with increased levels of thyroid antibodies and may affect other hormones. \n\nGiven the patient's symptoms and clinical context, it is important to identify which of the listed hormones would likely be abnormal. \n\nAction: I will search for specific lab findings associated with postpartum thyroiditis to clarify which hormone is expected to be decreased or increased.\n\nAction Input: search_docs(\"postpartum thyroiditis serum lab abnormalities\") \n", "type": "AgentAction"}}, "I will search for specific lab findings associated with postpartum thyroiditis to clarify which hormone is expected to be decreased or increased. is not a valid tool, try one of [search_docs]."], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "search_docs(\"postpartum thyroiditis serum lab abnormalities\") \n", "log": "I will search for specific lab findings associated with postpartum thyroiditis to clarify which hormone is expected to be decreased or increased.\n\nAction: search_docs  \nAction Input: search_docs(\"postpartum thyroiditis serum lab abnormalities\") \n", "type": "AgentAction"}}, "In clinical practice, postpartum thyroiditis is diagnosed infre quently because it typically develops months after delivery and causes vague and nonspeciic symptoms (Stagnaro-Green, 2004). he clinical presentation varies, and classically two clinical phases that may develop in succession are\n\n424.\n\nLucas A, Pizarro E, Granada ML, et al. Postpartum thyroiditis: long-term follow-up. Thyroid 2005;15:1177\u20131181.\n\n425.\n\nLazarus JH, Ammari F, Oretti R, et al. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997;47:305\u2013308.\n\n426.\n\ndocumented abnormal TSH level (either depressed or elevated) during the first year postpartum, and (iii) absence of a positive TSH-receptor antibody titer (Graves disease) or a toxic nodule. A number of studies describe clinical and biochemical evidence of postpartum thyroid dysfunction in 5% to"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "search_docs(\"hormonal changes postpartum thyroiditis\") \n", "log": "The information retrieved indicates that postpartum thyroiditis can lead to abnormal thyroid-stimulating hormone (TSH) levels, which may be either depressed or elevated. Given the patient's symptoms of fatigue and cold intolerance, it is likely that she is experiencing hypothyroidism as a result of postpartum thyroiditis, which would typically be associated with increased TSH levels and potentially decreased levels of thyroid hormones.\n\nNow, I need to analyze the options provided in the context of the expected lab findings:\n\n- **A: Decreased prolactin** - Prolactin levels may not be directly affected by thyroid function.\n- **B: Decreased thyroid releasing hormone** - This is not typically expected in hypothyroidism.\n- **C: Increased follicle stimulating hormone** - This may not be directly related to thyroid function.\n- **D: Increased luteinizing hormone** - Similar to FSH, this is not directly related to thyroid function.\n\nGiven that hypothyroidism is characterized by increased TSH and potentially decreased thyroid hormones, it appears that none of the options directly reflect what I expect, but I need to choose the most relevant one based on the context of hormonal changes due to postpartum thyroiditis.\n\nI will search for more specific information on the hormonal changes in postpartum thyroiditis. \n\nAction: search_docs  \nAction Input: search_docs(\"hormonal changes postpartum thyroiditis\") \n", "type": "AgentAction"}}, "Postpartum thyroiditis usually begins with a transient hyperthyroid phase between 6 weeks and 6 months postpartum followed by a hypothyroid phase. Only one-fourth of the cases follow this classic clinical picture, and more than one-third have either hyperthyroidism or hypothyroidism alone.\n\n424.\n\nLucas A, Pizarro E, Granada ML, et al. Postpartum thyroiditis: long-term follow-up. Thyroid 2005;15:1177\u20131181.\n\n425.\n\nLazarus JH, Ammari F, Oretti R, et al. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract 1997;47:305\u2013308.\n\n426.\n\nIn clinical practice, postpartum thyroiditis is diagnosed infre quently because it typically develops months after delivery and causes vague and nonspeciic symptoms (Stagnaro-Green, 2004). he clinical presentation varies, and classically two clinical phases that may develop in succession are"]]},"48": {"question": "A 2-day-old male newborn is brought to the physician because he became somnolent and felt cold after breastfeeding. Pregnancy and delivery were uncomplicated. He was born at 40 weeks' gestation and weighed 3538 g (7 lb 13 oz); he currently weighs 3311 g (7 lb 5 oz). Examination shows generalized hypotonia. Serum studies show an ammonia concentration of 150 \u03bcmol/L (N < 50 \u03bcmol/L). Which of the following is the most likely cause of the patient's neurological symptoms?", "options": {"A": "Increased succinyl-CoA concentration", "B": "Increased glutamate concentration", "C": "Decreased acylcarnitine concentration", "D": "Decreased \u03b3-aminobutyric acid concentration"}, "output": "B", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "newborn neurological symptoms elevated ammonia levels causes\" \n", "log": "I need to analyze the clinical presentation of the newborn, including the symptoms of somnolence, coldness, hypotonia, and elevated ammonia levels. These findings suggest a metabolic disorder, possibly related to amino acid or urea cycle metabolism. I will search for relevant information regarding the causes of neurological symptoms associated with elevated ammonia levels in newborns.\n\nAction: search_docs\nAction Input: \"newborn neurological symptoms elevated ammonia levels causes\" \n", "type": "AgentAction"}}, "Infants with genetic defects in urea synthesis, transient neonatal hyperammonemia, and impaired synthesis of urea and glutamine secondary to genetic disorders of organic acid metabolism can have levels of blood ammonia (>1000 \u03bcmol/L) more than 10 times normal in the neonatal period. Poor feeding,\n\nCorrect answer = B. Deficiencies of the enzymes of the urea cycle result in the failure to synthesize urea and lead to hyperammonemia in the first few weeks after birth. Glutamine will also be elevated because it acts as a nontoxic storage and transport form of ammonia. Therefore, elevated\n\nlevels can be >1,000 \u00b5mol/l. Such hyperammonemia is a medical emergency, because ammonia has a direct neurotoxic effect on the CNS. For example, elevated concentrations of ammonia in the blood cause the symptoms of ammonia intoxication, which include tremors, slurring of speech, somnolence"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "hyperammonemia neurological symptoms glutamate concentration newborn\"\n", "log": "The information gathered indicates that the elevated ammonia levels in the newborn are likely due to a deficiency in the urea cycle enzymes, which leads to hyperammonemia and subsequent neurological symptoms. The most relevant cause among the options provided is related to increased glutamate concentration, as glutamate is involved in the metabolism of ammonia and its elevation is associated with hyperammonemia. \n\nAction: search_docs\nAction Input: \"hyperammonemia neurological symptoms glutamate concentration newborn\"\n", "type": "AgentAction"}}, "Moderate neonatal hyperammonemia (range, 200 to 400 \u03bcmol/L) is associated with depression of the central nervous system, poor feeding, and vomiting. Seizures are not characteristic. Respiratory alkalosis may occur. This type of hyperammonemia may be caused by partial or more distal blocks in urea\n\nhas been attributed to the accumulation of glutamate secondary to a suppression of glutamate synthetase. These changes have been reproduced in animals by the injection of ammonium chloride. When the hyperammonemia is abrupt in onset and severe, the resulting combination of encephalopathy, brain\n\nIn all the neonatal hyperammonemic diseases, the liver is often enlarged and liver cells appear to be inadequate in their metabolic functions, but how the enzymatic deficiencies or other disorders of amino acid metabolism affect the brain remains uncertain. It must be assumed that in some the"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "newborn hyperammonemia increased glutamate neurological symptoms\"  \n", "log": "The gathered information reinforces the connection between elevated ammonia levels and neurological symptoms in newborns. Specifically, the elevation of glutamate is linked to hyperammonemia, which can lead to central nervous system depression and other neurological issues. Given the options provided, the most logical choice that aligns with the pathophysiology described is the increased glutamate concentration.\n\nAction: search_docs  \nAction Input: \"newborn hyperammonemia increased glutamate neurological symptoms\"  \n", "type": "AgentAction"}}, "Moderate neonatal hyperammonemia (range, 200 to 400 \u03bcmol/L) is associated with depression of the central nervous system, poor feeding, and vomiting. Seizures are not characteristic. Respiratory alkalosis may occur. This type of hyperammonemia may be caused by partial or more distal blocks in urea\n\nIn all the neonatal hyperammonemic diseases, the liver is often enlarged and liver cells appear to be inadequate in their metabolic functions, but how the enzymatic deficiencies or other disorders of amino acid metabolism affect the brain remains uncertain. It must be assumed that in some the\n\nhas been attributed to the accumulation of glutamate secondary to a suppression of glutamate synthetase. These changes have been reproduced in animals by the injection of ammonium chloride. When the hyperammonemia is abrupt in onset and severe, the resulting combination of encephalopathy, brain"]]},"49": {"question": "A 48-year-old woman presents to the emergency room because of severe back pain after a fall. She says that she was walking home from work when she slipped on a patch of ice on the sidewalk. Since she did not have anything to hold onto, she fell backwards and landed on her posterior iliac crests bilaterally. Immediately after the fall, she started experiencing back pain and tenderness that concerned her enough to call for an ambulance. Her past medical history is significant for arthritis, diabetes, and hypertension. On arrival, her temperature is 99\u00b0F (37.2\u00b0C), blood pressure is 129/86 mmHg, pulse is 112/min, respirations are 19/min. Physical exam reveals tenderness to palpation over the middle of her lower back. A drug that may have predisposed this patient to this outcome most likely has which of the following mechanisms?", "options": {"A": "Inhibition of leukotriene and prostaglandin production", "B": "Inhibition of circulating cytokine", "C": "Inhibition of folate processing", "D": "Inhibition of prostaglandin production alone"}, "output": "D", "intermediate_steps": [[{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "mechanism of action of drugs that predispose to back pain\" \n", "log": "To answer the question, I need to determine the mechanism of action of a drug that could predispose this patient to back pain after a fall. Given her medical history of arthritis, it is plausible that she may be on a nonsteroidal anti-inflammatory drug (NSAID) or another medication that affects inflammation or pain perception. \n\nThe options provided suggest different mechanisms related to inflammation and pain management. Specifically, options A and D mention inhibition of prostaglandin production, which is a common mechanism for NSAIDs. \n\nI will conduct a search to find relevant information regarding the mechanisms of drugs that may predispose patients to back pain, particularly focusing on those that involve prostaglandin inhibition.\n\nAction: search_docs \nAction Input: \"mechanism of action of drugs that predispose to back pain\" \n", "type": "AgentAction"}}, "Other Mechanisms of Drug Antagonism\n\nMechanism of Action\n\nMechanism of Action"], [{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "agent", "AgentAction"], "kwargs": {"tool": "search_docs", "tool_input": "NSAIDs mechanism of action and back pain\" \n", "log": "The search did not yield relevant information regarding the specific mechanisms of drugs that could predispose a patient to back pain, especially in the context of her medical history and the fall. I need to refine my search to focus more specifically on the mechanisms of NSAIDs or drugs commonly associated with back pain. \n\nAction: search_docs \nAction Input: \"NSAIDs mechanism of action and back pain\" \n", "type": "AgentAction"}}, "relief of back pain at 24\u201348 h after a full dose of NSAID.\u2002iFirst-or second-degree relatives with ankylosing spondylitis (AS), psoriasis, uveitis, reactive arthritis (ReA), or inflammatory bowel disease (IBD).\u2002jAfter exclusion of other causes of elevated CRP.\n\nMUSCULOSKELETAL, SKIN, AND CONNECTIVE TISSUE `\u2009phaRmaCology SECTION III 486 mEChanism NSAID that irreversibly inhibits cyclooxygenase (both COX-1 and COX-2) by covalent acetylation \u008e\u0090\u00a0synthesis of TXA2 and prostaglandins. \u008f\u00a0bleeding time. No effect on PT, PTT. Effect lasts until new platelets are\n\nNSAIDs were formerly viewed as the core of all other RA therapy, but they are now considered to be adjunctive therapy for management of symptoms uncontrolled by other measures. NSAIDs exhibit both analgesic and anti-inflammatory properties. The anti-inflammatory effects of NSAIDs derive from their"]]},"placeholder": "placeholder"}]